
<html lang="en"     class="pb-page"  data-request-id="c6ee698a-5121-4248-b42e-b9d4a7ede72c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-6;wgroup:string:ACHS website Group;article:article:10.1021/jm101527u;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors" /></meta><meta name="dc.Creator" content="Jesús R.  Medina" /></meta><meta name="dc.Creator" content="Christopher J.  Becker" /></meta><meta name="dc.Creator" content="Charles W.  Blackledge" /></meta><meta name="dc.Creator" content="Celine  Duquenne" /></meta><meta name="dc.Creator" content="Yanhong  Feng" /></meta><meta name="dc.Creator" content="Seth W.  Grant" /></meta><meta name="dc.Creator" content="Dirk  Heerding" /></meta><meta name="dc.Creator" content="William H.  Li" /></meta><meta name="dc.Creator" content="William H.  Miller" /></meta><meta name="dc.Creator" content="Stuart P.  Romeril" /></meta><meta name="dc.Creator" content="Daryl  Scherzer" /></meta><meta name="dc.Creator" content="Arthur  Shu" /></meta><meta name="dc.Creator" content="Mark A.  Bobko" /></meta><meta name="dc.Creator" content="Antony R.  Chadderton" /></meta><meta name="dc.Creator" content="Melissa  Dumble" /></meta><meta name="dc.Creator" content="Christine M.  Gardiner" /></meta><meta name="dc.Creator" content="Seth  Gilbert" /></meta><meta name="dc.Creator" content="Qi  Liu" /></meta><meta name="dc.Creator" content="Sridhar K.  Rabindran" /></meta><meta name="dc.Creator" content="Valery  Sudakin" /></meta><meta name="dc.Creator" content="Hong  Xiang" /></meta><meta name="dc.Creator" content="Pat G.  Brady" /></meta><meta name="dc.Creator" content="Nino  Campobasso" /></meta><meta name="dc.Creator" content="Paris  Ward" /></meta><meta name="dc.Creator" content="Jeffrey M.  Axten" /></meta><meta name="dc.Description" content="Phosphoinositide-dependent protein kinase-1(PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As this pathway is among the most common..." /></meta><meta name="Description" content="Phosphoinositide-dependent protein kinase-1(PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As this pathway is among the most common..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 22, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101527u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101527u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101527u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101527u" /></link>
        
    
    

<title>Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101527u" /></meta><meta property="og:title" content="Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0004.jpeg" /></meta><meta property="og:description" content="Phosphoinositide-dependent protein kinase-1(PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As this pathway is among the most commonly deregulated across all cancers, a selective inhibitor of PDK1 might have utility as an anticancer agent. Herein we describe our lead optimization of compound 1 toward highly potent and selective PDK1 inhibitors via a structure-based design strategy. The most potent and selective inhibitors demonstrated submicromolar activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines. In addition, reduction of phosphorylation of PDK1 substrates was demonstrated in vivo in mice bearing OCl-AML2 xenografts. These observations demonstrate the utility of these molecules as tools to further delineate the biology of PDK1 and the potential pharmacological uses of a PDK1 inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101527u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101527u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101527u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101527u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101527u&amp;href=/doi/10.1021/jm101527u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1871-1895</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm101513q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101541x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors<a class="ref internalNav" href="#ac1" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jes%C3%BAs+R.++Medina">Jesús R. Medina</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Becker">Christopher J. Becker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+W.++Blackledge">Charles W. Blackledge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celine++Duquenne">Celine Duquenne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanhong++Feng">Yanhong Feng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seth+W.++Grant">Seth W. Grant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Heerding">Dirk Heerding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+H.++Li">William H. Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+H.++Miller">William H. Miller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart+P.++Romeril">Stuart P. Romeril</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daryl++Scherzer">Daryl Scherzer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur++Shu">Arthur Shu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++Bobko">Mark A. Bobko</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antony+R.++Chadderton">Antony R. Chadderton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Dumble">Melissa Dumble</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+M.++Gardiner">Christine M. Gardiner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seth++Gilbert">Seth Gilbert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Liu">Qi Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sridhar+K.++Rabindran">Sridhar K. Rabindran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valery++Sudakin">Valery Sudakin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Xiang">Hong Xiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pat+G.++Brady">Pat G. Brady</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nino++Campobasso">Nino Campobasso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paris++Ward">Paris Ward</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+M.++Axten">Jeffrey M. Axten</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>‡</sup>Oncology Research and <sup>§</sup>Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 610-917-5889. Fax: 610-917-4206. E-mail: <a href="/cdn-cgi/l/email-protection#e48e81979197ca96ca8981808d8a85a483978fca878b89"><span class="__cf_email__" data-cfemail="95fff0e6e0e6bbe7bbf8f0f1fcfbf4d5f2e6febbf6faf8">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101527u&amp;href=/doi/10.1021%2Fjm101527u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1871–1895</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 22, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 November 2010</li><li><span class="item_label"><b>Published</b> online</span>22 February 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 March 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101527u" title="DOI URL">https://doi.org/10.1021/jm101527u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1871%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJes%25C3%25BAs%2BR.%2BMedina%252C%2BChristopher%2BJ.%2BBecker%252C%2BCharles%2BW.%2BBlackledge%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D6%26contentID%3Djm101527u%26title%3DStructure-Based%2BDesign%2Bof%2BPotent%2Band%2BSelective%2B3-Phosphoinositide-Dependent%2BKinase-1%2B%2528PDK1%2529%2BInhibitors%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1895%26publicationDate%3DMarch%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101527u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5016</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101527u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jesús&quot;,&quot;last_name&quot;:&quot;R. Medina&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Becker&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;W. Blackledge&quot;},{&quot;first_name&quot;:&quot;Celine&quot;,&quot;last_name&quot;:&quot;Duquenne&quot;},{&quot;first_name&quot;:&quot;Yanhong&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Seth&quot;,&quot;last_name&quot;:&quot;W. Grant&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Heerding&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;H. Li&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;H. Miller&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;P. Romeril&quot;},{&quot;first_name&quot;:&quot;Daryl&quot;,&quot;last_name&quot;:&quot;Scherzer&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;Shu&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. Bobko&quot;},{&quot;first_name&quot;:&quot;Antony&quot;,&quot;last_name&quot;:&quot;R. Chadderton&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Dumble&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;M. Gardiner&quot;},{&quot;first_name&quot;:&quot;Seth&quot;,&quot;last_name&quot;:&quot;Gilbert&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Sridhar&quot;,&quot;last_name&quot;:&quot;K. Rabindran&quot;},{&quot;first_name&quot;:&quot;Valery&quot;,&quot;last_name&quot;:&quot;Sudakin&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Xiang&quot;},{&quot;first_name&quot;:&quot;Pat&quot;,&quot;last_name&quot;:&quot;G. Brady&quot;},{&quot;first_name&quot;:&quot;Nino&quot;,&quot;last_name&quot;:&quot;Campobasso&quot;},{&quot;first_name&quot;:&quot;Paris&quot;,&quot;last_name&quot;:&quot;Ward&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;M. Axten&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;1871-1895&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101527u&quot;},&quot;abstract&quot;:&quot;Phosphoinositide-dependent protein kinase-1(PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As this pathway is among the most commonly deregulated across all cancers, a selective inhibitor of PDK1 might have utility as an anticancer agent. Herein we describe our lead optimization of compound 1 toward highly potent and selective PDK1 inhibitors via a structure-based design strategy. The most potent and selective inhibitors demonstrated submicromolar activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines. In addition, reduction of phosphorylation of PDK1 substrates was demonstrated in vivo in mice bearing OCl-AML2 xenografts. These observations demonstrate the utility of these molecules as tools to further delineate the biology of PDK1 and the potential pharmacological uses of a PDK1 inhibitor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101527u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101527u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101527u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101527u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101527u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101527u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101527u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101527u&amp;href=/doi/10.1021/jm101527u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101527u" /></input><a href="/doi/pdf/10.1021/jm101527u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101527u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101527u%26sid%3Dliteratum%253Aachs%26pmid%3D21341675%26genre%3Darticle%26aulast%3DMedina%26date%3D2011%26atitle%3DStructure-Based%2BDesign%2Bof%2BPotent%2Band%2BSelective%2B3-Phosphoinositide-Dependent%2BKinase-1%2B%2528PDK1%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D6%26spage%3D1871%26epage%3D1895%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292288" title="X-rays">X-rays</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291870" title="Piperidines">Piperidines</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jmcmar.2011.54.issue-6/production/jmcmar.2011.54.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0004.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Phosphoinositide-dependent protein kinase-1(PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As this pathway is among the most commonly deregulated across all cancers, a selective inhibitor of PDK1 might have utility as an anticancer agent. Herein we describe our lead optimization of compound <b>1</b> toward highly potent and selective PDK1 inhibitors via a structure-based design strategy. The most potent and selective inhibitors demonstrated submicromolar activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines. In addition, reduction of phosphorylation of PDK1 substrates was demonstrated in vivo in mice bearing OCl-AML2 xenografts. These observations demonstrate the utility of these molecules as tools to further delineate the biology of PDK1 and the potential pharmacological uses of a PDK1 inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> </h4><p class="last">PDB codes: <b>12f</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCQ">3QCQ</a>; <b>12k</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCS">3QCS</a>; (<i><b>R</b></i>)-<b>18a</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCX">3QCX</a>; (<i><b>S</b></i>)-<b>21a</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCY">3QCY</a>; (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>28a</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD0">3QD0</a>; (<b>3</b><i><b>R</b></i>,<b>6</b><i><b>S</b></i>)-<b>37c</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD3">3QD3</a>; <b>43a</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD4">3QD4</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphoinositide-dependent protein kinase-1 (PDK1), a master regulator of the AGC kinase signal transduction, phosphorylates and activates at least 23 related AGC protein kinases that are often constitutively activated in human cancers and enable tumorigenesis.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> PDK1 is a direct downstream effector of PI3K that positively regulates the AKT pathway,<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> resulting in inhibition of apoptosis, promotion of cell division, and stimulation of glucose uptake and storage. Activation of PI3K, mediated by the interaction of insulin and growth factors with their receptors, results in the production of phosphatidylinositol 3,4,-diphosphate (PIP2) and phosphatidylinositol 3,4,5-triphosphate (PIP3), which colocalize AKT and PDK1 to the plasma membrane through interaction with their pleckstrin homology (PH) domains, allowing PDK1 to phosphorylate the activation loop of AKT at Thr 308 and hence initiate the activation of AKT in a PI3K-dependent manner.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Furthermore, PDK1 is an activator of additional kinases involved in tumor progression such as protein kinase C (PKC), serum-and glucocorticoid-induced protein kinase (SGK), p70 ribosomal S6 kinase (S6K1), and p90 ribosomal S6 kinase (RSK).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> These kinases lack a PH domain and are therefore not dependent on colocalization with PDK1 at the plasma membrane. For these kinases, phophorylation at the hydrophobic motif by distinct upstream kinases enables PDK1 to recognize and interact with these enzymes through its PIF-pocket, a small phosphate binding groove located in the PDK1 catalytic domain. This interaction facilitates the T-loop phosphorylation of these substrates, activating them in a PI3K-independent manner.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Because PDK1 is involved in several distinct signaling pathways that are important for tumor progression, inhibitors of PDK1 might be beneficial for the treatment of cancer.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8-11)</a> As such, several classes of small-molecule PDK1 inhibitors have been reported.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Herein, we report our structure-based optimization of compound <b>1</b>, a lead generated from screening an in-house fragment library against PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analogues substituted at the 2-position of the pyrimidine ring were synthesized according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Suzuki coupling of 4-chloro-2-aminopyrimidine <b>2</b> with boronic acid <b>3</b> provided intermediate <b>4</b>, which was acetylated and then methylated to give <b>5</b>. Reaction with hydrazine monohydrate in ethanol at 95 °C both removed the acetyl group and formed the indazole ring to afford <b>8a</b>. Compounds <b>8b</b> and <b>8c</b> were prepared from intermediate <b>7</b>, which was synthesized by the bis-pinacolato diboron coupling of <b>6</b>, followed by Suzuki coupling with 2,4-dichloropyrimidine. Treatment of intermediate <b>7</b> with dimethylamine or ethylamine followed by removal of the acetyl group with acidic methanol afforded <b>8b</b> and <b>8c</b>, respectively. Compound <b>8d</b> was prepared by direct treatment of intermediate <b>7</b> with acidic methanol.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds of General Structure <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 95 °C; (b) (i) Ac<sub>2</sub>O, 80 °C, (ii) CH<sub>3</sub>I, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (c) (i) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, 100 °C, (ii) 2,4-dichloropyrimidine, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 100 °C; (d) for <b>8b</b> and <b>8c</b>, (i) amine, THF, 100 °C, (ii) HCl, CH<sub>3</sub>OH, 60 °C; for <b>8d</b>, HCl, CH<sub>3</sub>OH, 50 °C; (e) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, 95 °C.</p></p></figure><div class="NLM_p">Two general synthetic routes were employed to obtain a series of 6-substituted pyrimidine analogues <b>12</b> as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Route 1 involved the preparation of fluoronitrile intermediate <b>10</b> prior to the final cyclization, leading to the desired indazole analogues <b>12</b>. 6-Substituted aminopyrimidine compounds <b>9</b> were either commercially available or prepared by reaction of dichloropyrimidine <b>9a</b> with the corresponding nucleophile. Suzuki coupling of <b>9</b> with boronic acid <b>3</b> or the corresponding pinacol ester followed by hydrazine cyclization afforded compounds <b>12b</b>, <b>12e</b>−<b>j</b>, and <b>12l</b>−<b>m</b>. Compound <b>12c</b> was prepared by sequential Suzuki coupling of dichloropyrimidine <b>9a</b> with boronic acid <b>3</b> and then phenyl boronic acid, followed by hydrazine cyclization. Alternatively (route 2), intermediates <b>9k</b>−<b>m</b> were coupled with indazole boronic ester <b>11</b> under Suzuki conditions followed by acetyl group deprotection to provide the corresponding indazole analogues <b>12a</b>, <b>12d</b>, and <b>12k</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine, (EtOH, CH<sub>3</sub>OH or THF), 50−100 °C; (b) <b>3</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 90−100 °C; (c) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, 80−100 °C; (d) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, 100 °C; (e) (i) (<b>9k</b>, <b>9l</b>, or <b>9m</b>), PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 100 °C, (ii) HCl, CH<sub>3</sub>OH, 60 °C; (f) (i) <b>3</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 95 °C, (ii) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 95 °C.</p></p></figure><div class="NLM_p">Representative α-alkyl substituted cyclic amines were prepared as described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The α-methylmorpholine amine individual enantiomers <b>17a</b> were prepared from the corresponding optically pure 2-amino-1-propanols by reductive amination with benzaldehyde followed by cyclization with chloroacetyl chloride to provide the enantiomerically pure morpholinone intermediates <b>14</b>. Reduction with Red-Al provided the benzyl protected morpholines <b>15</b>, which upon debenzylation under hydrogenolysis conditions afforded the desired α-methylmorpholines <b>17a</b>. The α-ethyl and α-isopropyl morpholine amines ((<i><b>R</b></i>)-<b>17b</b> and (<i><b>R</b></i>)-<b>17c</b>, respectively) were prepared by direct cyclization of the corresponding aminoalcohol with chloroacetyl chloride to provide morpholinones <b>16a</b> and <b>16b</b>, respectively, followed by reduction with LiAlH<sub>4</sub>. These amines were then used to prepare analogues <b>18a</b>−<b>c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) following the synthetic routes described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0032.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of α-Alkyl Substituted Cyclic Amines <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) benzaldehyde, toluene, reflux, (ii) NaBH<sub>4</sub>, EtOH, 0 °C; (b) (i) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, 0 °C, (ii) NaOH<sub>(aq)</sub> (pH > 13), rt; (c) Red-Al, toluene, 0−60 °C; (d) H<sub>2</sub>, Pd/C, HCl, CH<sub>3</sub>OH, rt; (e) (i) NaH, toluene, 0 °C, (ii) chloroacetyl chloride, toluene, 90−110 °C; (f) LiAlH<sub>4</sub>, THF, 70 °C.</p></p></figure><div class="NLM_p">Compounds <b>21</b> were synthesized from their corresponding amines <b>20</b> following either synthetic routes 1 or 2 described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Amines <b>20</b> were readily prepared from the Boc protected 3-piperidine or 2-morpholineamine carboxylic acids <b>19</b> by coupling with the corresponding amines followed by Boc deprotection (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0031.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds of General Structure <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine, EDC, HOBt, <i>N</i>-methylmorpholine, rt; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">Several synthetic routes were used to prepare bis-substituted analogues of general structure <b>28</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Hydrogenation of methyl 6-methylnicotinate using PtO<sub>2</sub> as catalyst,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> followed by Cbz protection of the resulting secondary amine, afforded a 3/1 ratio of <i>cis</i>- and <i>trans</i>-2,5-bis-substituted piperidine isomers <b>22</b>, which were separated by flash chromatography. Chiral preparative HPLC separation afforded individual optically pure cis isomers (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>22</b> and (<b>3</b><i><b>R</b></i>,<b>6</b><i><b>S</b></i>)-<b>22</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound <b>23</b> was obtained after removal of the Cbz protecting group of (±)-<i>cis</i>-<b>22</b> and crystallization of the resulting secondary amine as the <span class="smallcaps smallerCapital">l</span>-(+)-tartrate salt. Hydrolysis of esters (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>22</b>, (<b>3</b><i><b>R</b></i>,<b>6</b><i><b>S</b></i>)-<b>22</b>, and (±)-<i>trans</i>-<b>22</b>, and subsequent coupling of the resulting acid with aniline followed by Cbz deprotection, provided the corresponding amines <b>24</b>. Compounds <b>28a</b> were prepared from amines <b>24</b> following synthetic route 1 described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Analogues (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>28b</b> and (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>28d</b> were prepared from <b>23</b>. Saponification of <b>23</b>, followed by reaction of the resulting piperidine acid derivative with <b>27</b>, gave <b>25</b>. Reaction of compound <b>25</b> with the corresponding amines provided the amides, which were converted to compounds (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>28b</b> and (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>28d</b> following the synthetic routes described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Compound (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>28c</b> was prepared from intermediate <b>26</b>, which was prepared from simultaneous ester hydrolysis and Cbz deprotection of (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>22</b> under acidic conditions, followed by reaction of the resulting piperidine acid derivative with pyrimidine <b>9a</b> and in situ Suzuki cross-coupling with boronic acid <b>3</b>. Reaction of intermediate <b>26</b> with cyclohexylamine, followed by cyclization with hydrazine, provided compound (<b>3</b><i><b>S</b></i>,<b>6</b><i><b>R</b></i>)-<b>28c</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0030.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Bis-substituted Piperidine Analogues <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) HCl, PtO<sub>2</sub>, CH<sub>3</sub>OH, (ii) CbzCl, DMAP, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 15−25 °C; (b) (i) 10% Pd/C, H<sub>2</sub> (65 psi), EtOAc, EtOH, rt, (ii) crystallization as the tartrate salt (<span class="smallcaps smallerCapital">l</span>-(+)-tartaric acid, IPA, water); (c) (i) LiOH·H<sub>2</sub>O, THF, water, CH<sub>3</sub>OH, rt, (ii) aniline, EDC, HOBt, Hünig’s base, DMF, rt, (iii) 10% Pd/C, H<sub>2</sub>, EtOAc, EtOH, rt; (d) (i) LiOH·H<sub>2</sub>O, water, rt, (ii) <b>27</b>, NaHCO<sub>3</sub>, 1,4-dioxane, 100 °C; (e) (i) amine, HATU, Hünig’s base, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, (ii) route 1 or 2; (f) (i) 1,4-dioxane, conc HCl, 100 °C, (ii) <b>9a</b>, NaHCO<sub>3</sub>, 1,4-dioxane, water, 120 °C, (iii) <b>3</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, 1,4-dioxane, water, 120 °C; (g) (i) cyclohexylamine, HATU, Hünig’s base, DMF, rt, (ii) H<sub>2</sub>NNH<sub>2</sub>, EtOH, 110 °C.</p></p></figure><div class="NLM_p">The syntheses of the morpholine analogues <b>34</b> are illustrated in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Bis-substituted morpholines <b>29</b> were prepared according to the reported protocol for similar compounds.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Removal of the benzyl protecting group in <b>29a</b>, followed by reaction with dichloroaminopyrimidines <b>9a</b> and <b>27</b>, afforded intermediates <b>30a</b> and <b>30b</b>, respectively. Suzuki coupling of <b>30</b> with boronic acid <b>3</b>, followed by oxidation<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> of the primary alcohol to the carboxylic acid, provided intermediates <b>31</b>. Reaction of intermediates <b>31</b> with an amine, followed by hydrazine cyclization, furnished the desired analogues <b>34a</b> and <b>34c</b>. Alternatively, replacement of the benzyl protecting group in <b>29b</b> with Boc, followed by oxidation of the primary alcohol, provided carboxylic acid <b>32</b>. Compound <b>32</b> was then converted to the amines <b>33</b> by reaction with the corresponding amine followed by deprotection of the Boc group. Final compounds <b>34b</b> and <b>34d</b> were synthesized from amines <b>33</b> by following synthetic route 1 described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0029.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Bis-substituted Morpholine Analogues <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) (<i>R</i>)-(−)-epichlorohydrin, LiClO<sub>4</sub>, toluene, or 1,2-dichloroethane, rt, (ii) NaOCH<sub>3</sub> in CH<sub>3</sub>OH or NaOEt in EtOH, rt; (b) (i) HCl, EtOH, H<sub>2</sub>, 10% Pd/C (Degussa type), rt, (ii) for <b>30a</b> (<b>9a</b>, Hünig’s base, CH<sub>3</sub>CN, 160 °C (MW)), for <b>30b</b> (<b>27</b>, K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux); (c) (i) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH, rt, (ii) Boc<sub>2</sub>O, Hünig’s base, THF, 40 °C, (iii) TEMPO, iodobenzene diacetate, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C−rt; (d) (i) <b>3</b>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), Pd(PPh<sub>3</sub>)<sub>4</sub>, 100 °C, (ii) for <b>31a</b> (H<sub>5</sub>IO<sub>6</sub>/CrO<sub>3</sub>, wet CH<sub>3</sub>CN, 0−15 °C), for <b>31b</b> (TEMPO, iodobenzene diacetate, CH<sub>2</sub>Cl<sub>2</sub>, water, 0 °C−rt); (e) (i) EDC, HOAt, amine, CH<sub>2</sub>Cl<sub>2</sub>, rt, (ii) HCl, dioxane, rt; (f) (i) aniline, EDC, HOBT, DMF, rt, (ii) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, 100 °C; (g) (i) cyclohexylamine, HATU, Hünig’s base, DMF, rt, (ii) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, 1,4-dioxane, 100 °C.</p></p></figure><div class="NLM_p">Compounds <b>37b</b> and <b>37c</b> were prepared from amines <b>36</b> and <b>35</b>, respectively, following the general procedures (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). While amine <b>36</b> was commercially available, amine <b>35</b> was prepared from compound <b>22</b> by ester hydrolysis, followed by Curtius rearrangement and subsequent Cbz deprotection. Compound (±)-<b>37a</b> was synthesized from (±)-<b>37b</b>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0028.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) LiOH·H<sub>2</sub>O, THF, water, CH<sub>3</sub>OH, rt, (ii) DPPA, <i>t</i>-butyl alcohol, Et<sub>3</sub>N, 100 °C, (iii) Pd/C, H<sub>2</sub>(50 psi), EtOAc, rt; (b) (i) conc HCl, 0 °C−rt, (ii) benzoyl chloride, NaHCO<sub>3</sub>, THF, water, 0 °C−rt, (iii) HCl, CH<sub>3</sub>OH, 65 °C.</p></p></figure><div class="NLM_p">A series of enantiomerically pure 5-methyl-3-aminopiperidine compounds of general structure <b>43</b> was prepared according to Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>. Boc protection of dimethyl <span class="smallcaps smallerCapital">d</span>-glutamate, followed by stereoselective α-methylation, provided compound <b>38</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Reduction of the esters, followed by mesylation of the resulting diol <b>39</b> and subsequent treatment with neat benzylamine at 70 °C, provided piperidine <b>40a</b> with the desired regio- and stereochemistry. Methylation of the BocNH functionality on <b>40a</b> provided compound <b>40b</b>. Debenzylation of compounds <b>40</b> afforded amines <b>41</b>, which were converted to compounds <b>43a</b>−<b>b</b> by following the general synthetic route 1. Additionally, <b>41b</b> was converted to <b>42</b> by reaction with <b>9a</b>, Boc deprotection, and amide formation, which was then elaborated to <b>43c</b>.</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0027.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Analogues <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>3</sub>OH, rt; (b) (i) LiHMDS, THF, −78 °C, (ii) CH<sub>3</sub>I, −78 °C; (c) CaCl<sub>2</sub>, NaBH<sub>4</sub>, EtOH:THF (1:1), 0 °C; (d) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (e) benzylamine, 70 °C; (f) (i) NaH, DMF, rt, (ii) CH<sub>3</sub>I, rt; (g) Pd/C (Degussa type), H<sub>2</sub>, EtOH, rt; (h) (i) <b>9a</b>, Et<sub>3</sub>N, EtOH, 100 °C, (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, (iii) 3,3-dimethylbutanoyl chloride, Hünig’s base, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An X-ray crystal structure of compound <b>1</b> bound to PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a) shows key hydrogen bonding interactions between the aminoindazole and Ser160 and Ala162 in the hinge region. Preliminary SAR at the 3-position of the indazole ring confirmed the importance of the amino group as a hydrogen bond donor for optimum binding (data not shown). In addition, the aminopyrimidine ring is engaged in a tight hydrogen bond network with the protein, with the pyrimidine ring nitrogens acting as acceptors for the catalytic Lys111 and Thr222 at the floor of the binding pocket. The amino group of the pyrimidine is a hydrogen bond donor to the catalytic residue Glu130. In agreement with the X-ray structural information, we previously demonstrated by SAR the importance that each nitrogen functionality of the aminopyrimidine contributes to PDK1 binding and inhibition of kinase activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Further inspection of the X-ray crystal structure revealed a small lipophilic pocket in the region occupied by the exocyclic amino group of the pyrimidine ring and defined by amino acid residues Met134, Val143, and Leu159. To further understand the SAR in this region, we varied substituents at the 2-position of the pyrimidine ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Consistent with the X-ray crystal structure, replacement of one NH<sub>2</sub> hydrogen with CH<sub>3</sub> (<b>8a</b>) was tolerated, causing only a minor reduction (0.4 log units) in enzyme potency relative to <b>1</b>, but increasing the size of the alkyl group to ethyl (<b>8c</b>) resulted in a significant reduction in potency. In addition, substituting both hydrogens with CH<sub>3</sub> (<b>8b</b>) or replacing the pyrimidine NH<sub>2</sub> with a methoxy group (<b>8d</b>) resulted in a significant reduction in potency, confirming the importance of a hydrogen bond donor at this position for favorable contact with Glu 130. This excellent agreement between the X-ray structural information and preliminary SAR provided a basis for further structure-based optimization of PDK1 activity.</div><figure id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0026.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of compound <b>1</b> bound to PDK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUN">3NUN</a>). (a) Hydrogen bond distances in Å. (b) Surface of G-loop illustrating small hydrophobic pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of the Hydrogen Bond Substitution at the Pyrimidine 2-Position</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0025.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">PDK1 pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">LE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr></tbody></table></div></div><div class="NLM_p">Further examination of the crystal structure suggested that substitution at the pyrimidine 6-position could fill the lipophilic pocket under the G-loop (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b). Substitution with either alkyl, aryl, alkoxy, thiolate, alkylamine, or arylamine was tolerated and, in many instances, improved PDK1 potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Additionally, many of these substituents conferred good-to-excellent selectivity over other kinases such as Aurora A, Aurora B, ALK5, and ROCK1. These kinases were chosen as representative specificity targets based on profiling of <b>1</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compound <b>12a</b>, with a 6-methyl group, exhibited a 0.5 log increase in potency and maintained ligand efficiency (LE)<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> relative to compound <b>1</b>. Increasing the size of the alkyl substituent to <i>i</i>-Pr (<b>12b</b>) retained potency relative to <b>12a</b> with a concomitant decrease in LE. The methoxy compound <b>12d</b> showed similar potency to <b>12b</b>, whereas methylamine substitution (<b>12e</b>) increased potency and LE. Interestingly, although dimethylamine substitution (<b>12j</b>) did not result in an increase in potency relative to <b>1</b>, it significantly increased selectivity over other kinases such as ALK5, Aurora A, Aurora B, and ROCK1. These observations proved to be quite general, with monosubstituted amines providing a higher level of potency and LE (<b>12e</b>−<b>i</b>) and tertiary amines (<b>12j</b>−<b>m</b>) conferring a higher level of kinase selectivity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selected SAR of 6-Substituted Pyrimidines</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0024.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0023.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div></div><div class="NLM_p">The X-ray crystal structure of <b>12k</b> bound to PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a) showed that the morpholine group was easily accommodated by PDK1 and situated under the G-loop. Interestingly, the crystal structure of the 6-ethylamino derivative <b>12f</b> with PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b) revealed that the ethyl group is oriented toward the G-loop and is accommodated by a small lipophilic pocket. An overlay of <b>12f</b> and <b>12k</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c) suggested that an axial alkyl group α to the amine on a cyclic amine could also fill this pocket. This substitution had potential to provide the higher potency observed for monoalkylamines as well as the high degree of kinase selectivity associated with tertiary amine substitution. We surmised that the axial conformation would be preferred based on allylic strain principles.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0022.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structures and overlay of compounds <b>12k</b> and <b>12f</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As predicted from the X-ray crystal structure overlay of <b>12f</b> and <b>12k</b>, methyl substitution at the α-position of the morpholine ring ((<i><b>R</b></i>)-<b>18a</b>) increased enzyme potency (∼0.5 log units) and LE relative to unsubstituted morpholine <b>12k</b> and also maintained an excellent level of kinase selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The α-methyl substituted piperidine analogue <b>18d</b> exhibited similar potency to (<i><b>R</b></i>)-<b>18a</b>. The predicted binding mode was confirmed by a crystal structure of (<i><b>R</b></i>)-<b>18a</b> bound to PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Consistent with the structural data, the enantiomer (<i><b>S</b></i>)-<b>18a</b> was less active than the unsubstituted morpholine derivative <b>12k</b>. Additionally, while ethyl substitution at the α-position of the morpholine ring increased enzyme potency (<b>18b</b>) relative to <b>12k</b>, increasing the size further to isopropyl (<b>18c</b>) had only a marginal effect.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Results of α-Alkyl Substituted Cyclic Amines</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0021.gif" alt="" id="fx4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0020.gif" alt="" id="fx5" /></img></td></tr></tbody></table></div></div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0019.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of compound (<i><b>R</b></i>)-<b>18a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further examination of the X-ray crystal structure of <b>12k</b> bound to PDK1 suggested that additional favorable interactions with another lipophilic pocket along the G-loop could be accessed through carboxamide substitution at the β-position of either a morpholine or piperidine ring (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a). Both optically pure <i>N</i>-phenylcarboxamide substituted morpholine (<i><b>S</b></i>)-<b>21a</b> and piperidine (<i><b>S</b></i>)-<b>21b</b> analogues showed a significant increase in potency (∼10-fold) relative to their unsubstituted counterparts <b>12k</b> and <b>12m</b>, with good kinase selectivity for PDK1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The binding mode was confirmed by a crystal structure of (<i><b>S</b></i>)-<b>21a</b> bound to PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b), wherein interactions extending beyond the morpholine ring under the G-loop are observed. The carboxamide offers good contacts for H-bonding with a water molecule and serves as a linker for the phenyl ring to extend into the lipophilic pocket. Consistent with the binding mode, the corresponding enantiomers (<i><b>R</b></i>)-<b>21a</b> and (<i><b>R</b></i>)-<b>21b</b> were less potent. Cyclohexylcarboxamide substituted compound (<i><b>S</b></i>)-<b>21c</b> exhibited comparable potency to (<i><b>S</b></i>)-<b>21b</b>. Cyclopentylcarboxamide (<b><i>S</i></b>)-<b>21d</b> showed a slight reduction in potency, while compounds containing smaller alkylcarboxamide substituents were significantly less active (data not shown).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Carboxamide Substitution on Morpholine and Piperidine Analogues</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0017.gif" alt="" id="fx6" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0016.gif" alt="" id="fx7" /></img></td></tr></tbody></table></div></div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0018.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structures of compounds <b>12k</b> and (<i><b>S</b></i>)-<b>21a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Examination of the X-ray crystal structures of (<i><b>R</b></i>)-<b>18a</b> and (<i><b>S</b></i>)-<b>21a</b> revealed that the morpholine ring adopts the same conformation with either the β-carboxamide or the α-alkyl substituent. Therefore, we hypothesized that incorporating both groups on a cis-disubstituted six-membered ring scaffold would be beneficial. This requires that the carboxamide occupies an equatorial position while the alkyl substituent occupies an axial position, filling the lipophilic G-loop pockets. Indeed, the combination of substituted carboxamides with alkyl substituents provided an additive effect (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). For instance, the bis-substituted piperidine (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> and morpholine <b>34a</b> analogues showed an approximately 100-fold increase in potency relative to the corresponding unsubstituted amines <b>12m</b> and <b>12k</b>, respectively. The X-ray crystal structure of (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> with PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) confirmed the expected binding mode, where the α-methyl substituent occupies a small pocket under the G-loop and the phenyl carboxamide substituent extends beyond the piperidine ring under the G-loop. Consistent with this binding mode, the corresponding enantiomer (<b>3</b><i><b>R</b></i>,<b>6<i>S</i></b>)-<b>28a</b> and its racemic trans-stereoisomer (±)-<i>trans</i>-<b>28a</b> showed >100-fold lower potency.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of Bis-substituted Morpholine and Piperidine Analogues</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0015.gif" alt="" id="fx8" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0014.gif" alt="" id="fx9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray crystal structure of compound (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having achieved high enzyme potency and selectivity, we evaluated several compounds in a mechanistic cellular assay in PC-3 cells to determine the effect of inhibiting PDK1 on PI3-kinase dependent and independent pathways. PDK1-mediated phosphorylation of Thr<sup>308</sup>-AKT (PI3K-dependent) and Ser<sup>221</sup>-RSK (PI3K-independent) were evaluated as well as the PDK1-independent phosphorylation state of Ser<sup>473</sup>-AKT. Consistent with potent and selective inhibition of PDK1, compounds (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> and <b>34a</b> exhibited submicromolar inhibition of the phosphorylation of both Thr<sup>308</sup>-AKT and Ser<sup>221</sup>-RSK and did not affect the phosphorylation of Ser<sup>473</sup>-AKT (IC<sub>50</sub> > 29300 nM). Interestingly, methyl substitution on the pyrimidine 2-amino group provided compounds with increased cellular potency and kinase selectivity ((<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28b</b> vs (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> and (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> (GSK2334470)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> vs (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28c</b>). A similar trend was observed for <b>34b</b>−<b>d</b>.</div><div class="NLM_p">As part of our optimization process, we also investigated functionalities at the β-position to the nitrogen of the six-membered ring other than carboxamide. The activities of selected representatives are depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. The reverse amide (±)-<b>37a</b> and the carbamate (±)-<b>37b</b> exhibited similar potency to phenylcarboxamide (<i><b>S</b></i>)-<b>21b</b>. Although the expected increase in potency when adding the α-methyl group was observed ((±)-<i>cis</i>-<b>37c</b>), it was not as pronounced as in the carboxamide series. Surprisingly, an X-ray crystal structure of (±)-<i>cis</i>-<b>37c</b> with PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) revealed that the opposite antipode occupied the active site (compared to the carboxamide series). To accommodate this stereoisomer, the piperidine adopted the alternate chair conformation, which places the methyl group away from the pocket in the G-loop. Consistent with the X-ray results, (<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>37c</b> exhibited approximately 100-fold higher potency relative to its enantiomer (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>37c</b>, although it showed only a modest increase in potency (∼0.5 log units) relative to its corresponding nonmethylated analogue (<i><b>R</b></i>)-<b>37b</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selected SAR Data for Aminopiperidine Derivatives of General Structure <b>37</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0012.gif" alt="" id="fx10" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0011.gif" alt="" id="fx11" /></img></td></tr></tbody></table></div></div><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0010.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystal structure of compound (<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>37c</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analysis of the X-ray crystal structure of (<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>37c</b> in PDK1 suggested that moving the methyl group to the β-position of the piperidine ring with a trans relationship to the carbamate functionality could potentially fill the lipophilic pocket under the G-loop. Thus a series of piperidine compounds of general structure <b>43</b> was investigated (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Indeed, compound <b>43a</b> exhibited high potency in the PDK1 enzyme assay as well as excellent potency in the mechanistic cellular assays. The binding mode was confirmed by an X-ray crystal structure of <b>43a</b> bound to PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The β-methyl substituent points toward the lipophilic pocket under the G-loop, and a hydrogen bond network involving the carbamate carbonyl group and both the catalytic lysine 111 and serine 94 is observed. The <i>N</i>-Me carbamate <b>43b</b> exhibited higher potency in the PDK1 enzyme assay (∼10-fold), and the cellular mechanistic assay (∼5-fold), relative to the NH carbamate <b>43a</b>. In addition, replacement of the oxygen atom in carbamate <b>43b</b> with carbon afforded amide <b>43c</b>, which also exhibited a similar potency profile in the PDK1 enzyme and mechanistic assays.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. SAR of 3-Methyl-5-aminopiperidine Analogues of General Structure <b>43</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0009.gif" alt="" id="fx12" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0008.gif" alt="" id="fx13" /></img></td></tr></tbody></table></div></div><figure id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0007.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray crystal structure of carbamate <b>43a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Selected compounds with potent mechanistic cellular activity were tested for antiproliferative activity against a panel of leukemia cell lines. We found that AML cell lines were more sensitive to PDK1 inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>), which is consistent with published data in which overexpression of PDK1 was found to be a common feature of acute myeloid leukemia (45% of patients), promoting monocyte colony formation and translocation of PKC.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, we found that AML cell lines were not uniformly inhibited and only a subset of AML cell lines was sensitive to growth inhibition by our PDK1 inhibitors (data not shown).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Antiproliferative Activity of Selected PDK1 Inhibitors against a Panel of AML Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">cell IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">K562 <br /></br>(chronic myelogenous leukemia)</th><th class="colsep0 rowsep0" align="center" char=".">OCI-AML2 <br /></br>(acute myeloid leukemia)</th><th class="colsep0 rowsep0" align="center" char=".">OCI-AML3 <br /></br>(acute myeloid leukemia)</th><th class="colsep0 rowsep0" align="center" char=".">HEL 92.1.7 <br /></br>(erythroleukemia)</th><th class="colsep0 rowsep0" align="center" char=".">F-36P <br /></br>(acute myeloid leukemia)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28b</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b></td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34c</b></td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34d</b></td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td><td class="colsep0 rowsep0" align="char" char=".">0.76</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43a</b></td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43b</b></td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td></tr></tbody></table></div></div><div class="NLM_p">Compound (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> was further evaluated through an in vitro kinase selectivity panel of 285 protein and lipid kinases.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Only 24 kinases were inhibited >50% in the presence of 10 μM (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). IC<sub>50</sub> values available from our internal kinase panel for a subset of kinases including members from the AGC family are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>. (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> exhibited >1000-fold selectivity against each of these kinases compared to potency against PDK1.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Kinase Selectivity Data for (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> Screened at 10 μM<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">%RA</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">%RA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SGK2(h)</td><td class="colsep0 rowsep0" align="char" char=".">−2</td><td class="colsep0 rowsep0" align="left">Rsk2(h)</td><td class="colsep0 rowsep0" align="char" char=".">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDK1(h)</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">CHK2(h)</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PrKX(h)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">PKCζ(h)</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Rsk4(h)</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left">BrSK1(h)</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SGK(h)</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left">Rsk1(r)</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Rsk3(h)</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left">NLK(h)</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ARK5(h)</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left">Met(D1246H)(h)</td><td class="colsep0 rowsep0" align="char" char=".">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ROCK-II(r)</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left">BrSK2(h)</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ZIPK(h)</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="left">Aurora-B(h)</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKBγ(h)</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="left">Ret(h)</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DRAK1(h)</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">Rsk1(h)</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ROCK-II(h)</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="left">Met(Y1248H)(h)</td><td class="colsep0 rowsep0" align="char" char=".">49</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">h = human; r = rat; RA = remaining activity.</p></div></div></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Inhibitory Activity of (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> against Other Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDK1</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT1</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK5</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ASK1</td><td class="colsep0 rowsep0" align="char" char=".">>27542</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora A</td><td class="colsep0 rowsep0" align="char" char=".">39810</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora B</td><td class="colsep0 rowsep0" align="char" char=".">3162</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3b</td><td class="colsep0 rowsep0" align="char" char=".">>25118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKK1</td><td class="colsep0 rowsep0" align="char" char=".">>25118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kγ</td><td class="colsep0 rowsep0" align="char" char=".">25118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ROCK1</td><td class="colsep0 rowsep0" align="char" char=".">7943</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SYK</td><td class="colsep0 rowsep0" align="char" char=".">>25118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR2</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div></div><div class="NLM_p">The ability of (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> to inhibit PDK1 signaling in vivo was evaluated using SCID mice bearing OCI-AML2 xenografts. At its MTD dose (100 mg/kg, ip, single dose), which afforded high exposure (AUC = 31362 ng·h/mL; <i>C</i><sub>max</sub> = 4510 ng/mL), (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> exhibited 58% and 29% reduction of AKT<sup>T308</sup> phosphorylation at 3 and 6 h, respectively, and 57% and 71% reduction of RSK<sup>S221</sup> phosphorylation at 3 and 6 h, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Consistent with the in vitro findings, we observed no inhibition of AKT<sup>S473</sup> phosphorylation.</div><figure id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0006.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> on the pharmacodynamic markers in OCL-AML2 xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The optimization of compound <b>1</b> into highly potent and selective PDK1 inhibitors was accomplished via a structure-based design strategy targeting specific binding opportunities presented by the PDK1 G-loop to increase potency and selectivity. Interestingly, the majority of kinase inhibitors do not exploit the potential interactions presented by the G-loop, probably due to its typical high flexibility, which could pose a challenge for achieving high ligand binding affinity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> However, X-ray crystallography revealed distinct pockets in the PDK1 G-loop, which enabled optimization of the morpholine and piperidine derivatives through proper introduction of small alkyl groups on the six-membered ring. The most potent and selective inhibitors demonstrated submicromolar mechanistic cellular activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines. Experiments with compound (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> did confirm the ability of a PDK1 inhibitor to modulate downstream signaling in vivo. However, preliminary results from an efficacy study (SCID mice bearing OCI-AML2 tumors) indicated that compound (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> only modestly inhibits tumor growth inhibition in vivo (data not shown). Taken together, these results advise that further biology studies will be necessary to determine the utility of a PDK1 inhibitor in the treatment of cancer either as a single agent or in combination therapies. The discovery of potent and highly selective PDK1 inhibitors, exemplified by (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b>, permits further delineation of PDK1 mediated signal transduction and potential pharmacological uses of a PDK1 inhibitor.<a onclick="showRef(event, 'ref23 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref28">(23, 28)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Methods</h4><div class="NLM_p last">Unless otherwise noted, commercially available materials were used without further purification. Air- or moisture-sensitive reactions were carried out under a nitrogen or argon atmosphere. Anhydrous solvents were obtained from Sigma-Adrich. Flash chromatography was performed using silica gel under standard techniques or using silica gel cartridges on an Analogix instrument. NMR spectra were recorded on a Bruker 400 MHz spectrometer. Chemical shifts (δ) are quoted in parts per million (ppm) relative to an internal solvent referance. Coupling constants (<i>J</i>) are recorded in hertz. LC-MS data were collected from a Sciex or Agilent instrument. Reverse phase HPLC purifications were conducted on a Gilson HPLC (monitoring at 215 and 254 nm) with a C18 column eluting with an acetonitrile/water gradient with 0.1% TFA in each solvent unless otherwise noted. Analytical HPLC data were generated by injecting 5 μL of very dilute sample solution in the appropriate solvent to a reverse phase HPLC system run over 4 min (5−95% acetonitrile/water with 0.1% TFA in each solvent). The products were detected by UV (254, 214, and 333 nm). All tested compounds were determined to be ≥95% purity by LC-MS and analytical HPLC unless otherwise noted.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(2-Amino-4-pyrimidinyl)-2-fluorobenzonitrile (<b>4</b>)</h4><div class="NLM_p last">In a 25 mL sealed tube under argon were combined 4-chloro-2-pyrimidinamine (100 mg, 0.772 mmol) and (4-cyano-3-fluorophenyl)boronic acid (127 mg, 0.772 mmol) in 1,4-dioxane (5 mL) and saturated aqueous NaHCO<sub>3</sub> (1.25 mL). This mixture was degassed for 10 min with argon. Pd(PPh<sub>3</sub>)<sub>4</sub> (50 mg, 0.04 mmol) was then added, and the reaction sealed and heated at 95 °C in an oil bath. After 3 h, the reaction was allowed to cool to room temperature and then poured onto water (50 mL) and EtOAc (50 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), filtered through a pad of Celite503, and concentrated to dryness. The resulting light-yellow solid was dissolved in CHCl<sub>3</sub> and purified by flash chromatography on SiO<sub>2</sub> (eluent: 90/10/1 CHCl<sub>3</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH) to afford the title compound (138 mg, 83%). LC-MS (ES) <i>m</i>/<i>z</i> = 215 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.88 (s, 2H), 7.29 (d, <i>J</i> = 5.1 Hz, 1H), 8.04−8.22 (m, 3H), 8.43 (d, <i>J</i> = 5.1 Hz, 1H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-[4-(4-Cyano-3-fluorophenyl)-2-pyrimidinyl]-<i>N</i>-methylacetamide (<b>5</b>)</h4><div class="NLM_p">To 4-(2-amino-4-pyrimidinyl)-2-fluorobenzonitrile (230 mg, 1.07 mmol) was added acetic anhydride (10 mL), and the reaction mixture was stirred overnight at 80 °C. LCMS analysis showed a ∼2:1 mixture of mono- and diacetate products. The solvent was partially removed under vacuum. Ethanol was added, and the solvents were evaporated. This process was repeated 2 more times until most of the acetic anhydride and acetic acid was removed. Methanol was added, and an insoluble white solid was observed which was immediately filtered to afford <i>N</i>-[4-(4-cyano-3-fluorophenyl)-2-pyrimidinyl]acetamide (145 mg, 53%) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 279 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.26 (s, 3H), 7.90 (d, <i>J</i> = 5.3 Hz, 1H), 8.12−8.19 (m, 1H), 8.22−8.28 (m, 1H), 8.28−8.34 (m, 1H), 8.83 (d, <i>J</i> = 5.1 Hz, 1H), 10.72 (s, 1H).</div><div class="NLM_p last">To <i>N</i>-[4-(4-cyano-3-fluorophenyl)-2-pyrimidinyl]acetamide (140 mg, 0.546 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (196 mg, 0.60 mmol) in DMF (5 mL) was added iodomethane (0.038 mL, 0.60 mmol), and the reaction mixture was stirred for 3 h at room temperature. Water was added (ca. 20 mL), and a white precipitate was formed. The mixture was filtered, and the solid was washed with more water. The solid was dissolved in EtOAc, and the solution was dried (MgSO<sub>4</sub>), filtered, and concentrated to afford the title compound (135 mg, 91%) as an off-white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 293 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.45 (s, 3H), 3.44 (s, 3H), 8.02 (d, <i>J</i> = 5.3 Hz, 1H), 8.15 (dd, <i>J</i> = 8.1, 6.8 Hz, 1H), 8.26 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 8.33 (dd, <i>J</i> = 10.7, 1.4 Hz, 1H), 8.95 (d, <i>J</i> = 5.3 Hz, 1H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-[2-(Methylamino)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>8a</b>)</h4><div class="NLM_p last">To <i>N</i>-[4-(4-cyano-3-fluorophenyl)-2-pyrimidinyl]-<i>N</i>-methylacetamide (135 mg, 0.500 mmol) in ethanol (8 mL) was added hydrazine monohydrate (2 mL, 41 mmol), and the reaction mixture was stirred overnight at 95 °C. The solution was poured onto water. A precipitate started to form. The mixture was filtered, and the solid was washed with water followed by Et<sub>2</sub>O. The residual solvent was removed under vacuum to afford the title compound (85 mg, 71%) as a light-yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 241 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.89 (d, 3H), 5.43 (s, 2H), 7.05−7.14 (m, 1H), 7.16 (d, <i>J</i> = 5.3 Hz, 1H), 7.62 (d, <i>J</i> = 8.1 Hz, 1H), 7.77 (d, <i>J</i> = 8.3 Hz, 1H), 8.02 (br s, 1H), 8.34 (d, <i>J</i> = 4.8 Hz, 1H), 11.61 (s, 1H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-Acetyl-<i>N</i>-(1-acetyl-6-bromo-1<i>H</i>-indazol-3-yl)acetamide (<b>6</b>)</h4><div class="NLM_p last">In a 100 mL flask under argon were combined 6-bromo-1<i>H</i>-indazol-3-amine (2.47 g, 11.7 mmol), acetic anhydride (22 mL, 233 mmol), and DMAP (0.071 g, 0.58 mmol), and the resulting mixture was heated at 120 °C for 5 h. The reaction was allowed to cool to room temperature, stirred overnight, and then concentrated to dryness. The resulting residue was dry loaded onto SiO<sub>2</sub> using acetone and purified by flash chromatography on SiO<sub>2</sub> using EtOAc/Hex as the eluent to afford the title compound (2.84 g, 68%) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 360, 362 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.31 (s, 6H), 2.70 (s, 3H), 7.67 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 7.83 (d, <i>J</i> = 8.3 Hz, 1H), 8.53 (d, <i>J</i> = 1.5 Hz, 1H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-[6-(2-Chloro-4-pyrimidinyl)-1<i>H</i>-indazol-3-yl]acetamide (<b>7</b>)</h4><div class="NLM_p last">To a mixture of <i>N</i>-acetyl-<i>N</i>-(1-acetyl-6-bromo-1<i>H</i>-indazol-3-yl)acetamide (0.439 g, 1.299 mmol), <i>N</i>-(1-acetyl-6-bromo-1<i>H</i>-indazol-3-yl)acetamide (0.063 g, 0.211 mmol), bis(pinacolato)diboron (0.384 g, 1.51 mmol), and KOAc (0.445 g, 4.53 mmol) was added 1,4-dioxane (8 mL), and nitrogen gas was bubbled through the mixture for 10 min. PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub> (0.062 g, 0.076 mmol) was added, and the reaction mixture was stirred for 2 h at 100 °C in a sealed tube. The reaction mixture was cooled to room temperature and treated with 2,4-dichloropyrimidine (0.225 g, 1.510 mmol) and saturated aqueous NaHCO<sub>3</sub> (3 mL). Nitrogen gas was bubbled through the mixture for 10 min. PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub> (0.062 g, 0.076 mmol) was added, and the reaction mixture was stirred overnight at 100 °C in a sealed tube. The mixture was cooled to room temperature and poured into EtOAc and water and then filtered. The filtrate was poured into a separatory funnel, and the organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated. Flash chromatography on SiO<sub>2</sub> (gradient: CHCl<sub>3</sub> to 90:10:1 CHCl<sub>3</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH) afforded the title compound (84 mg, 19%) as a yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 288 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.13 (s, 3H), 7.85 (d, <i>J</i> = 8.8 Hz, 1H), 7.97 (d, <i>J</i> = 8.6 Hz, 1H), 8.25 (d, <i>J</i> = 5.3 Hz, 1H), 8.28−8.36 (m, 1H), 8.84 (d, <i>J</i> = 5.3 Hz, 1H), 10.51 (s, 1H), 13.00 (br. s., 1H).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-[2-(Dimethylamino)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>8b</b>)</h4><div class="NLM_p last">To <i>N</i>-[6-(2-chloro-4-pyrimidinyl)-1<i>H</i>-indazol-3-yl]acetamide (20 mg, 0.070 mmol) was added dimethylamine (2.0 M in THF, 4 mL, 8.00 mmol), and the reaction mixture was stirred overnight at 100 °C. The mixture was poured into EtOAc and water, and the organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated. To the resulting residue was added CH<sub>3</sub>OH (6 mL), followed by concentrated HCl (0.3 mL, 3.60 mmol), and the reaction mixture was stirred for 3 h at 60 °C. The solution was concentrated and evaporated from toluene twice. The resulting residue was triturated with Et<sub>2</sub>O to afford an HCl salt of the desired product (20 mg, 88%) as a yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 255 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 3.39−3.56 (m, 6H), 7.68 (d, <i>J</i> = 6.8 Hz, 1H), 8.15 (s, 2H), 8.41−8.47 (m, 2H).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6-[2-(Ethylamino)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>8c</b>)</h4><div class="NLM_p last">The title compound was prepared following synthetic procedures similar to the preparation of <b>8b</b>. LC-MS (ES) <i>m</i>/<i>z</i> = 255 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.40 (t, <i>J</i> = 7.2 Hz, 3H), 3.55−3.85 (m, 2H), 7.69 (d, <i>J</i> = 6.6 Hz, 1H), 8.09−8.23 (m, 2H), 8.43 (d, <i>J</i> = 6.6 Hz, 1H), 8.45 (s, 1H).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6-[2-(Methyloxy)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>8d</b>)</h4><div class="NLM_p last">To <i>N</i>-[6-(2-chloro-4-pyrimidinyl)-1<i>H</i>-indazol-3-yl]acetamide (8.5 mg, 0.030 mmol) in CH<sub>3</sub>OH (4 mL) was added concentrated HCl (0.2 mL, 2.400 mmol), and the reaction mixture was stirred overnight in a sealed tube at 50 °C. The solution was poured into saturated aqueous NaHCO<sub>3</sub> and EtOAc. The organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated to afford the crude desired product (6.5 mg) as a yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 242 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 4.13 (s, 3H), 7.65 (d, <i>J</i> = 5.3 Hz, 1H), 7.74−7.89 (m, 2H), 8.18 (s, 1H), 8.59 (d, <i>J</i> = 5.3 Hz, 1H).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-Chloro-<i>N</i><sup>4</sup>-ethyl-2,4-pyrimidinediamine (<b>9d</b>)</h4><div class="NLM_p last">In a 50 mL flask under argon were combined 4,6-dichloro-2-pyrimidinamine (0.50 g, 3.05 mmol) and ethylamine (2.0 M in CH<sub>3</sub>OH, 15.24 mL, 30.5 mmol), and the reaction mixture was stirred at 50 °C for 3 h. The mixture was cooled to room temperature and concentrated. The resulting yellow solid was dissolved in EtOAc, and the solution was washed with water. The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated to afford the title compound (368 mg, 69%) as a yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 173 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.08 (t, <i>J</i> = 7.2 Hz, 3H), 3.11−3.30 (m, 2H), 5.70 (s, 1H), 6.37 (bs, 2H), 7.08 (bs, 1H).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-[2-Amino-6-(ethylamino)-4-pyrimidinyl]-2-fluorobenzonitrile (<b>10d</b>)</h4><div class="NLM_p last">In a 25 mL sealable tube under nitrogen were added (4-cyano-3-fluorophenyl)boronic acid (0.29 g, 1.74 mmol) and 6-chloro-<i>N</i><sup>4</sup>-ethyl-2,4-pyrimidinediamine (0.30 g, 1.74 mmol), followed by 1,4-dioxane (11.1 mL) and a saturated aqueous solution of NaHCO<sub>3</sub> (2.8 mL). The mixture was degassed with nitrogen for 10 min. Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.10 g, 0.087 mmol) was added, the vial was sealed, and the reaction mixture was stirred for 16 h at 95 °C. The reaction was cooled to room temperature, filtered, and concentrated. The resulting residue was partitioned between EtOAc and water. The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting yellow oil was dissolved in CH<sub>3</sub>CN (5 mL w/5 drops TFA). DMSO (3 drops) and water (0.5 mL) were added, and the solution was purified by reverse-phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O w/0.1%TFA). The fractions containing the desired product were combined and concentrated until most of the CH<sub>3</sub>CN was removed (∼half the original volume). The resulting precipitate was filtered, washed with water, and dried under vacuum to afford a TFA salt of the title compound (164 mg) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 258 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.17 (t, <i>J</i> = 7.2 Hz, 3H), 3.37−3.50 (m, 2H), 6.38 (bs, 1H), 7.77 (bs, 1H), 7.94 (bs, 1H), 8.13−8.25 (m, 1H), 8.73 (bs, 1H).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 6-(3-Amino-1<i>H</i>-indazol-6-yl)-<i>N</i><sup>4</sup>-ethyl-2,4-pyrimidinediamine (<b>12f</b>)</h4><div class="NLM_p">To a 25 mL flask under argon was added 4-[2-amino-6-(ethylamino)-4-pyrimidinyl]-2-fluorobenzonitrile (0.164 g, 0.442 mmol), followed by EtOH (3.5 mL). Hydrazine monohydrate (0.87 mL, 17.7 mmol) was added, and the reaction mixture was stirred for 6 h at 80 °C. The reaction was cooled to room temperature and concentrated to near dryness. Water (3 mL) was added (orange oil was formed), followed by CH<sub>3</sub>CN (8 drops), and the mixture was sonicated. A light-yellow precipitate formed. The suspension was cooled on an ice bath and the solid was filtered, washed with water, and dried under vacuum at 40 °C to afford the title compound (82 mg, 68%) as a light-yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 270 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.13 (t, <i>J</i> = 7.2 Hz, 3H), 3.20−3.40 (m, 2H), 5.36 (s, 2H), 5.97 (s, 2H), 6.25 (s, 1H), 6.82 (bs, 1H), 7.41 (d, <i>J</i> = 8.3 Hz, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.84 (s, 1H), 11.50 (s, 1H).</div><div class="NLM_p last">Compounds <b>12b</b>, <b>12e</b>, <b>12g</b>−<b>j</b>, and <b>12l</b>−<b>m</b> were synthesized by following synthetic procedures similar to the preparation of <b>12f</b> (route 1).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 6-[2-Amino-6-(1-methylethyl)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>12b</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 269 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.24 (d, <i>J</i> = 6.8 Hz, 6H), 2.83 (m, 1H), 5.42 (s, 2H), 6.54 (s, 2H), 7.07 (s, 1H), 7.60 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.76 (d, <i>J</i> = 8.3 Hz, 1H), 7.99 (s, 1H), 11.59 (s, 1H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-(3-Amino-1<i>H</i>-indazol-6-yl)-<i>N</i><sup>4</sup>-methyl-2,4-pyrimidinediamine (<b>12e</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 256 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.81 (d, 3H), 5.37 (s, 2H), 6.00 (s, 2H), 6.25 (s, 1H), 6.80 (bs, 1H), 7.43 (d, <i>J</i> = 8.3 Hz, 1H), 7.69 (d, <i>J</i> = 8.6 Hz, 1H), 7.85 (s, 1H), 11.50 (s, 1H).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 6-(3-Amino-1<i>H</i>-indazol-6-yl)-<i>N</i><sup>4</sup>-(1-methylethyl)-2,4-pyrimidinediamine (<b>12g</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 284 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.15 (d, <i>J</i> = 6.6 Hz, 6H), 4.12 (bs, 1H), 5.36 (s, 2H), 5.94 (s, 2H), 6.24 (s, 1H), 6.71 (d, <i>J</i> = 7.6 Hz, 1H), 7.40 (d, <i>J</i> = 8.6 Hz, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.82 (s, 1H), 11.50 (bs, 1H).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 6-(3-Amino-1<i>H</i>-indazol-6-yl)-<i>N</i><sup>4</sup>-cyclopentyl-2,4-pyrimidinediamine (<b>12h</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 310 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.38−1.61 (m, 4H), 1.61−1.78 (m, 2H), 1.92 (m, 2H), 4.22 (bs, 1H), 5.37 (s, 2H), 5.97 (bs, 2H), 6.26 (s, 1H), 6.87 (bs, 1H), 7.40 (d, <i>J</i> = 8.6 Hz, 1H), 7.70 (d, <i>J</i> = 8.4 Hz, 1H), 7.82 (s, 1H), 11.51 (s, 1H).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-(3-Amino-1<i>H</i>-indazol-6-yl)-<i>N</i><sup>4</sup>-phenyl-2,4-pyrimidinediamine (<b>12i</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 318 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.53 (s, 1H), 7.00−7.13 (m, 1H), 7.27−7.38 (m, 2H), 7.48 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 7.64−7.72 (m, 2H), 7.77 (dd, <i>J</i> = 8.3, 0.8 Hz, 1H), 7.81−7.85 (m, 1H).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 6-(3-Amino-1<i>H</i>-indazol-6-yl)-<i>N</i><sup>4</sup>,<i>N</i><sup>4</sup>-dimethyl-2,4-pyrimidinediamine (<b>12j</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 270 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.07 (s, 6H), 5.37 (s, 2H), 6.02 (s, 2H), 6.44 (s, 1H), 7.56 (dd, <i>J</i> = 8.3, 1.3 Hz, 1H), 7.71 (d, <i>J</i> = 8.6 Hz, 1H), 7.94 (s, 1H), 11.50 (s, 1H).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 6-[2-Amino-6-(1-pyrrolidinyl)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>12l</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 296 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.93 (bs, 4H), 3.45 (bs, 4H), 5.37 (s, 2H), 6.00 (s, 2H), 6.27 (s, 1H), 7.54 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 7.70 (d, <i>J</i> = 8.6 Hz, 1H), 7.92 (s, 1H), 11.49 (s, 1H).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-[2-Amino-6-(1-piperidinyl)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>12m</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 310 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.53 (m, 4H), 1.64 (m, 2H), 3.47−3.79 (m, 4H), 5.37 (s, 2H), 6.03 (s, 2H), 6.58 (s, 1H), 7.57 (dd, <i>J</i> = 8.3, 1.3 Hz, 1H), 7.70 (d, <i>J</i> = 8.6 Hz, 1H), 7.94 (s, 1H), 11.49 (s, 1H).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(2-Amino-6-phenyl-4-pyrimidinyl)-2-fluorobenzonitrile (<b>10a</b>)</h4><div class="NLM_p">In a 25 mL sealable tube under argon were combined (4-cyano-3-fluorophenyl)boronic acid (0.50 g, 3.03 mmol), 4,6-dichloro-2-pyrimidinamine (0.497 g, 3.03 mmol), saturated aqueous NaHCO<sub>3</sub> (4.04 mL), and 1,4-dioxane (16.2 mL), and the mixture was degassed with argon for 5 min. Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.175 g, 0.152 mmol) was added, the vial was sealed, and the reaction mixture was stirred for 16 h at 95 °C. The reaction was cooled to room temperature, filtered through a plug of Celite503, and concentrated. The resulting orange tar was partitioned between EtOAc and water. The organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting orange solid was sonicated in CHCl<sub>3</sub> (50 mL) for 2 min. The mixture was filtrated, the solid was washed with CHCl<sub>3</sub>, and the filtrate was concentrated. Flash chromatography on SiO<sub>2</sub> (40 g) of the resulting residue (gradient: CHCl<sub>3</sub> to 5% EtOAc/CHCl<sub>3</sub>) afforded intermediate 4-(2-amino-6-chloro-4-pyrimidinyl)-2-fluorobenzonitrile (267 mg) as a yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 249, 251 [M + H]<sup>+</sup>.</div><div class="NLM_p last">In a 25 mL sealable tube under argon were combined 4-(2-amino-6-chloro-4-pyrimidinyl)-2-fluorobenzonitrile (0.196 g, 0.788 mmol) and phenylboronic acid (0.096 g, 0.79 mmol) in 1,4-dioxane (5.0 mL) and saturated aqueous NaHCO<sub>3</sub> (1.3 mL), and the mixture was degassed with argon for 5 min. Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.046 g, 0.04 mmol) was added, the vial was sealed, and the reaction mixture was stirred overnight at 95 °C. The reaction was cooled to room temperature and filtered, and the filtrate was concentrated to dryness. The resulting solid was partitioned between EtOAc and water. The organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated. Purification of the resulting solids on reverse phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O w/0.1% TFA) afforded a TFA salt of the title compound (52 mg) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 291 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.95 (s, 2H), 7.49−7.64 (m, 3H), 7.90 (s, 1H), 8.08−8.16 (m, 1H), 8.26 (dd, <i>J</i> = 8.1, 1.5 Hz, 2H), 8.30 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 8.36 (dd, <i>J</i> = 11.1, 1.3 Hz, 1H).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 6-(2-Amino-6-phenyl-4-pyrimidinyl)-1<i>H</i>-indazol-3-amine (<b>12c</b>)</h4><div class="NLM_p last">Into a 25 mL sealable tube under argon were added 4-(2-amino-6-phenyl-4-pyrimidinyl)-2-fluorobenzonitrile (0.052 g, 0.18 mmol) and EtOH (5 mL). Hydrazine monohydrate (0.35 mL, 7.17 mmol) was added, the vial was sealed, and the reaction mixture was stirred overnight at 95 °C. The reaction was cooled to room temperature and concentrated. The resulting solid was sonicated in a mixture of EtOH (1 mL) and water (10 mL), filtered, washed with water, and dried under vacuum at 40 °C to afford the title compound as a yellow solid (44 mg, 77%). LC-MS (ES) <i>m</i>/<i>z</i> = 303 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 5.43 (s, 2H), 6.74 (s, 2H), 7.46−7.59 (m, 3H), 7.69−7.84 (m, 3H), 8.12 (s, 1H), 8.23 (m, 2H), 11.63 (s, 1 H).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 6-[2-Amino-6-(4-morpholinyl)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>12k</b>)</h4><div class="NLM_p">In a 25 mL sealable tube under argon were combined <i>N</i>-acetyl-<i>N</i>-(1-acetyl-6-bromo-1<i>H</i>-indazol-3-yl)acetamide (0.25 g, 0.74 mmol), bis(pinacolato)diboron (0.197 g, 0.776 mmol), and potassium acetate (0.145 g, 1.48 mmol) in 1,4-dioxane (4.9 mL). The mixture was degassed with argon for 5 min. PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub> (0.024 g, 0.03 mmol) was added, the tube was sealed, and the reaction mixture was stirred for 5 h at 100 °C. The mixture was cooled to room temperature, the tube was unsealed, and 4-chloro-6-(4-morpholinyl)-2-pyrimidinamine (0.175 g, 0.813 mmol), NaHCO<sub>3</sub> (0.25 g, 2.96 mmol), water (1.64 mL), and PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub> (0.024 g, 0.03 mmol) were added. The tube was resealed under argon, and the reaction mixture was stirred overnight at 100 °C. The mixture was cooled to room temperature, diluted with CH<sub>3</sub>CN (10 mL), filtered through a pad of Celite503, and concentrated. The resulting brown solid was dissolved in 10 mL of solvent (30/70 CH<sub>3</sub>CN/H<sub>2</sub>O w/0.25 mL TFA), and the solution was filtered through a 0.45 μ filter disk. The filtrate was purified by reverse-phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O w/0.1% TFA) to afford a TFA salt of the acetylated Suzuki coupling intermediate (151 mg) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 354 [M + H]<sup>+</sup>. This intermediate was then dissolved in CH<sub>3</sub>OH (10 mL). HCl (12 M, 0.69 mL, 8.3 mmol) was added, and the reaction mixture was stirred at 60 °C for 4 h. The mixture was cooled to room temperature and filtered. The solid was washed with hexanes to afford an HCl salt of the title compound (75 mg) as a light-yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 312 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.73 (m, 4H), 3.89 (m, 4H), 6.98 (s, 1H), 7.66 (d, <i>J</i> = 8.6 Hz, 1H), 8.08 (m, 2H).</div><div class="NLM_p last">Compounds <b>12a</b> and <b>12d</b> were synthesized following synthetic procedures similar to the preparation of <b>12k</b> (route 2).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-(2-Amino-6-methyl-4-pyrimidinyl)-1<i>H</i>-indazol-3-amine (<b>12a</b>)</h4><div class="NLM_p last">HCl salt. LC-MS (ES) <i>m</i>/<i>z</i> = 241 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.51 (s, 3H {assumed to be hidden beneath DMSO peak}), 7.59 (s, 1H), 7.81 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 7.99 (d, <i>J</i> = 8.6 Hz, 1H), 8.21 (s, 1H), 12.72 (bs, 1H).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 6-[2-Amino-6-(methyloxy)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine (<b>12d</b>)</h4><div class="NLM_p last">LC-MS (ES) <i>m</i>/<i>z</i> = 257 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.86 (s, 3H), 5.40 (s, 2H), 6.58 (s, 1H), 6.64 (s, 2H), 7.54 (dd, <i>J</i> = 8.6, 1.0 Hz, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 1H), 7.95 (s, 1H), 11.57 (s, 1H).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (2<i>R</i>)-2-[(Phenylmethyl)amino]-1-propanol ((<i><b>R</b></i>)-<b>13</b>)</h4><div class="NLM_p last">To (2<i>R</i>)-2-amino-1-propanol (4.5 g, 60 mmol) in toluene (120 mL) was added benzaldehyde (636 mL). A Dean−Stark trap was placed on the flask, and the reaction mixture was heated to reflux until no further water evolved. The reaction was cooled down to room temperature and concentrated. The resulting residue was dissolved in ethanol (120 mL) and treated with NaBH<sub>4</sub> (5.67 g, 150 mmol) at 0 °C, followed by sufficient 4N HCl in dioxane to adjust the pH to 2. The reaction mixture was stirred overnight at room temperature and then concentrated in vacuo. The resulting residue was dissolved in 1N aq HCl (200 mL) and washed with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The aqueous phase was then adjusted to pH > 13 with 6N aqueous NaOH and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 150 mL). The combined organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the title compound (9.44 g, 95%) as a colorless oil, which solidified under high vacuum. LC-MS (ES) <i>m</i>/<i>z</i> = 166 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.12 (d, <i>J</i> = 6.6 Hz, 3H), 2.07 (bs, 2H), 2.78−2.96 (m, 1H), 3.30 (dd, <i>J</i> = 10.6, 6.8 Hz, 1H), 3.63 (dd, <i>J</i> = 10.6, 4.0 Hz, 1H), 3.73−3.81 (m, 1H), 3.86−3.95 (m, 1H), 7.24−7.32 (m, 1H), 7.35 (m, 4H).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (3<i>R</i>)-3-Methyl-4-(phenylmethyl)morpholine ((<i><b>R</b></i>)-<b>15</b>)</h4><div class="NLM_p">To (2<i>R</i>)-2-[(phenylmethyl)amino]-1-propanol (8.43 g, 51 mmol) in THF (50 mL) was added a solution of K<sub>2</sub>CO<sub>3</sub> (21.15 g, 153 mmol) in water (50 mL). To the resulting mixture at 0 °C was added slowly via syringe chloroacetyl chloride (5.7 mL, 71.4 mmol) with vigorous stirring, and the reaction mixture was stirred for 1 h at 0 °C. A 50% aqueous NaOH solution was added to adjust the pH > 13, and the resulting mixture was warmed up overnight to room temperature. The solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 200 mL), and the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to afford (5<i>R</i>)-5-methyl-4-(phenylmethyl)-3-morpholinone ((<i>R</i>)-<b>14</b>) as a colorless oil. LC-MS (ES) <i>m</i>/<i>z</i> = 206 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a solution of (5<i>R</i>)-5-methyl-4-(phenylmethyl)-3-morpholinone (11.7 g, 57 mmol) in toluene (140 mL) at 0 °C was added sodium bis(2-methoxyethoxy)aluminumhydride (Red-Al, 35 mL, 3 mL/g of morpholinone) slowly via addition funnel, and the reaction mixture was stirred overnight at 60 °C. The reaction was cooled down to 0 °C and quenched by dropwise addition of 1N aqueous NaOH (15 mL). The resulting mixture was partitioned between Et<sub>2</sub>O (100 mL) and 1N aqueous NaOH (100 mL). The organic layer was separated, and the aqueous layer was further extracted with Et<sub>2</sub>O (50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The resulting residue was azeotroped with CH<sub>3</sub>OH (50 mL) to afford the title compound (10.69 g) as a colorless oil. LC-MS (ES) <i>m</i>/<i>z</i> = 192 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.11 (d, <i>J</i> = 6.1 Hz, 3H), 2.14−2.32 (m, 1H), 2.45−2.56 (m, 1H), 2.61 (d, <i>J</i> = 11.9 Hz, 1H), 3.16 (d, <i>J</i> = 13.1 Hz, 1H), 3.26−3.42 (m, 1H), 3.57−3.66 (m, 1H), 3.68−3.79 (m, 2H), 4.08 (d, <i>J</i> = 13.1 Hz, 1H), 7.23−7.30 (m, 1H), 7.30−7.40 (m, 4H).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (3<i>R</i>)-3-Methylmorpholine ((<i><b>R</b></i>)-<b>17a</b>)</h4><div class="NLM_p last">To (3<i>R</i>)-3-methyl-4-(phenylmethyl)morpholine (10.7 g, 56 mmol) in CH<sub>3</sub>OH (110 mL) were added 6N aqueous HCl (9.3 mL) and Pd/C (1.07 g, 10 wt %), and the reaction mixture was stirred overnight at room temperature under a H<sub>2</sub> atmosphere (balloon setup). The mixture was filtered through a glass fiber filter, and the filter cake was washed with CH<sub>3</sub>OH. The combined filtrate was concentrated and azeotroped with CH<sub>3</sub>OH (4 × 100 mL) to afford the HCl salt of the title compound as a yellow oil that solidified under high vacuum (7.91 g). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 3.95−4.05 (m, 2H), 3.77 (m, 1H), 3.47−3.54 (m, 1H), 3.38−3.47 (m, 1H), 3.30−3.34 (m, 1H), 3.18−3.28 (m, 1H), 1.29 (d, <i>J</i> = 6.3 Hz, 3H).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-{2-Amino-6-[(3<i>R</i>)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1<i>H</i>-indazol-3-amine ((<i><b>R</b></i>)-<b>18a</b>)</h4><div class="NLM_p last">The title compound was prepared from amine (<i>R</i>)-<b>17a</b> by following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 326 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.19 (d, <i>J</i> = 6.8 Hz, 3H), 3.11 (m, 1H), 3.44 (m, 1H), 3.56−3.63 (m, 1H), 3.68−3.74 (m, 1H), 3.92 (dd, <i>J</i> = 11.1, 3.0 Hz, 1H), 4.05−4.14 (m, 1H), 4.49 (bs, 1H), 5.38 (s, 2H), 6.11 (s, 2H), 6.55 (s, 1H), 7.57 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 7.71 (d, <i>J</i> = 8.6 Hz, 1H), 7.95 (s, 1 H), 11.52 (s, 1H). Compound (<b><i>S</i></b>)-<b>18a</b> was prepared similarly.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (5<i>R</i>)-5-Ethyl-3-morpholinone (<b>16a</b>)</h4><div class="NLM_p last">NaH (1.51 g, 37.9 mmol) in dry toluene (10 mL) was cooled to 0 °C under nitrogen, and (2<i>R</i>)-2-amino-1-butanol (1.5 g, 16.8 mmol) in toluene (5 mL) was added dropwise. The mixture was stirred for 20 min, warming up to room temperature, and chloroacetyl chloride (1.5 mL, 18.9 mmol) in toluene (5 mL) was added dropwise. An exotherm was observed, so the mixture was cooled in an ice bath during the addition. After the addition was completed, the reaction mixture was heated to 110 °C overnight. The mixture was cooled to room temperature, and 5 g of ammonium chloride were added portionwise. The mixture was stirred for 20 min and filtered. The filter cake was washed with toluene and discarded. The filtrate was concentrated to give an orange oil that was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and purified by SiO<sub>2</sub> chromatography (gradient: CH<sub>2</sub>Cl<sub>2</sub> to 90:10:1 CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH) to afford the title compound (1.2 g, 55%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.96 (t, <i>J</i> = 7.6 Hz, 3H), 1.52−1.63 (m, 2H), 3.40−3.51 (m, 2H), 3.85−3.94 (m, 1H), 4.07−4.20 (m, 2H), 7.55 (bs, 1H).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (3<i>R</i>)-3-Ethylmorpholine ((<i><b>R</b></i>)-<b>17b</b>)</h4><div class="NLM_p last">A solution of 1 M LiAlH<sub>4</sub> in THF (7.7 mL, 7.7 mmol) was cooled in an ice bath under nitrogen. A solution of (5<i>R</i>)-5-ethyl-3-morpholinone (500 mg, 3.87 mmol) in THF (10 mL) was added dropwise, and the solution was heated to 70 °C for 16 h. After aproximately 2 h, a thick white precipitate had formed. The reaction mixture was cooled down to room temperature and carefully quenched with water (1 mL), 2 M NaOH (1 mL), and water (4 mL). The resulting slurry was stirred at room temperature for 1 h and then filtered through Celite. The filter cake was washed with EtOAc and discarded. The filtrate was washed with brine, dried (MgSO<sub>4</sub>), and filtered. HCl in ether (3.87 mL, 3.87 mmol) was added, producing a cloudy solution, and the solvent was evaporated to afford the HCl salt of the title compound (251 mg, 56%) as an orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.88−0.97 (m, 3H), 1.46−1.72 (m, 2H), 2.91−3.18 (m, 3H), 3.46 (dd, <i>J</i> = 12.3, 10.2 Hz, 1H), 3.71 (td, <i>J</i> = 11.8, 2.7 Hz, 1H), 3.82−3.97 (m, 2H), 9.68 (bs, 2H).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 6-{2-Amino-6-[(3<i>R</i>)-3-ethyl-4-morpholinyl]-4-pyrimidinyl}-1<i>H</i>-indazol-3-amine (<b>18b</b>)</h4><div class="NLM_p last">The title compound was prepared from amine (<i>R</i>)-<b>17b</b> following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 340 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.88 (t, <i>J</i> = 7.5 Hz, 3H), 1.63−1.80 (m, 2H), 3.09 (td, <i>J</i> = 12.8, 3.2 Hz, 1H), 3.37−3.46 (m, 2H), 3.51 (dd, <i>J</i> = 11.4, 2.8 Hz, 1H), 3.80−3.91 (m, 2H), 4.30 (bs, 1H), 5.38 (s, 2H), 6.09 (bs, 2H), 6.56 (s, 1H), 7.56 (dd, <i>J</i> = 8.6, 1.0 Hz, 1H), 7.71 (d, <i>J</i> = 8.3 Hz, 1H), 7.94 (s, 1H), 11.52 (s, 1H).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-{2-Amino-6-[(3<i>R</i>)-3-(1-methylethyl)-4-morpholinyl]-4-pyrimidinyl}-1<i>H</i>-indazol-3-amine (<b>18c</b>)</h4><div class="NLM_p last">The title compound was synthesized following synthetic procedures similar to the preparation of <b>18b</b>. LC-MS (ES) <i>m</i>/<i>z</i> = 354 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 0.88 (d, <i>J</i> = 6.8 Hz, 3H), 1.10 (d, <i>J</i> = 6.6 Hz, 3H), 2.47−2.54 (m, 1H), 3.21−3.30 (m., 1H), 3.51−3.58 (m, 2H), 3.93 (dd, <i>J</i> = 11.2, 3.41 Hz, 1H), 4.10 (d, <i>J</i> = 11.6 Hz, 1H), 6.46 (s, 1H), 7.47 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.76 (d, <i>J</i> = 8.6 Hz, 1H), 7.79 (s, 1H).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 6-{2-Amino-6-[(2<i>R</i>)-2-methyl-1-piperidinyl]-4-pyrimidinyl}-1<i>H</i>-indazol-3-amine (<b>18d</b>)</h4><div class="NLM_p last">The title compound was prepared from commercially available (2<i>R</i>)-2-methylpiperidine following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 324 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.14 (d, <i>J</i> = 6.8 Hz, 3H), 1.29−1.44 (m, 1H), 1.52−1.82 (m, 5H), 2.80−2.98 (m, 1H), 4.35 (d, <i>J</i> = 12.6 Hz, 1H), 4.80 (bs, 1H), 5.38 (s, 2H), 6.02 (s, 2H), 6.53 (s, 1H), 7.56 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 7.70 (d, <i>J</i> = 8.3 Hz, 1H), 7.93 (s, 1 H), 11.50 (s, 1H).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (3<i>S</i>)-<i>N</i>-Phenyl-3-piperidinecarboxamide ((<i><b>S</b></i>)-<b>20b</b>)</h4><div class="NLM_p last">To a mixture of (3<i>S</i>)-1-{[(1,1-dimethylethyl)oxy]carbonyl}-3-piperidinecarboxylic acid (500 mg, 2.181 mmol), HOBt (668 mg, 4.36 mmol), and EDC (502 mg, 2.62 mmol) in DMF (5 mL) was added <i>N</i>-methylmorpholine (1.20 mL, 10.90 mmol), and the solution was stirred for 10 min. Aniline (223 mg, 2.399 mmol) was added, and the reaction mixture was stirred overnight at room temperature. The reaction was diluted with EtOAc (50 mL) and then washed with water and brine. The organic layer was then dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to give a light-yellow oil. The oil was purified on Biotage SP1 25 m column with a gradient of 0−40% EtOAc in hexane over 14 column volumes. The residue was taken up in a premixed 2:1 CH<sub>2</sub>Cl<sub>2</sub>:TFA solution (5 mL), and the resulting mixture was stirred for 15 min and then concentrated to isolate the crude TFA salt of the title compound. LC-MS (ES) <i>m</i>/<i>z</i> = 205 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.61−1.73 (m, 2H), 1.79−1.89 (m, 1H), 2.00−2.07 (m, 1H), 2.77−2.85 (m, 1H), 2.92 (d, <i>J</i> = 10.6 Hz, 1H), 3.08 (dd, <i>J</i> = 10.7, 5.9 Hz, 1H), 3.20 (d, <i>J</i> = 11.9 Hz, 1H), 3.33 (d, <i>J</i> = 10.9 Hz, 1H), 7.06 (t, <i>J</i> = 7.3 Hz, 1H), 7.31 (t, <i>J</i> = 8.0 Hz, 2H), 7.59 (d, <i>J</i> = 7.6 Hz, 2H), 8.61 (bs, 1H), 10.18 (s, 1H).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (3<i>S</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-<i>N</i>-phenyl-3-piperidinecarboxamide ((<i><b>S</b></i>)-<b>21b</b>)</h4><div class="NLM_p last">The title compound was prepared from amine (<b><i>S</i></b>)-<b>20b</b> following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 429 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.43−1.59 (m, 1H), 1.75−1.94 (m, 2H), 2.03−2.16 (m, 1H), 2.57−2.69 (m, 1H), 3.12−3.31 (m, 2H), 3.43−3.54 (m, 2H), 4.40−4.58 (m, 1H), 4.72−5.07 (m, 1H), 6.94−7.11 (m, 2H), 7.30 (m, 2H), 7.37−7.43 (m, 1H), 7.61 (d, <i>J</i> = 8.1 Hz, 2H), 7.75 (bs, 1H), 7.90 (d, 1H), 10.08 (d, <i>J</i> = 12.9 Hz, 1H), 12.10 (bs, 2H). Compound ((<i><b>R</b></i>)-<b>21b</b>) was prepared similarly.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-<i>N</i>-phenyl-2-morpholinecarboxamide ((±)-<b>21a</b>)</h4><div class="NLM_p">The title compound was synthesized from (±)-<b>19a</b> following synthetic procedures similar to the preparation of ((<b><i>S</i></b>)-<b>21b</b>). LC-MS (ES) <i>m</i>/<i>z</i> = 431 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.99−3.16 (m, 2H), 3.70 (td, <i>J</i> = 11.4, 2.5 Hz, 1H), 4.09 (d, <i>J</i> = 11.4 Hz, 1H), 4.15−4.29 (m, 2H), 4.65 (bs, 1H), 5.38 (s, 2H), 6.23 (bs, 2H), 6.68 (s, 1H), 7.09 (t, <i>J</i> = 7.45 Hz, 1H), 7.33 (t, <i>J</i> = 8.0 Hz, 2H), 7.60 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 7.69−7.74 (m, 3H), 7.97 (s, 1H), 9.84 (s, 1H), 11.53 (s, 1H).</div><div class="NLM_p last">The individual enantiomers (<b><i>S</i></b>)-<b>21a</b> and (<i><b>R</b></i>)-<b>21a</b> were separated by preparative HPLC on a Chiralpak AD-H (250 mm × 20 mm) column: 5:95 = CH<sub>3</sub>OH:CH<sub>3</sub>CN (+0.1% isopropylamine) at 20 mL/min; 23 °C; UV 254 nm.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (3<i>S</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-3-piperidinecarboxamide ((<b><i>S</i></b>)-<b>21c</b>)</h4><div class="NLM_p last">Amine (<b><i>S</i></b>)-<b>20c</b> was prepared according to the synthetic procedures described for (<b><i>S</i></b>)-<b>20b</b>, and converted to (<b><i>S</i></b>)-<b>21c</b> following synthetic route 2. LC-MS (ES) <i>m</i>/<i>z</i> = 435 [M + H]<sup>+</sup>. NMR spectrum observed a large water peak. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.08−1.30 (m, 4H), 1.36−1.59 (m, 2H), 1.59−1.77 (m, 4H), 1.91 (d, <i>J</i> = 3.3 Hz, 1H), 3.09 (d, <i>J</i> = 11.9 Hz, 1H), 3.20 (d, <i>J</i> = 11.4 Hz, 1H), 4.38 (bs, 1H), 4.57−4.91 (m, 1H), 6.99 (d, <i>J</i> = 14.2 Hz, 1H), 7.57 (dd, <i>J</i> = 8.0, 4.7 Hz, 1H), 7.85 (d, <i>J</i> = 7.3 Hz, 1H), 7.94−8.01 (m, 2H), 12.62 (d, <i>J</i> = 1.0 Hz, 1H).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (3<i>S</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-<i>N</i>-cyclopentyl-3-piperidinecarboxamide ((<i><b>S</b></i>)-<b>21d</b>)</h4><div class="NLM_p last">Amine (<i><b>S</b></i>)-<b>20d</b> was prepared according to the synthetic procedures described for (<b><i>S</i></b>)-<b>20b</b> and converted to (<i><b>S</b></i>)-<b>21d</b> following synthetic route 2. LC-MS (ES) <i>m</i>/<i>z</i> = 421 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.37 (m, 2H), 1.42−1.55 (m, 2H), 1.55−1.70 (m, 2H), 1.78 (m, 2H), 1.90 (m, 1H), 2.36 (m, 1H), 3.03−3.12 (m, 1H), 3.17 (m, 1H), 3.36−3.50 (m, 1H), 3.98 (m, 1H), 4.33 (m, 2H), 4.67 (d, <i>J</i> = 12.9 Hz, 1H), 4.86 (d, <i>J</i> = 11.4 Hz, 1H), 6.96−7.09 (m, 1H), 7.66 (m, 1H), 7.98 (d, <i>J</i> = 7.3 Hz, 1H), 8.02−8.10 (m, 2H), 12.83 (bs, 1H).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>cis</i>-3-Methyl 1-(Phenylmethyl)-6-methyl-1,3-piperidinedicarboxylate ((±)-<i>cis</i>-<b>22</b>)</h4><div class="NLM_p">A solution of methyl 6-methylnicotinate (50 g, 331 mmol, 1 equi.) in CH<sub>3</sub>OH (400 mL) and conc HCl (26 mL) was added to a slurry of platinum(IV) oxide (2.0 g) in 50 mL of CH<sub>3</sub>OH/water (4/1) in a Parr bottle. The mixture was hydrogenated at room temperature under 60 psi of hydrogen gas for 4.5 h. The mixture was then filtered through Celite. The filtrate was concentrated in vacuo, after chasing with 500 mL of toluene, to about 77 g of syrup. This residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) and chilled in an ice bath. To this stirred solution was added DMAP (0.4 g, 3.31 mmol), followed by TEA (101 mL, 728 mmol, 2.2 equiv) portionwise. A suspension formed when TEA was added. This mixture was chilled to 15 °C. To the resulting suspension was added benzylchloroformate (52 mL, 364 mmol, 1.1 equiv) dropwise over a 25 min period such that the temperature of the mixture was kept at 15−20 °C. After completion of benzylchloroformate addition, the mixture was stirred chilled with an ice bath for another 30 min and then at ambient temperature for 1 h. This mixture was washed with 300 mL of cold 1N HCl. The organic was concentrated in vacuo. The residue was partitioned between toluene (400 mL), MTBE (200 mL), and water (250 mL). The organic was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give an oil (97 g) as the crude (NMR showed ∼3:1 cis/trans ratio of isomers). Silica gel column chromatography using gradient elution of EtOAc in hexane gave 64.4 g (65% yield) of the title compound. LC-MS (ES) <i>m</i>/<i>z</i> = 292 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.19 (d, <i>J</i> = 6.8 Hz, 3H), 1.51 (m, 1H), 1.65−1.84 (m, 2H), 1.90−2.00 (m, 1H), 2.44 (t, <i>J</i> = 11.2 Hz, 1H), 2.89−3.11 (m, 1H), 3.71 (s, 3H), 4.29 (bs, 1H), 4.51 (bs, 1H), 5.16 (s, 2H), 7.32−7.50 (m, 5H).</div><div class="NLM_p">(±)-<i>trans</i>-<b>22</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (d, <i>J</i> = 6.8 Hz, 3H), 1.37−1.42 (m, 1H), 1.78−1.91 (m, 2H), 2.04−2.10 (m, 1H), 2.61 (m, 1H), 3.13 (dd, <i>J</i> = 13.9, 4.3 Hz, 1H), 3.62 (s, 3H) 4.45 (m, 1H), 4.50 (d, <i>J</i> = 14.1 Hz, 1H), 5.14 (m, 2H), 7.25−7.40 (m, 5H).</div><div class="NLM_p last">(±)-<i>cis</i>-<b>22</b> was resolved by chiral stationary phase HPLC, supercritical fluid chromatography (SFC) or by crystallization of a tartrate salt. The following conditions were used for the HPLC analysis and preparative resolution:</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Analytical Separation Method</h4><div class="NLM_p last">A ChiralPak AD-3 column (150 mm × 4.6 mm I.D.) was used eluting with a mixture of 15% ethanol and 85% hexane containing 0.1% diethylamine at a flow rate of 1 mL/min.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Preparative Separation Method</h4><div class="NLM_p last">The separation was run in a Berger Multi-Gram III preparative SFC instrument. The column used was a ChiralPak IC (250 mm × 30 mm I.D.) eluting with a mixture of 75% SFC CO<sub>2</sub> and 25% 2-propanol at a flow rate of 90 mL/min. (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>22</b>. [α]<sup>23</sup><sub>D</sub> = +14.5 (<i>c</i> 1.35, CHCl<sub>3</sub>). (<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>22</b>. [α]<sup>23</sup><sub>D</sub> = −13.1 (<i>c</i> 0.95, CHCl<sub>3</sub>).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Resolution by Crystallization of the Tartrate Salt: Methyl (3<i>S</i>,6<i>R</i>)-6-Methyl-3-piperidinecarboxylate <span class="smallcaps smallerCapital">l</span>-(+)-Tartaric Acid Salt (<b>23</b>)</h4><div class="NLM_p">A solution of <i>cis</i>-3-methyl 1-(phenylmethyl)-6-methyl-1,3-piperidinedicarboxylate (69 g, 237 mol) in EtOH (50 mL) and EtOAc (300 mL) was added to a slurry of 10% Pd/C (3.7 g) in EtOAc (30 mL) and EtOH (10 mL) under nitrogen in a Parr shaker bottle. The mixture was hydrogenated under 65 psi at room temperature for 4 h. The mixture was filtered through Celite and washed with EtOAc. The filtrate was concentrated in vacuo to give 37 g of <i>cis</i>-3-methyl 1-(phenylmethyl)-6-methyl-1,3-piperidinedicarboxylate as a liquid. LC-MS (ES) <i>m</i>/<i>z</i> = 158 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.08 (d, <i>J</i> = 6.32 Hz, 3H), 1.15−1.33 (m, 1H), 1.53−1.64 (m, 1H), 1.64−1.78 (m, 1H), 2.13−2.25 (m, 1H), 2.31 (bs, 1H), 2.48−2.57 (m, 1H), 2.63−2.77 (m, 1H), 2.86 (dd, <i>J</i> = 13.1, 3.8 Hz, 1H), 3.39−3.51 (m, 1H), 3.74 (s, 3H).</div><div class="NLM_p last">A suspension of <span class="smallcaps smallerCapital">l</span>-(+)-tartaric acid (39 g, 260 mmol, 1.05 equiv) in 2-propanol (200 mL) and water (13 mL) was heated in a water bath at 60 °C until all dissolved. To this hot stirred solution was added <i>cis</i>-3-methyl 1-(phenylmethyl)-6-methyl-1,3-piperidinedicarboxylate (39 g, 248 mmol), followed by addition of 25 mL of 2-propanol rinse. The resulting mixture was heated to 60 °C, resulting in a clear solution, and then cooled to room temperature while the hot water bath was removed. This hot solution was seeded with a sample of methyl (3<i>S</i>,6<i>R</i>)-6-methyl-3-piperidinecarboxylate <span class="smallcaps smallerCapital">l</span>-(+)-tartaric acid salt that had a chiral purity of 98% ee and aged at ambient temperature (with the water bath removed) for 20 min. The mixture turned into an oily texture with seeds still present. To the mixture was added 5 mL of water and heated in the warm water bath at 43 °C. The mixture became clear with the seeds still present. The heating was stopped, and the mixture was stirred in the warm water bath. After 20 min, the mixture gradually turned into a paste. After another 10 min, the water bath was removed, and the mixture was stirred at ambient temperature for another 1 h. The resulting paste was filtered. The cake was washed with 50 mL of 2-propanol, giving 62 g of wet solids. This cake was taken up in 150 mL of 2-propanol and 8 mL of water and stirred as a slurry while being heated in a water bath to 60 °C (internal temp 55 °C) for 5 min. The heating was turned off while the mixture was still stirred in the warm water bath. After 30 min, the mixture was filtered. The cake was washed with 100 mL of 2-propanol. Drying under house vacuum at room temperature for 48 h gave 46.7 g of solids. An analytical sample was derivatized to the corresponding <i>N</i>-Cbz derivative, which was determined by chiral HPLC (methods used to analyze the resolution of (±)-<i>cis</i>-<b>22</b> above) to have 85% ee. This material was taken up in 2-propanol (420 mL) and water (38 mL) as a suspension. The mixture was heated in a water bath to 65 °C, at which time the mixture became a clear solution. The heating bath was removed. The mixture was seeded and aged at ambient temperature for 20 h. The solids formed were filtered and then washed with 100 mL of 2-propanol. The solids collected were dried under house vacuum at room temperature for 24 h and then under vacuum at room temperature for another 24 h to give 28.5 g of the title compound. An analytical sample was converted to the <i>N</i>-Cbz derivative. The ee was determined to be 97.7%. LC-MS (ES) <i>m</i>/<i>z</i> = 158 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.13 (d, <i>J</i> = 6.4 Hz, 3H), 1.24−1.43 (m, 1H), 1.59−1.79 (m, 2H), 1.93−2.06 (m, 1H), 2.77−2.88 (m, 1H), 2.98−3.14 (m, 2H), 3.38 (dd, <i>J</i> = 12.9, 2.8 Hz, 1H), 3.89 (s, 2H).</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (3<i>S</i>,6<i>R</i>)-6-Methyl-<i>N</i>-phenyl-3-piperidinecarboxamide ((<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>24</b>)</h4><div class="NLM_p">To a solution of 3-methyl 1-(phenylmethyl) (3<i>S</i>,6<i>R</i>)-6-methyl-1,3-piperidinedicarboxylate (15 g, 51.5 mmol) in THF/water/CH<sub>3</sub>OH (10/5/1, 480 mL) was added LiOH·H<sub>2</sub>O (2.59 g, 61.8 mmol), and the reaction mixture was stirred at room temperature for about 1 h. The mixture was acidified with 1N HCl until the pH was ∼5 and then concentrated in vacuo. The resulting residue was extracted with EtOAc (2 × 300 mL) and CHCl<sub>3</sub> (2 × 300 mL), and the combined organic layers were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo to afford (3<i>S</i>,6<i>R</i>)-6-methyl-1-{[(phenylmethyl)oxy]carbonyl}-3-piperidinecarboxylic acid (17 g). LC-MS (ES) <i>m</i>/<i>z</i> = 278 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.19 (d, <i>J</i> = 7.1 Hz, 3H), 1.57−1.91 (m, 3H), 1.94−2.05 (m, 1H), 2.48 (m, 1H), 3.02 (t, <i>J</i> = 12.8 Hz, 1H), 4.30 (bs, 1H), 4.53 (bs, 1H), 5.16 (s, 2H), 7.32−7.50 (m, 5H).</div><div class="NLM_p">To a solution of (3<i>S</i>,6<i>R</i>)-6-methyl-1-{[(phenylmethyl)oxy]carbonyl}-3-piperidinecarboxylic acid (17 g, 61.3 mmol) in DMF (400 mL) was added aniline (8.56 g, 92 mmol), Hünig’s base (32.1 mL, 184 mmol), HOBt (14.08 g, 92 mmol), and EDC (17.63 g, 92 mmol) at room temperature. The reaction mixture was stirred overnight at room temperature then diluted with H<sub>2</sub>O (∼100 mL) and extracted with EtOAc (3 × 250 mL). The combined organic layers were washed with 1N HCl (100 mL), H<sub>2</sub>O (3 × 100 mL), and brine (100 mL), and then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo to afford crude phenylmethyl (2<i>R</i>,5<i>S</i>)-2-methyl-5-[(phenylamino)carbonyl]-1-piperidinecarboxylate (21 g). LC-MS (ES) <i>m</i>/<i>z</i> = 353 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of phenylmethyl (2<i>R</i>,5<i>S</i>)-2-methyl-5-[(phenylamino)carbonyl]-1-piperidinecarboxylate (21 g, 59.6 mmol) in EtOAc (250 mL) and EtOH (250 mL) was degassed. Pd/C (10%, 6.34 g, 5.96 mmol) was added, and then H<sub>2</sub> was bubbled through the mixture. The reaction mixture was stirred at room temperature under H<sub>2</sub> balloon overnight. The mixture was filtered through a pad of Celite and concentrated in vacuo to afford the crude title compound (12 g). LC-MS (ES) <i>m</i>/<i>z</i> = 219 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (d, <i>J</i> = 6.1 Hz, 3H), 1.36−1.51 (m, 1H), 1.55−1.65 (m, 1H), 1.68−1.83 (m, 1H), 2.10−2.21 (m, 1H), 2.54−2.62 (m, 1H), 2.70−2.84 (m, 1H), 2.96 (dd, <i>J</i> = 12.0, 3.2 Hz, 1H), 3.40 (m, 1 H), 7.05−7.12 (m, 1H), 7.30−7.37 (m, 2H), 7.56−7.65 (m, 2H), 11.16 (bs, 1H).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (3<i>S</i>,6<i>R</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-6-methyl-<i>N</i>-phenyl-3-piperidinecarboxamide ((<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b>)</h4><div class="NLM_p last">The title compound was prepared from amine (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>24</b> following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 443 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.18 (d, <i>J</i> = 6.8 Hz, 3H), 1.75 (s, 2H), 1.83 (m, 1H), 1.92 (m, 1H), 5.37 (s, 2H), 6.10 (s, 2H), 6.64 (s, 1H), 7.03 (s, 1H), 7.32 (s, 2H), 7.29−7.34 (m, 2H), 7.64 (d, <i>J</i> = 7.3 Hz, 4H), 7.96 (s, 1H), 8.32 (s, 1H), 10.06 (s, 1H), 11.49 (s, 1H). Compound (<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>28a</b> was prepared similarly.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>trans</i>-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-6-methyl-<i>N</i>-phenyl-3-piperidinecarboxamide ((±)-<i>trans</i>-<b>28a</b>)</h4><div class="NLM_p last">The title compound was synthesized following synthetic procedures similar to the preparation of (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b>. LC-MS (ES) <i>m</i>/<i>z</i> = 443 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.21 (d, <i>J</i> = 6.6 Hz, 3H), 1.42−1.55 (m, 1H), 1.90−2.06 (m, 3H), 2.83 (bs, 1H), 3.35−3.41 (m, 1H), 4.61 (bs, 1H), 4.70 (d, <i>J</i> = 6.6 Hz, 1H), 5.37 (s, 2H), 6.07 (s, 2H), 6.55 (s, 1H), 6.90−7.06 (m, 1H), 7.23 (t, <i>J</i> = 8.0 Hz, 2H), 7.44−7.52 (m, 1H), 7.58 (d, <i>J</i> = 7.6 Hz, 2H), 7.67 (d, <i>J</i> = 8.3 Hz, 1H), 7.90 (s, 1H), 9.83 (s, 1H), 11.50 (s, 1H).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 4,6-Dichloro-<i>N</i>-methyl-2-pyrimidinamine (<b>27</b>)</h4><div class="NLM_p last">Methylamine (2 M solution in THF, 113 mL, 217 mmol, 2.05 equiv) was charged to a 1 L three-neck flask fitted with a magnetic stirrer and a thermometer. The mixture was chilled in an ice bath. To this stirred solution was added via addition funnel a solution of 4,6-dichloro-2-(methylsulfonyl)pyrimidine (25 g, 110 mmol) in EtOAc (250 mL) portionwise over a 25 min period. The temp was between 5−10 °C. After completion of addition, the ice bath was removed, and the mixture was stirred for 1 h at ambient temperature. LC-MS showed complete conversion. The suspension was filtered and washed with EtOAc. The filtrate was concentrated in vacuo. The residue was partitioned between water (100 mL) and EtOAc (450 mL). The organic layer was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give white solids, which were triturated in 150 mL of CH<sub>2</sub>Cl<sub>2</sub>. These solids were collected by filtration and washed with cold CH<sub>2</sub>Cl<sub>2</sub> (50 mL). Drying under house vacuum at room temperature for 20 h and then high vacuum at room temperature for 3 h gave the title compound (9.31 g) as a solid. LC-MS (ES) <i>m</i>/<i>z</i> = 179 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.04 (s, 3H), 5.57 (bs, 1H), 6.63 (s, 1H).</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (3<i>S</i>,6<i>R</i>)-1-[6-(3-Amino-1<i>H</i>-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-6-methyl-<i>N</i>-phenyl-3-piperidinecarboxamide ((<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28b</b>)</h4><div class="NLM_p">Methyl (3<i>S</i>,6<i>R</i>)-6-methyl-3-piperidinecarboxylate <span class="smallcaps smallerCapital">l</span>-tartaric acid salt (4.0 g, 13.02 mmol) was dissolved in water (25 mL), to which was added LiOH·H<sub>2</sub>O (1.80 g, 43.0 mmol, 3.3 equiv). The mixture was stirred at room temperature for 20 h. LC-MS showed complete ester hydrolysis. To this mixture was added NaHCO<sub>3</sub> (4.81 mg, 57.3 mmol, 4.4 equiv), 4,6-dichloro-<i>N</i>-methyl-2-pyrimidinamine (2.32 g, 13.02 mmol, 1 equiv), and 1,4-dioxane (25 mL). The reaction mixture was heated under reflux at 100 °C for 24 h. The mixture was concentrated in vacuo. The resulting residue was suspended in 40 mL of water, to which was added cold 2N HCl until pH = 3. The resulting mixture was filtered, and the solids were washed with water, dried under house vacuum at room temperature for 18 h, and then under vacuum over P<sub>2</sub>O<sub>5</sub> at room temperature for 24 h to give (3<i>S</i>,6<i>R</i>)-1-[6-chloro-2-(methylamino)-4-pyrimidinyl]-6-methyl-3-piperidinecarboxylic acid (<b>25</b>) (3.23 g) as a solid. LC-MS (ES) <i>m</i>/<i>z</i> = 285 [M + H]<sup>+</sup>.</div><div class="NLM_p">To (3<i>S</i>,6<i>R</i>)-1-[6-chloro-2-(methylamino)-4-pyrimidinyl]-6-methyl-3-piperidinecarboxylic acid (880 mg, 3.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) at room temperature was added Hünig’s base (1.62 mL, 9.27 mmol, 3 equiv) and aniline (0.56 mL, 6.18 mmol, 2 equiv), and the resulting mixture was chilled in an ice bath. To this stirred solution was added HATU (1.29 g, 3.40 mmol, 1.1 equiv) in one portion. The resulting suspension was stirred in the ice bath for 45 min. LC-MS showed complete conversion. The mixture was filtered, and the filtrate was concentrated in vacuo. Silica gel column chromatography with gradient elution of 1% EtOAc in CHCl<sub>3</sub> to 35% EtOAc in CHCl<sub>3</sub> gave (3<i>S</i>,6<i>R</i>)-1-[6-chloro-2-(methylamino)-4-pyrimidinyl]-6-methyl-<i>N</i>-phenyl-3-piperidinecarboxamide (700 mg). LC-MS (ES) <i>m</i>/<i>z</i> = 360 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.27 (d, <i>J</i> = 6.8 Hz, 3H), 1.71−1.95 (m, 3H), 2.03−2.14 (m, 1H), 2.49−2.62 (m, 1H), 2.87 (s, 3H), 3.08−3.23 (m, 1H), 6.11 (s, 1H), 7.06−7.16 (m, 1H), 7.26−7.38 (m, 2H), 7.52−7.62 (m, 2H).</div><div class="NLM_p last">The title compound was prepared from (3<i>S</i>,6<i>R</i>)-1-[6-chloro-2-(methylamino)-4-pyrimidinyl]-6-methyl-<i>N</i>-phenyl-3-piperidinecarboxamide following route 2. LC-MS (ES) <i>m</i>/<i>z</i> = 457 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.33 (d, <i>J</i> = 6.8 Hz, 3H), 1.82−1.97 (m, 3H), 2.06−2.16 (m, 1H), 2.57−2.65 (m, 1H), 2.98 (s, 3H), 3.15−3.25 (m, 1H), 6.51 (s, 1H), 7.12 (t, <i>J</i> = 7.5 Hz, 1H), 7.34 (t, <i>J</i> = 8.1 Hz, 2H), 7.54 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 7.60 (dd, <i>J</i> = 8.6, 1.3 Hz, 2H), 7.76 (d, <i>J</i> = 8.3 Hz, 1H), 7.87 (s, 1H).</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (3<i>S</i>,6<i>R</i>)-1-[6-(3-Amino-1<i>H</i>-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-6-methyl-3-piperidinecarboxamide ((<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b>)</h4><div class="NLM_p">To a suspension of (3<i>S</i>,6<i>R</i>)-1-[6-chloro-2-(methylamino)-4-pyrimidinyl]-6-methyl-3-piperidinecarboxylic acid (3.05 g, 10.71 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) at room temperature was added Hünig’s base (2.70 mL, 15.43 mmol, 1.3 equiv) and cyclohexylamine (1.60 mL, 14.2 mmol, 1.2 equiv), and the resulting mixture was chilled in an ice bath. To this stirred solution was added HATU (4.96 g, 13.1 mmol, 1.1 equiv) in one portion, and the resulting suspension was stirred in the ice bath for 30 min. LC-MS showed complete conversion. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and filtered through Celite. The filtrate was washed water (2 × 25 mL) and then brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Silica gel column chromatography using gradient elution of 1% EtOAc in CHCl<sub>3</sub> to 50% EtOAc in CHCl<sub>3</sub> afforded (3<i>S</i>,6<i>R</i>)-1-[6-chloro-2-(methylamino)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-6-methyl-3-piperidinecarboxamide (4.26 g) as a foam. LC-MS (ES) <i>m</i>/<i>z</i> = 366 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The title compound was prepared from (3<i>S</i>,6<i>R</i>)-1-[6-chloro-2-(methylamino)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-6-methyl-3-piperidinecarboxamide following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 463 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.16−1.32 (m, 3H), 1.29 (d, <i>J</i> = 6.8 Hz, 3H), 1.34−1.45 (m, 2H), 1.65−1.68 (m, 1H), 1.76−1.81 (m, 5H), 1.85−1.92 (m, 2H), 1.97−2.05 (m, 1H), 2.35−2.42 (m, 1H), 2.97 (s, 3H), 3.11−3.15 (m, 1H), 3.64−3.70 (m, 1H), 4.45−4.65 (bs, 1H), 4.72−4.92 (bs, 1H), 6.45 (s, 1H), 7.52 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 7.75 (d, <i>J</i> = 8.3 Hz, 1H), 7.85 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 14.6, 22.9, 24.6, 25.3, 27.9, 29.0, 32.5, 42.6, 47.2, 89.1, 107.7, 114.7, 116.6, 119.9, 136.7, 141.7, 149.2, 162.5, 163.0, 163.3, 172.3</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (3<i>S</i>,6<i>R</i>)-1-[2-Amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-6-methyl-3-piperidinecarboxylic acid (<b>26</b>)</h4><div class="NLM_p">Into a 75 mL sealable tube were added 3-methyl 1-(phenylmethyl) (3<i>S</i>,6<i>R</i>)-6-methyl-1,3-piperidinedicarboxylate (10 g, 34.3 mmol), 1,4-dioxane (20 mL), and concentrated HCl (20 mL), and the mixture was stirred at 100 °C for 3 h. The mixture was then cooled to room temperature. The solution was transferred to a 500 mL round-bottom flask and concentrated to dryness. Trituration with Et<sub>2</sub>O and CH<sub>3</sub>CN afforded the HCl salt of (3<i>S</i>,6<i>R</i>)-6-methyl-3-piperidinecarboxylic acid (6.17 g) as a colorless oil that turned into a white solid after standing overnight. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.34 (d, <i>J</i> = 6.6 Hz, 3H), 1.46−1.63 (m, 1H), 1.83−2.03 (m, 2H), 2.13−2.33 (m, 1H), 2.88−3.01 (m, 1H), 3.18 (dd, <i>J</i> = 13.1, 4.0 Hz, 1H), 3.22−3.31 (m, 1H), 3.58−3.71 (m, 1H).</div><div class="NLM_p last">A mixture of 4,6-dichloro-2-pyrimidinamine (3.0 g, 18.3 mmol), (3<i>S</i>,6<i>R</i>)-6-methyl-3-piperidinecarboxylic acid (3.98 g, 20.12 mmol), and NaHCO<sub>3</sub> (7.68 g, 91 mmol) in 1,4-dioxane (100 mL) and water (50 mL) was stirred overnight at 117 °C in a sealed tube. The reaction was allowed to cool to room temperature. LC-MS showed that most of the 4,6-dichloro-2-pyrimidinamine had been consumed. Then 4-cyano-3-fluorobenzeneboronic acid (3.32 g, 20.12 mmol) and Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.423 g, 0.366 mmol) were added, and the reaction mixture was stirred for 24 h at 117 °C. The mixture was poured into water (300 mL) and EtOAc (200 mL). The pH of the solution was 9, and the desired product was in the aqueous layer. The aqueous layer was separated from the organic layer, and then it was filtered. 6N HCl was added dropwise to the filtrate to make the pH = 4. A precipitate formed. The precipitate was filtered, washed with water, and dried to afford the crude title compound (3.6 g) as a light-yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 356 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.13 (d, <i>J</i> = 6.8 Hz, 3H), 1.56−1.94 (m, 5H), 2.26−2.39 (m, 1H), 2.86 (bs, 1H), 6.26 (s, 2H), 6.77 (s, 1H), 7.97−8.05 (m, 1H), 8.10−8.24 (m, 2H), 12.47 (bs, 1H).</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (3<i>S</i>,6<i>R</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-6-methyl-3-piperidinecarboxamide ((<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28c</b>)</h4><div class="NLM_p">To a solution of (3<i>S</i>,6<i>R</i>)-1-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-6-methyl-3-piperidinecarboxylic acid (415 mg, 1.128 mmol) and HATU (533 mg, 1.401 mmol) in DMF (3 mL) in a 10 mL round-bottom flask was added Hünig’s base (0.408 mL, 2.34 mmol), and the resulting mixture was stirred at room temperature for 15 min. Cyclohexylamine (0.16 mL, 1.401 mmol) was added, and the reaction mixture was stirred at room temperature for 0.5 h. LC-MS showed the reaction was complete. The reaction was poured into water, and EtOAc was added to extract the product. The organic layer was concentrated, and the formed solid was recrystallized from CH<sub>3</sub>CN to afford (3<i>S</i>,6<i>R</i>)-1-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-6-methyl-3-piperidinecarboxamide (245 mg) as a light-yellow solid. LC-MS (ES) <i>m</i>/<i>z</i> = 437 [M + H]<sup>+</sup>.</div><div class="NLM_p last">In a microwave vial, (3<i>S</i>,6<i>R</i>)-1-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-6-methyl-3-piperidinecarboxamide (235 mg, 0.538 mmol), EtOH (5 mL), Hünig’s base (0.376 mL, 2.153 mmol), and anhydrous hydrazine (0.101 mL, 3.23 mmol) were combined, and the yellow suspension was heated overnight at 110 °C in an oil bath. When the temperature of the reaction reached 100 °C all of the solids were dissolved. After overnight, there was a yellow suspension as well as some black-colored solid formed. LCMS showed mainly product. The black solid and the yellow solid were carefully separated due to the black solid being heavier than yellow solid in the CH<sub>3</sub>OH solvent. The yellow solid in CH<sub>3</sub>OH was filtered and washed with CH<sub>3</sub>OH to remove the color and afford the title compound (157 mg) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 449 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.05−1.35 (m, 8H), 1.50−1.88 (m, 9H), 2.24 (s, 1H), 2.90 (s, 1H), 3.46−3.60 (m, 1H), 5.38 (s, 2H), 6.07 (s, 2H), 6.57 (s, 1H), 7.57 (d, <i>J</i> = 8.3 Hz, 1H), 7.70 (d, <i>J</i> = 8.3 Hz, 1H), 7.79 (d, <i>J</i> = 7.6 Hz, 1 H), 7.94 (s, 1H), 11.49 (s, 1H).</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> [(2<i>S</i>,5<i>R</i>)-5-Methyl-4-(phenylmethyl)-2-morpholinyl]methanol (<b>29a</b>)</h4><div class="NLM_p last">To a stirred solution of (2<i>R</i>)-2-[(phenylmethyl)amino]-1-propanol (1.65 g, 9.99 mmol) in toluene (50 mL) was added (<i>R</i>)-(−)-epichlorohydrin (1.02 mL, 12.98 mmol), followed by lithium perchlorate (1.062 g, 9.99 mmol) under nitrogen. After stirring 2 days, TLC (5% methanol−dichloromethane) showed there was only a trace of starting material and a major product. A solution of sodium methoxide (25 wt % in CH<sub>3</sub>OH) (5.71 mL, 24.96 mmol) was then added and the mixture was stirred for 3 days. Saturated aq NH<sub>4</sub>Cl (75 mL) was added, and the product was extracted with EtOAc (3 × 75 mL). The combined organics were washed with brine, dried (MgSO<sub>4</sub>), filtered, and evaporated to give the crude product, which was purified by chromatography (Analogix RS-120 silica cartridge) eluting with 20−50% EtOAc in hexanes to afford the title compound (1.11 g) as a colorless oil. LC-MS (ES) <i>m</i>/<i>z</i> = 222 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.12 (d, <i>J</i> = 6.6 Hz, 3H), 2.23−2.61 (m, 3H), 2.80 (m, 1H), 3.49−3.57 (m, 1H), 3.60−3.77 (m, 5H), 3.78−3.86 (m, 1H), 7.17−7.47 (m, 5H). [α]<sub>D</sub> = −5.2 (<i>c</i> = 1.55, CH<sub>3</sub>OH, 23.5 °C).</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> [(2<i>S</i>,5<i>R</i>)-4-(2-Amino-6-chloro-4-pyrimidinyl)-5-methyl-2-morpholinyl]methanol (<b>30a</b>)</h4><div class="NLM_p">To a stirred solution of [(2<i>S</i>,5<i>R</i>)-5-methyl-4-(phenylmethyl)-2-morpholinyl]methanol (1.05 g, 4.74 mmol) in ethanol (15 mL) was added concentrated hydrochloric acid (0.435 mL, 5.22 mmol). The mixture was purged with nitrogen to degas, and then 10% palladium on carbon (Degussa Type E101 NE/W, 50% wet, 150 mg, 0.070 mmol) was added and the mixture was purged with hydrogen and then stirred under a balloon of H<sub>2</sub>. After stirring 4 h, TLC (50% EtOAc−hexanes) showed no starting material and baseline product. The mixture was degassed with nitrogen, filtered through Celite, and evaporated to dryness to afford [(2<i>S</i>,5<i>R</i>)-5-methyl-2-morpholinyl]methanol (880 mg) as the hydrochloride salt. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 1.34 (d, <i>J</i> = 7.1 Hz, 3H), 3.04−3.12 (m, 1H), 3.14−3.24 (m, 1H), 3.50−3.67 (m, 3H), 3.74−3.83 (m, 2H), 3.83−3.89 (m, 1H).</div><div class="NLM_p last">In a microwave vessel, Hünig’s base (0.59 mL, 3.35 mmol) was added to [(2<i>S</i>,5<i>R</i>)-5-methyl-2-morpholinyl]methanol hydrochloride (208 mg, 1.12 mmol) in CH<sub>3</sub>CN (3 mL), and then 2-amino-4,6-dichloropyrimidine (174 mg, 1.06 mmol) was added. The mixture was heated with stirring in a microwave reactor at 160 °C for 1 h. HPLC indicated complete conversion. The mixture was filtered through a 0.45 μm filter disk, evaporated, and the product was purified further by chomatography (Analogix SF25−40 g silica column) eluting with 2−5% CH<sub>3</sub>OH in CHCl<sub>3</sub> to afford the title compound (258 mg) as a white foam. LC-MS (ES) <i>m</i>/<i>z</i> = 260 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28 (d, <i>J</i> = 6.8 Hz, 3H), 1.98 (bs, 1H), 2.99 (bs, 1H), 3.53−3.63 (m, 1H), 3.70 (bs, 1H), 3.75−3.82 (m, 2H), 3.83−3.89 (m, 1H), 4.87 (bs, 2H), 5.95 (s, 1H).</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (2<i>S</i>,5<i>R</i>)-4-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-5-methyl-<i>N</i>-phenyl-2-morpholinecarboxamide (<b>34a</b>)</h4><div class="NLM_p">In a sealable vessel was added (4-cyano-3-fluorophenyl)boronic acid (163 mg, 0.986 mmol), [(2<i>S</i>,5<i>R</i>)-4-(2-amino-6-chloro-4-pyrimidinyl)-5-methyl-2-morpholinyl]methanol (232 mg, 0.897 mmol) and 1,4-dioxane (5 mL), and saturated aqueous NaHCO<sub>3</sub> (2.5 mL). The mixture was purged with nitrogen to degas, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (104 mg, 0.090 mmol) was added and the vessel was sealed and heated at 100 °C overnight. HPLC and LC-MS indicated the product had formed but some starting pyrimidine remained. Another portion of (4-cyano-3-fluorophenyl)boronic acid (50 mg, 0.303 mmol) was added, and the reaction was stirred at 120 °C in a microwave for 30 min. The reaction was worked up by diluting with toluene and water. The aqueous layer was extracted with toluene (2 × 5 mL) and the combined organics were washed with water and brine, dried (MgSO<sub>4</sub>), filtered, and evaporated. The product was purified by silica gel chromatography (Analogix SF25−40 g) eluting with 2−10% CH<sub>3</sub>OH in CHCl<sub>3</sub> to give 4-{2-amino-6-[(2<i>S</i>,5<i>R</i>)-2-(hydroxymethyl)-5-methyl-4-morpholinyl]-4-pyrimidinyl}-2-fluorobenzonitrile (193 mg) as an off-white foam. LC-MS (ES) <i>m</i>/<i>z</i> = 344 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.32 (d, <i>J</i> = 6.8 Hz, 3H), 2.06 (d, <i>J</i> = 6.1 Hz, 1H), 3.05 (bs, 1H), 3.59−3.68 (m, 1H), 3.68−3.78 (m, 1H), 3.78−3.94 (m, 3H), 4.91 (bs, 2H), 6.31 (s, 1H), 7.70 (dd, <i>J</i> = 8.3, 6.6 Hz, 1H), 7.78−7.92 (m, 2H).</div><div class="NLM_p">A stock solution of oxidant was prepared by dissolving H<sub>5</sub>IO<sub>6</sub> (11.4 g, 50 mmol) and CrO<sub>3</sub> (23 mg, 1.15 mol %) in wet CH<sub>3</sub>CN (0.75% water) to a volume of 114 mL (takes about 2 h to dissolve).</div><div class="NLM_p">In a 100 mL RB was placed 4-{2-amino-6-[(2<i>S</i>,5<i>R</i>)-2-(hydroxymethyl)-5-methyl-4-morpholinyl]-4-pyrimidinyl}-2-fluorobenzonitrile (188 mg, 0.548 mmol) and wet CH<sub>3</sub>CN (0.75% water, 4.5 mL). The stirred solution was cooled in an ice bath, and 4.37 mL of the above stock solution was added very slowly dropwise (over 10 min). After 2 h, there was a small amount of starting material observed by TLC (NaHCO<sub>3</sub> added to an aliquot, 5% CH<sub>3</sub>OH−CHCl<sub>3</sub>), so the reaction was placed in the refrigerator overnight. At this time, there was no starting material by TLC. The reaction was quenched by adding Na<sub>2</sub>HPO<sub>4</sub> (0.5 g) in 5 mL of water. After stirring a few minutes, the mixture was cloudy and the pH = 5. The product was extracted with EtOAc (5 × 10 mL), and the combined organics were washed with 5% NaHSO<sub>3</sub>, brine, dried (MgSO<sub>4</sub>), filtered, and evaporated to afford the crude (2<i>S</i>,5<i>R</i>)-4-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-5-methyl-2-morpholinecarboxylic acid (<b>38a</b>) (102 mg) as an off-white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 358 [M + H]<sup>+</sup>.</div><div class="NLM_p">A 5 mL vial was charged with (2<i>S</i>,5<i>R</i>)-4-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-5-methyl-2-morpholinecarboxylic acid (72 mg, 0.201 mmol), HOBt (29.9 mg, 0.222 mmol), and DMF (1 mL) under nitrogen. The mixture was stirred and cooled in an ice bath, and then EDC (42.5 mg, 0.222 mmol) was added. After stirring 10 min, aniline (0.020 mL, 0.222 mmol) was added and the mixture was allowed to warm to room temperature and stir. After 4 h, there was no change in progress. The mixture was diluted with EtOAc and washed with water, saturated NaHCO<sub>3</sub>, brine, and dried (MgSO<sub>4</sub>). After filtering, the filtrate was concentrated, and the product was purified by silica gel chromatography (Analogix SF-4 g) eluting with 20−50% EtOAc in CHCl<sub>3</sub> to afford (2<i>S</i>,5<i>R</i>)-4-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-5-methyl-<i>N</i>-phenyl-2-morpholinecarboxamide (59 mg) as a light-orange oil. LC-MS (ES) <i>m</i>/<i>z</i> = 433 [M + H]<sup>+</sup>.</div><div class="NLM_p last">(2<i>S</i>,5<i>R</i>)-4-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-5-methyl-<i>N</i>-phenyl-2-morpholinecarboxamide (57 mg, 0.132 mmol) was dissolved in ethanol (3 mL) with stirring in a 5 mL microwave vessel. Hydrazine monohydrate (150 μL, 3.09 mmol) was added, and the mixture was capped and heated at 100 °C in an oil bath for 24 h. The mixture was partitioned between EtOAc and water, and the aqueous layer was extracted with EtOAc. The combined organics were washed with brine, dried (MgSO<sub>4</sub>), filtered, and evaporated. Purification by silica gel chromatograpy (Analogix RS-4 g) eluting with 90:10:1 CHCl<sub>3</sub>:CH<sub>3</sub>OH:conc aq NH<sub>4</sub>OH afforded the title compound (19 mg, 0.041 mmol, 30.8% yield) as a colorless film/foam. NMR showed a residual solvent peak with singlets at 1.9 and 3.36, so the material was azeotroped with CH<sub>3</sub>CN and then triturated to give a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.24 (d, <i>J</i> = 6.3 Hz, 3H), 3.04 (bs, 1H), 3.82 (d, <i>J</i> = 9.8 Hz, 1H), 3.93 (d, <i>J</i> = 11.1 Hz, 1H), 4.07−4.23 (m, 1H), 4.53 (bs, 2H), 5.39 (bs, 2H), 6.22 (bs, 2H), 6.61 (s, 1H), 7.10 (t, <i>J</i> = 7.1 Hz, 1H), 7.34 (t, <i>J</i> = 7.7 Hz, 2H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.69−7.78 (m, 3H), 7.96 (s, 1H), 9.87 (bs, 1H), 11.52 (s, 1H).</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> {(2<i>S</i>,5<i>R</i>)-4-[6-Chloro-2-(methylamino)-4-pyrimidinyl]-5-methyl-2-morpholinyl}methanol (<b>30b</b>)</h4><div class="NLM_p last">The title compound was prepared similarly to <b>30a</b> but using pyrimidine <b>27</b>. LC-MS (ES) <i>m</i>/<i>z</i> = 273, 275 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.15 (d, <i>J</i> = 6.8 Hz, 3H), 2.76 (s, 3H), 2.85 (bs, 1H), 3.31−3.55 (m, 3H), 3.56−3.66 (m, 1H), 3.67−3.78 (m, 1H), 6.19 (bs, 1H).</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (2<i>S</i>,5<i>R</i>)-4-[6-(3-amino-1<i>H</i>-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-5-methyl-2-morpholinecarboxamide (<b>34c</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>30b</b> following similar synthetic procedures to the synthesis of <b>34a</b>. LC-MS (ES) <i>m</i>/<i>z</i> = 465 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.04−1.16 (m, 1H), 1.19 (d, <i>J</i> = 6.6 Hz, 3H), 1.23−1.37 (m, 4H), 1.52−1.63 (m, 1H), 1.63−1.79 (m, 4H), 2.76−2.99 (m, 4H), 3.55−3.68 (m, 1H), 3.74 (dd, <i>J</i> = 11.4, 2.8 Hz, 1H), 3.86 (d, <i>J</i> = 11.1 Hz, 1H), 3.91 (dd, <i>J</i> = 11.4, 2.8 Hz, 1H), 4.20−4.83 (bs, 2H), 5.39 (s, 2H), 6.50−6.71 (m, 2H), 7.56−7.69 (m, 2H), 7.72 (d, <i>J</i> = 8.3 Hz, 1H), 7.99 (s, 1H), 11.50 (s, 1H).</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> [(2<i>S</i>,5<i>R</i>)-5-Ethyl-4-(phenylmethyl)-2-morpholinyl]methanol (<b>29b</b>)</h4><div class="NLM_p">To (<i>R</i>)-(−)-2-amino-1-butanol (5 g, 56.1 mmol) in CH<sub>3</sub>OH (120 mL) was added benzaldehyde (6.24 mL, 61.7 mmol), and the reaction mixture was stirred under nitrogen for 15 min. The mixture was then cooled in an ice bath, and sodium borohydride (2.33 g, 61.7 mmol) was added portionwise. The mixture was stirred in the ice bath for 1.5 h. NaOH (6 N, 25 mL) was added, and the mixture was concentrated. The resulting residue was taken up in 100 mL of H<sub>2</sub>O and extracted with Et<sub>2</sub>O (2×). The organics were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford (2<i>R</i>)-2-[(phenylmethyl)amino]-1-butanol (10.92 g) as a fluffy white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 180 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a solution of (2<i>R</i>)-2-[(phenylmethyl)amino]-1-butanol (10.06 g, 56.1 mmol) in 1,2-dichloroethane (DCE, 250 mL) was added (<i>R</i>)-(−)-epichlorohydrin (6.75 g, 72.9 mmol), followed by lithium perchlorate (5.97 g, 56.1 mmol) under nitrogen. The reaction was stirred for 2 days at room temperature, then sodium ethoxide (21 wt % in ethanol, 52.4 mL, 140 mmol) was added and the reaction continued to stir for 3 days. Saturated NH<sub>4</sub>Cl was added, and the product was extracted with EtOAc. The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford the title compound (16.2 g) as a colorless oil. LC-MS (ES) <i>m</i>/<i>z</i> = 236 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.80 (t, <i>J</i> = 7.5 Hz, 3H), 1.44−1.71 (m, 2H), 2.26−2.45 (m, 3H), 3.19−3.50 (m, 4H), 3.49−3.80 (m, 3H), 4.60 (bs, 1H), 7.19−7.27 (m, 1H), 7.28−7.37 (m, 4H).</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (2<i>S</i>,5<i>R</i>)-4-[6-(3-Amino-1<i>H</i>-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-5-ethyl-<i>N</i>-phenyl-2-morpholinecarboxamide (<b>34b</b>)</h4><div class="NLM_p">[(2<i>S</i>,5<i>R</i>)-5-Ethyl-4-(phenylmethyl)-2-morpholinyl]methanol (0.5 g, 2.125 mmol) was dissolved in CH<sub>3</sub>OH (20 mL) and placed under a nitrogen atmosphere. Palladium on carbon (10 wt %, 0.023 g, 0.212 mmol) was added, and the flask was flushed with nitrogen and evacuated (3×). Then the reaction was placed under an atmosphere of hydrogen (balloon) and stirred at room temperature overnight. The reaction mixture was filtered through Celite and concentrated to afford [(2<i>S</i>,5<i>R</i>)-5-ethyl-2-morpholinyl]methanol (0.309 g) as a colorless oil. LC-MS (ES) <i>m</i>/<i>z</i> = 146 [M + H]<sup>+</sup>.</div><div class="NLM_p">To [(2<i>S</i>,5<i>R</i>)-5-ethyl-2-morpholinyl]methanol (0.309 g, 2.125 mmol) in THF (10 mL) were added Boc<sub>2</sub>O (0.493 mL, 2.125 mmol) and Hünig’s base (0.371 mL, 2.125 mmol), and the reaction mixture was heated to 40 °C and stirred overnight. The reaction was then cooled to room temperature and concentrated to afford 1,1-dimethylethyl (2<i>S</i>,5<i>R</i>)-5-ethyl-2-(hydroxymethyl)-4-morpholinecarboxylate (0.488 g). LC-MS (ES) <i>m</i>/<i>z</i> = 246 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a vigorously stirred solution of 1,1-dimethylethyl (2<i>S</i>,5<i>R</i>)-5-ethyl-2-(hydroxymethyl)-4-morpholinecarboxylate (2.52 g, 10.27 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) that was cooled to 0 °C were added TEMPO (0.321 g, 2.054 mmol) and (diacetoxyiodo)benzene (7.28 g, 22.60 mmol). The ice bath was removed, and the reaction was allowed to warm to room temperature and stirred overnight. The reaction was quenched with CH<sub>3</sub>OH and then concentrated to afford crude (2<i>S</i>,5<i>R</i>)-4-{[(1,1-dimethylethyl)oxy]carbonyl}-5-ethyl-2-morpholinecarboxylic acid (<b>32</b>) (0.711 g) as a yellow oil. LC-MS (ES) <i>m</i>/<i>z</i> = 260 [M + H]<sup>+</sup>.</div><div class="NLM_p">To (2<i>S</i>,5<i>R</i>)-4-{[(1,1-dimethylethyl)oxy]carbonyl}-5-ethyl-2-morpholinecarboxylic acid (0.250 g, 0.964 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added aniline (0.088 mL, 0.964 mmol), HOAt (0.131 g, 0.964 mmol), and EDC (0.222 g, 1.157 mmol), and the reaction mixture was stirred at room temperature overnight. The reaction mixture was washed with water (2×), and the organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to afford 1,1-dimethylethyl (2<i>S</i>,5<i>R</i>)-5-ethyl-2-[(phenylamino)carbonyl]-4-morpholinecarboxylate (0.247 g) as a brown oil. LC-MS (ES) <i>m</i>/<i>z</i> = 240 [M + H]<sup>+</sup>.</div><div class="NLM_p">1,1-Dimethylethyl (2<i>S</i>,5<i>R</i>)-5-ethyl-2-[(phenylamino)carbonyl]-4-morpholinecarboxylate (0.269 g, 0.804 mmol) was taken up in HCl in 1,4-dioxane (4 M, 0.024 mL, 0.804 mmol) and stirred at room temperature overnight. The reaction was concentrated to yield an HCl salt of (2<i>S</i>,5<i>R</i>)-5-ethyl-<i>N</i>-phenyl-2-morpholinecarboxamide (<b>33a</b>) (0.198 g) as a brown oil. LC-MS (ES) <i>m</i>/<i>z</i> = 235 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The title compound was prepared from amine <b>33a</b> following route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 473 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.92 (t, 3H), 1.74−1.86 (m, 2H), 3.34 (s, 3H), 3.71−3.74 (m, 1H), 3.74−3.77 (m, 1H), 4.03 (bs, 1H), 4.06 (bs, 1H), 4.10−4.16 (m, 1H), 4.64−4.85 (m, 1H), 5.39 (bs, 2H), 6.60−6.67 (m, 2H), 7.07−7.13 (m, 1H), 7.31−7.36 (m, 2H), 7.60−7.64 (m, 1H), 7.70−7.74 (m, 3H), 8.00 (s, 1H), 9.87 (bs, 1H), 11.50 (bs, 1H).</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (2<i>S</i>,5<i>R</i>)-4-[6-(3-Amino-1<i>H</i>-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-<i>N</i>-cyclohexyl-5-ethyl-2-morpholinecarboxamide (<b>34d</b>)</h4><div class="NLM_p last">The title compound was synthesized following synthetic procedures similar to the preparation of <b>34b</b>. TFA salt. LC-MS (ES) <i>m</i>/<i>z</i> = 479 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.85−0.92 (m, 3H), 1.07−1.15 (m, 2H), 1.20−1.35 (m, 4H), 1.52−1.61 (m, 2H), 1.65−1.80 (m, 4H), 2.81−2.88 (m, 5H), 3.56−3.63 (m, 1H), 3.63−3.69 (m, 1H), 3.86−3.92 (m, 1H), 3.93−3.99 (m, 1H), 4.57−4.83 (m, 2H), 5.38 (bs, 1H), 6.53−6.64 (m, 2H), 7.58−7.67 (m, 2H), 7.70−7.74 (m, 1H), 7.97 (bs, 1H), 11.49 (bs, 1H).</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1,1-Dimethylethyl {1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-3-piperidinyl}carbamate ((±)-<b>37b</b>)</h4><div class="NLM_p">The title compound was prepared from amine <b>36</b> following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 425 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.38 (s, 9H), 1.43 (m, 2H), 1.66−1.79 (m, 1H), 1.80−1.95 (m, 1H), 2.78−2.93 (m, 1H), 2.95−3.10 (m, 1H), 3.29−3.40 (m, 1H), 4.11 (d, <i>J</i> = 12.6 Hz, 1H), 4.26 (bs, 1H), 5.38 (s, 2H), 6.08 (bs, 2H), 6.57 (s, 1H), 6.93 (d, <i>J</i> = 7.3 Hz, 1H), 7.55 (d, <i>J</i> = 8.3 Hz, 1H), 7.70 (d, <i>J</i> = 8.3 Hz, 1H), 7.93 (s, 1H), 11.51 (s, 1H).</div><div class="NLM_p last">Each pure enantiomer of <b>37b</b> was prepared following the same synthetic route as described for ((±)-<b>37b</b>), starting from the corresponding pure enantiomer of <b>36</b>.</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-{1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-3-piperidinyl}benzamide ((±)-<b>37a</b>)</h4><div class="NLM_p">1,1-Dimethylethyl {1-[2-amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-3-piperidinyl}carbamate (865 mg, 2.04 mmol) was added portionwise to ice-cooled concentrated hydrochloric acid (8 mL, 96 mmol) with stirring. A solid yellow mass formed. The ice bath was removed, and the reaction was allowed to warm to room temperature with stirring. HPLC indicated complete conversion. The mixture was diluted with ice−water (20 mL), and the solution was concentrated under reduced pressure. The residue was dissolved in ethanol (15 mL) and evaporated, followed by suspending in CH<sub>3</sub>CN (15 mL) and evaporating. The residue was then triturated with 2-propanol (10 mL) and filtered, washed with 2-propanol followed by hexanes, and dried under vacuum to afford 6-[2-amino-6-(3-amino-1-piperidinyl)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine trihydrochloride (761 mg) as a yellow powder. A 140 mg portion was suspended in CH<sub>3</sub>OH (2 mL) and water (1 mL) and was brought to pH 10 with 1 N NaOH. The solution was filtered and purified by Gilson automated reverse phase HPLC (Gemini Phenomenex C18 5 μ, 100 mm × 300 mm), eluting with 5−90% CH<sub>3</sub>CN in water + 0.1%NH<sub>4</sub>OH). Pure fractions were combined, evaporated, and dried to afford the free base (72 mg) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 325 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.15−1.29 (m, 1H), 1.31−1.46 (m, 1H), 1.51 (bs, 2H), 1.62−1.75 (m, 1H), 1.87 (d, <i>J</i> = 10.6 Hz, 1H), 2.53−2.68 (m, 2H), 2.83 (t, <i>J</i> = 12.1 Hz, 1H), 4.30 (m, 2H), 5.38 (s, 2H), 6.03 (bs, 2H), 6.58 (s, 1H), 7.56 (d, <i>J</i> = 8.6 Hz, 1H), 7.70 (d, <i>J</i> = 8.3 Hz, 1H), 7.94 (s, 1H), 11.52 (s, 1H).</div><div class="NLM_p last">Sodium bicarbonate (145 mg, 1.73 mmol) was added to a solution of 6-[2-amino-6-(3-amino-1-piperidinyl)-4-pyrimidinyl]-1<i>H</i>-indazol-3-amine trihydrochloride (150 mg, 0.346 mmol) in water (1.5 mL) with stirring. Tetrahydrofuran (1.5 mL) was added, the mixture was cooled in an ice bath, and benzoyl chloride (0.044 mL, 0.380 mmol) was added dropwise with stirring. The mixture was then warmed to room temperature and stirred for 2 h. LC-MS showed starting material, product, and bis-benzoylation. Additional portions of benzoyl chloride (0.040 mL, 0.345 mmol) and NaHCO<sub>3</sub> (145 mg, 1.73 mmol) were added, and the mixture was stirred for 1 h. HPLC showed complete conversion to multibenzoylated product. The reaction was diluted with EtOAc, washed with water, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated. The crude residue was suspended in CH<sub>3</sub>OH (8 mL), concentrated aqueous HCl (1 mL, 12 mmol) was added, and the mixture was stirred for 3 days at 65 °C. HPLC showed conversion to the desired product. The mixture was concentrated to ca. 2 mL and then diluted with CH<sub>3</sub>CN (ca. 8 mL) and heated. Additional CH<sub>3</sub>CN was added to the hot solution until turbid. The mixture was allowed to cool slowly to room temperature with strring over 2 h. The precipitate was collected by filtration and washed with CH<sub>3</sub>CN, then Et<sub>2</sub>O, and finally hexanes. Drying afforded the title compound (156 mg) dihydrochloride as an off-white solid. A 100 mg portion was purified further by reverse phase HPLC (Gemini Phenomenex C18 5 μ, 100 mm × 300 mm), eluting with 5−90% CH<sub>3</sub>CN in water + 0.1%NH<sub>4</sub>OH) to give the title compound (55 mg) as a white solid. LC-MS (ES) <i>m</i>/<i>z</i> = 429 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.43−1.60 (m, 1H), 1.60−1.74 (m, 1H), 1.76−1.86 (m, 1H), 1.92−2.03 (m, 1H), 2.87−3.00 (m, 2H), 3.83−3.95 (m, 1H), 4.27−4.39 (m, 1H), 4.49 (bs, 1H), 5.38 (s, 2H), 6.12 (s, 2H), 6.64 (s, 1H), 7.46 (t, <i>J</i> = 7.3 Hz, 2H), 7.50−7.54 (m, 1H), 7.54−7.61 (m, 1H), 7.71 (d, <i>J</i> = 8.6 Hz, 1H), 7.87 (d, <i>J</i> = 7.1 Hz, 2H), 7.94 (s, 1H), 8.39 (d, <i>J</i> = 7.6 Hz, 1H), 11.52 (s, 1H).</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 1,1-Dimethylethyl [(3<i>R</i>,6<i>S</i>)-6-Methyl-3-piperidinyl]carbamate ((<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>35</b>)</h4><div class="NLM_p">(3<i>R</i>,6<i>S</i>)-6-Methyl-1-{[(phenylmethyl)oxy]carbonyl}-3-piperidinecarboxylic acid (prepared as described in the experimental procedure for (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28b</b>, 85 g, 307 mmol) in a 2 L RB flask was azeotroped with toluene (3 × 200 mL). The residue (an oil) was dissolved in 500 mL of <i>t</i>-butanol (anhydrous grade). To this solution was added triethylamine (64.1 mL, 460 mmol, 1.5 equiv) at room temperature in one portion. Diphenyl azidophosphate (110 g, 398 mmol, 1.3 equiv) was added via an addition funnel at room temperature portionwise into this stirred mixture. Addition took 20 min. The resulting mixture (a light-yellow clear solution) was stirred at room temperature for 30 min, followed by heating in an oil bath to 100 °C under reflux for 20 h. LC-MS showed complete conversion. The mixture was concentrated in vacuo to remove as much <i>t</i>-butanol as possible. The residue was diluted with EtOAc (1 L), which was washed with 200 mL of cold 2N HCl, followed by 200 mL of 2.5 N NaOH. The NaOH portion was salted with NaCl and back-extracted with EtOAc (400 mL). All the organic portions were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was taken up in hexane (500 mL) and EtOAc (20 mL). A waxy paste developed. The mixture was chilled in the refrigerator for 20 h, resulting in a two-phase mixture. The top layer was decanted off and gave 42 g as an oil after concentration in vacuo, which would undergo further silica gel column purification. The waxy bottom component was taken up in CHCl<sub>3</sub> (300 mL) and EtOAc (30 mL). The mixture was stirred for 5 min and filtered. The filtrate was concentrated in vacuo to give an oil (150 g), which would undergo further silica gel column purification. The waxy solids (30 g) collected were identified as (PhO)<sub>2</sub>POOH and were discarded. Silica gel column chromatography of the above two oils on multiple runs using gradient elution of 1−50% EtOAc in CHCl<sub>3</sub> gave phenylmethyl (2<i>S</i>,5<i>R</i>)-5-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-2-methyl-1-piperidinecarboxylate (88.28 g) as a thick clear syrup. LC-MS (ES) <i>m</i>/<i>z</i> = 349 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.17 (d, <i>J</i> = 7.1 Hz, 3H), 1.45 (s, 9H), 1.56−1.66 (m, 2H), 1.73−1.78 (m, 2H), 2.66 (t, <i>J</i> = 12.0 Hz, 1H), 4.41−4.44 (m, 1H), 5.14 (s, 2H), 7.31−7.39 (m, 5H).</div><div class="NLM_p last">Pd/C (6.30 g) was added to a 2 L Parr bottle, followed by addition of EtOAc (50 mL) under nitrogen. The mixture was stirred as a slurry, followed by addition of a solution of phenylmethyl (2<i>S</i>,5<i>R</i>)-5-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-2-methyl-1-piperidinecarboxylate (58 g, 166 mmol) in EtOAc (330 mL). The mixture was shaken under 50 psi of hydrogen at room temperature for 4 h. LC-MS showed complete conversion. The mixture was filtered through Celite and rinsed with EtOAc. The filtrate was concentrated in vacuo to give the title compound (35.47 g) as an oil. LC-MS (ES) <i>m</i>/<i>z</i> = 215 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.13 (d, <i>J</i> = 6.3 Hz, 3H), 1.34−1.40 (m, 1H), 1.47 (s, 9H), 1.56−1.62 (m, 1H), 1.66−1.75 (m, 1H), 1.79−1.86 (m, 1H), 2.71−2.78 (m, 1H), 2.87 (m, 1H),) 2.98−3.05 (m, 1H), 3.61 (bs, 1H).</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 1,1-Dimethylethyl {(3<i>R</i>,6<i>S</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-6-methyl-3-piperidinyl}carbamate ((<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>37c</b>)</h4><div class="NLM_p">The title compound was prepared from (<b>3<i>R</i></b>,<b>6</b><i><b>S</b></i>)-<b>35</b> following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 439 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 1.25 (d, <i>J</i> = 7.1 Hz, 3H), 1.48 (s, 9H), 1.64−1.77 (m, 2H), 1.78−1.87 (m, 2H), 2.73 (t, <i>J</i> = 12.1 Hz, 1H), 3.41−3.48 (m, 1H), 4.50−4.60 (bs, 1H), 4.75−4.85 (bs, 1H), 6.52 (s, 1H), 7.48 (d, <i>J</i> = 8.3 Hz, 1H), 7.77 (d, <i>J</i> = 8.3 Hz, 1H), 7.80 (s, 1H).</div><div class="NLM_p last">Compounds (±)-<i>cis</i>-<b>37c</b> and (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>37c</b> were prepared from (±)-<i>cis</i>-<b>35</b> and (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>35</b>, respectively, following the synthetic procedures described for (2<i>S</i>,5<i>R</i>)-<b>37c</b>.</div></div><div id="sec5_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Dimethyl (4<i>R</i>)-<i>N</i>-{[(1,1-Dimethylethyl)oxy]carbonyl}-4-methyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>38</b>)</h4><div class="NLM_p">In a 20 mL RB flask was dissolved dimethyl <span class="smallcaps smallerCapital">d</span>-glutamate (25 g, 118 mmol) in CH<sub>3</sub>OH (150 mL). Triethylamine (36.2 mL, 260 mmol) was added, followed by Boc<sub>2</sub>O (33.5 g, 154 mmol), and the reaction mixture was stirred at room temperature for 18 h. The reaction was concentrated and then dissolved in 200 mL of CH<sub>2</sub>Cl<sub>2</sub>. The resulting organic solution was washed with 1N HCl (2 × 50 mL), followed by brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification was done on a 350 g Biotage SNAP column with gradient of 0−35% EtOAc in hexane over 35 min to isolate dimethyl <i>N</i>-{[(1,1-dimethylethyl)oxy]carbonyl}-<span class="smallcaps smallerCapital">d</span>-glutamate (30.7 g) as a clear oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.38 (s, 9H), 1.79 (ddd, <i>J</i> = 14.5, 8.8, 6.1 Hz, 1H), 1.94 (t, <i>J</i> = 13.4 Hz, 1H), 2.33−2.43 (m, 2H), 3.59 (s, 3H), 3.62 (s, 3H), 4.00 (dd, <i>J</i> = 9.4, 7.6 Hz, 1H), 7.29 (d, <i>J</i> = 7.8 Hz, 1H).</div><div class="NLM_p last">Dimethyl <i>N</i>-{[(1,1-dimethylethyl)oxy]carbonyl}-<span class="smallcaps smallerCapital">d</span>-glutamate (4 g, 14.53 mmol) in THF (40 mL) was placed in a 250 mL RB flask, and it was cooled to −78 °C. LiHMDS (1.0 M in THF, 30.5 mL, 30.5 mmol) was added dropwise, and the mixture was stirred at −78 °C for 0.5 h. Methyl iodide (1.817 mL, 29.1 mmol) was then added as rapidly as possible, and the solution was stirred at −78 °C for 4.5 h. The reaction was then quenched with 1N HCl solution (40 mL) and extracted with EtOAc (3 × 50 mL). The organics were combined and washed with saturated NaHCO<sub>3</sub> followed by brine, then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give a red−amber colored oil. The oil was purified on a Biotage SNAP 50 g column with a gradient of 0 to 35% EtOAc in hexane over 35 min to give the title compound (1.37 g) as a clear oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.08 (d, <i>J</i> = 7.1 Hz, 3H), 1.38 (s, 9H), 1.71 (ddd, <i>J</i> = 13.6, 8.3, 5.1 Hz, 1H), 1.94 (ddd, <i>J</i> = 13.9, 10.1, 6.1 Hz, 1H), 2.43−2.49 (m, 1H), 3.60 (s, 3H), 3.62 (s, 3H), 4.01 (ddd, <i>J</i> = 9.9, 8.4, 5.2 Hz, 1H), 7.29 (d, <i>J</i> = 8.3 Hz, 1H).</div></div><div id="sec5_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 1,1-Dimethylethyl [(1<i>R</i>,3<i>R</i>)-4-hydroxy-1-(hydroxymethyl)-3-methylbutyl]carbamate (<b>39</b>)</h4><div class="NLM_p last">To a solution of dimethyl (4<i>R</i>)-<i>N</i>-{[(1,1-dimethylethyl)oxy]carbonyl}-4-methyl-<span class="smallcaps smallerCapital">d</span>-glutamate (1.79 g, 6.19 mmol) in ethanol (15 mL) and THF (15 mL) was added CaCl<sub>2</sub> (2.83 g, 24.8 mmol), and the resulting mixture was cooled in an ice bath. Sodium borohydride (1.873 g, 49.5 mmol) was added portionwise, and the white cloudy mixture was stirred for 0.5 h in an ice bath. The reaction was then allowed to stir overnight at room temperature. A 10% Na<sub>2</sub>CO<sub>3</sub> solution was added to quench the reaction, but the solution was too thick and an additional 20 mL of water was added. The white slurry was extracted with EtOAc (3 × 60 mL). The organics were combined and washed with saturated NaCl solution, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the crude title compound (1.56 g) as a clear oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.82 (d, <i>J</i> = 6.6 Hz, 3H), 1.18 (t, <i>J</i> = 7.1 Hz, 1H), 1.31 (d, <i>J</i> = 3.0 Hz, 1H), 1.37 (s, 9H), 1.49−1.60 (m, 1H), 3.09−3.33 (m, 4H), 3.45 (td, <i>J</i> = 7.0, 5.1 Hz, 2H), 4.37 (dt, <i>J</i> = 9.2, 5.2 Hz, 1H), 4.56 (t, <i>J</i> = 5.7 Hz, 1H).</div></div><div id="sec5_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 1,1-Dimethylethyl [(3<i>R</i>,5<i>R</i>)-5-Methyl-1-(phenylmethyl)-3-piperidinyl]carbamate (<b>40a</b>)</h4><div class="NLM_p">1,1-Dimethylethyl [(1<i>R</i>,3<i>R</i>)-4-hydroxy-1-(hydroxymethyl)-3-methylbutyl]carbamate (1.56 g, 6.69 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) in a 250 mL RB flask capped with a rubber septa. The reaction flask was charged with N<sub>2</sub> and cooled in an ice bath. Triethylamine (3.73 mL, 26.7 mmol) was added, followed by dropwise addition of methanesulfonyl chloride (1.563 mL, 20.06 mmol). After the addition, the reaction was allowed to stir at 0 °C for 1 h. The reaction was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and washed with saturated NaHCO<sub>3</sub> (30 mL) then water, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the crude (2<i>R</i>,4<i>R</i>)-2-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-4-methyl-5-[(methylsulfonyl)oxy]pentyl methanesulfonate (2.61 g). LC-MS (ES) <i>m</i>/<i>z</i> = 390 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Into a 10 mL sealable vial was added (2<i>R</i>,4<i>R</i>)-2-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-4-methyl-5-[(methylsulfonyl)oxy]pentyl methanesulfonate (1.05 g, 2.70 mmol), followed by benzylamine (5.88 mL, 53.9 mmol), and the reaction was capped and heated at 70 °C for 24 h. The reaction was allowed to cool, and then it was transferred into a 1N NaOH solution (20 mL). The resulting oily mixture was then extracted with hexane (3 × 20 mL). The combined extracts were washed with saturated NaCl solution, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography on a 20 g Biotage SNAP column with gradient elution of 0−20% EtOAc in hexane over 20 min to afford the title compound (452 mg) as a clear oil. LC-MS (ES) <i>m</i>/<i>z</i> = 305 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.85−0.92 (m, 3H), 1.22−1.28 (m, 1H), 1.37 (s, 9H), 1.50 (m, 1H), 1.90 (bs, 2H), 2.29 (bs, 2H), 2.35−2.44 (m, 1H), 3.43 (m, 2H), 3.64 (bs, 1H), 6.44 (d, <i>J</i> = 6.8 Hz, 1H), 7.24 (m, 1H), 7.31 (m, 4H).</div></div><div id="sec5_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 1,1-Dimethylethyl [(3<i>R</i>,5<i>R</i>)-5-Methyl-3-piperidinyl]carbamate (<b>41a</b>)</h4><div class="NLM_p last">Into a Parr shaker jar was added 10% Pd/C (316 mg, 0.148 mmol, Degussa type), followed by a solution of 1,1-dimethylethyl [(3<i>R</i>,5<i>R</i>)-5-methyl-1-(phenylmethyl)-3-piperidinyl]carbamate (452 mg, 1.485 mmol) in ethanol (20 mL). The Parr shaker jar was then placed into the shaker, flushed with N<sub>2</sub>, and then pressurized with hydrogen to 30 psi. The reaction was shaken at room temperature overnight. The reaction was filtered and concentrated to give the crude title compound (310 mg). LC-MS (ES) <i>m</i>/<i>z</i> = 215 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.79 (d, <i>J</i> = 6.6 Hz, 3H), 1.16−1.27 (m, 1H), 1.39 (s, 9H), 1.65 (m, 2H), 2.11 (dd, <i>J</i> = 12.4, 8.6 Hz, 1H), 2.60 (m, 2H), 2.71 (dd, <i>J</i> = 12.1, 3.0 Hz, 1H), 3.27 (d, <i>J</i> = 7.1 Hz, 1H), 6.66 (m, 1H).</div></div><div id="sec5_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 1,1-Dimethylethyl{(3<i>R</i>,5<i>R</i>)-1-[2-amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-5-methyl-3-piperidinyl}carbamate (<b>43a</b>)</h4><div class="NLM_p last">The title compound was prepared from amine <b>41a</b> following synthetic route 1. LC-MS (ES) <i>m</i>/<i>z</i> = 439 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.88 (d, <i>J</i> = 6.8 Hz, 3H), 1.29 (s, 9H), 1.37−1.52 (m, 2H), 1.68 (m, 1H), 1.93−2.07 (m, 1H), 2.83 (bs, 1H), 3.38 (bs, 1H), 3.63 (bs, 1H), 3.89 (m, 1H), 5.37 (s, 2H), 6.04 (bs, 2H), 6.49 (s, 1H), 6.82 (d, <i>J</i> = 6.3 Hz, 1H), 7.50 (d, <i>J</i> = 8.6 Hz, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.89 (s, 1H), 11.49 (s, 1H).</div></div><div id="sec5_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 1,1-Dimethylethyl Methyl[(3<i>R</i>,5<i>R</i>)-5-methyl-1-(phenylmethyl)-3-piperidinyl]carbamate (<b>40b</b>)</h4><div class="NLM_p last">To 1,1-dimethylethyl [(3<i>R</i>,5<i>R</i>)-5-methyl-1-(phenylmethyl)-3-piperidinyl]carbamate (196 mg, 0.644 mmol) in DMF (3 mL) was added NaH (60% dispersion in mineral oil, 38.6 mg, 0.966 mmol), and the resulting mixture was vigorously stirred for 30 min. CH<sub>3</sub>I (0.044 mL, 0.708 mmol) was added, and the reaction mixture was stirred for 3 h at room temperature. Saturated aqueous NaHCO<sub>3</sub> was added carefully (ca. 5 mL, initial vigorous bubbling), and the resulting mixture was poured onto water and EtOAc. The organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated. Flash chromatography on SiO<sub>2</sub> (0−30% EtOAc in hexane gradient) afforded the title compound (162 mg) as a colorless oil. LC-MS (ES) <i>m</i>/<i>z</i> = 319 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.10 (d, <i>J</i> = 7.1 Hz, 3H), 1.39−1.54 (m, 10H), 1.64−1.75 (m, 1H), 2.01 (dt, <i>J</i> = 7.0, 3.7 Hz, 1H), 2.09−2.24 (m, 2H), 2.32 (bs, 1H), 2.68 (dd, <i>J</i> = 10.5, 3.9 Hz, 1H), 2.85 (s, 3H), 3.32−3.60 (m, 2H), 7.21−7.28 (m, 1H), 7.29−7.36 (m, 4H).</div></div><div id="sec5_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 1,1-Dimethylethyl {(3<i>R</i>,5<i>R</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-5-methyl-3-piperidinyl}methylcarbamate (<b>43b</b>)</h4><div class="NLM_p">A solution of 1,1-dimethylethyl methyl[(3<i>R</i>,5<i>R</i>)-5-methyl-1-(phenylmethyl)-3-piperidinyl]carbamate (160 mg, 0.502 mmol) in ethanol (6 mL) was degassed with N<sub>2</sub> for 10 min. Pd/C 10% (Degussa type, 54 mg) was added, and the resulting mixture was stirred for 3 days at room temperature under a hydrogen atmosphere (balloon setup). The mixture was degassed with N<sub>2</sub> and filtered through an Acrodisk, rinsing with ethanol (ca. 15 mL). The filtrate was concentrated under vacuum to afford crude 1,1-dimethylethyl methyl[(3<i>R</i>,5<i>R</i>)-5-methyl-3-piperidinyl]carbamate (<b>41b</b>). LC-MS (ES) <i>m</i>/<i>z</i> = 229 [M + H]<sup>+</sup>. The residue (<b>41b</b>) was taken up into 1,4-dioxane (6 mL), and to that solution were added 4,6-dichloro-2-pyrimidinamine (79 mg, 0.477 mmol) and satd aq NaHCO<sub>3</sub> (3 mL). The mixture was stirred overnight at 100 °C in a sealed tube and then allowed to cool to room temperature. (4-Cyano-3-fluorophenyl)boronic acid (124 mg, 0.754 mmol) was added, and N<sub>2</sub> gas was bubbled through the mixture for 10 min. Pd(PPh<sub>3</sub>)<sub>4</sub> (29.0 mg, 0.025 mmol) was added, the vessel was sealed, and the reaction mixture was stirred for 4 h at 100 °C. The mixture was then poured into water and EtOAc. The organic layer was separated, and the aqueous layer was further extracted with EtOAc. The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated. Flash chromatography on SiO<sub>2</sub> (0−70% EtOAc in hexane gradient) afforded 1,1-dimethylethyl {(3<i>R</i>,5<i>R</i>)-1-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-5-methyl-3-piperidinyl}methylcarbamate (170 mg) as a thick oil. LC-MS (ES) <i>m</i>/<i>z</i> = 441 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To 1,1-dimethylethyl {(3<i>R</i>,5<i>R</i>)-1-[2-amino-6-(4-cyano-3-fluorophenyl)-4-pyrimidinyl]-5-methyl-3-piperidinyl}methylcarbamate (170 mg, 0.386 mmol) in ethanol (6 mL) was added hydrazine monohydrate (0.70 mL, 14.3 mmol), and the reaction mixture was stirred overnight at 100 °C in a sealed tube. The mixture was poured into water (ca. 150 mL), and a white precipitate formed. It was filtered, and the solid was air-dried for 2 h. The resulting white solid was dried under vacuum at 45 °C for 1 h to afford the title compound (110 mg). LC-MS (ES) <i>m</i>/<i>z</i> = 453 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.92−1.02 (m, 3H), 1.41 (s, 9H), 1.46−1.55 (m, 1H), 1.85−1.99 (m, 1H), 2.07−2.19 (m, 1H), 2.76 (s, 3H), 3.02−3.14 (m, 1H), 3.12−3.23 (m, 1H), 3.90−4.15 (m, 2H), 4.35 (m, 1H), 5.38 (s, 2H), 6.07 (s, 2H), 6.60 (s, 1H), 7.57 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 7.70 (d, <i>J</i> = 8.6 Hz, 1H), 7.95 (s, 1H), 11.50 (s, 1H).</div></div><div id="sec5_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>N</i>-{(3<i>R</i>,5<i>R</i>)-1-[2-Amino-6-(3-amino-1<i>H</i>-indazol-6-yl)-4-pyrimidinyl]-5-methyl-3-piperidinyl}-<i>N</i>,3,3-trimethylbutanamide (<b>43c</b>)</h4><div class="NLM_p">In a 20 mL sealable vial was added 1,1-dimethylethyl methyl[(3<i>R</i>,5<i>R</i>)-5-methyl-3-piperidinyl]carbamate (<b>41b</b>, 443 mg, 1.94 mmol), 4,6-dichloro-2-pyrimidinamine (477 mg, 2.91 mmol), triethylamine (0.541 mL, 3.88 mmol), and ethanol (10 mL). The vial was sealed, and the reaction mixture was heated overnight at 100 °C. The reaction was concentrated, and the resulting residue was purified by flash chromatography on SiO<sub>2</sub> (gradient: 0−55% EtOAc in hexane) to afford 1,1-dimethylethyl [(3<i>R</i>,5<i>R</i>)-1-(2-amino-6-chloro-4-pyrimidinyl)-5-methyl-3-piperidinyl]methylcarbamate (678 mg). LC-MS (ES) <i>m</i>/<i>z</i> = 356, 358 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 0.91 (d, <i>J</i> = 7.1 Hz, 3H), 1.41 (s, 9H), 1.44−1.54 (m, 1H), 1.90 (td, <i>J</i> = 11.9, 4.8 Hz, 1H), 2.04−2.17 (m, 1H), 2.72 (s, 3H), 3.01 (t, <i>J</i> = 11.5 Hz, 1H), 3.10 (dd, <i>J</i> = 13.3, 2.9 Hz, 1H), 3.79 (bs, 1H), 4.03 (m, 1H), 6.08 (s, 1H), 6.47 (bs, 2H).</div><div class="NLM_p">To 1,1-dimethylethyl [(3<i>R</i>,5<i>R</i>)-1-(2-amino-6-chloro-4-pyrimidinyl)-5-methyl-3-piperidinyl]methylcarbamate (75 mg, 0.211 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added TFA (2 mL), and the reaction was allowed to sit at room temperature for 2 h. Toluene (∼15 mL) was added, and the resulting mixture was evaporated under vacuum. To the resulting residue were added CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and Hünig’s base (0.18 mL, 1.05 mmol), followed by 3,3-dimethylbutanoyl chloride (0.03 mL, 0.21 mmol), and the resulting mixture was stirred overnight at room temperature. Saturated aqueous NaHCO<sub>3</sub> (ca. 20 mL) was added, and the resulting mixture was extracted with EtOAc (ca. 50 mL). The organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated to afford crude <i>N</i>-[(3<i>R</i>,5<i>R</i>)-1-(2-amino-6-chloro-4-pyrimidinyl)-5-methyl-3-piperidinyl]-<i>N</i>,3,3-trimethylbutanamide (<b>42</b>, 80 mg). LC-MS (ES) <i>m</i>/<i>z</i> = 354 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The title compound was prepared from compound <b>42</b> following synthetic route 1 as a mixture of rotamers. LC-MS (ES) <i>m</i>/<i>z</i> = 451 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + 1 drop D<sub>2</sub>O): δ 0.98 (m, 12H), 1.41 and 1.52 (m, 1H), 1.87−2.41 (m, 4H), 2.76 and 2.90 (s, 3H), 2.99−3.25 (m, 2H), 3.84−3.99 (m, 1H), 4.01−4.26 (m, 1H), 4.39−4.66 (m, 1H), 6.57 and 6.62 (s, 1H), 7.50−7.60 (m, 1H), 7.70 (m, 1H), 7.92 (s, 1H).</div></div></div><div id="sec5_1_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Biochemical Characterization of PDK1 Inhibitors and Crystallographic Studies</h3><div class="NLM_p">pIC<sub>50</sub> = −log<sub>10</sub> (IC<sub>50</sub>), where the IC<sub>50</sub> is the molar concentration of compound required to inhibit the kinase activity by 50%. Experimental details describing (1) the in vitro PDK1 inhibition assays for pIC<sub>50</sub> determination and (2) PDK1 crystallography (Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>) are described in a previous publication.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Crystallographic Data Collection and Refinement Statistics</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top">compd</th><th class="colsep0 rowsep0" align="center" valign="top"><b>12f</b></th><th class="colsep0 rowsep0" align="center" valign="top"><b>12k</b></th><th class="colsep0 rowsep0" align="center" valign="top">(<i>R</i>)-<b>18a</b></th><th class="colsep0 rowsep0" align="center" valign="top">(<i>S</i>)-<b>21a</b></th><th class="colsep0 rowsep0" align="center" valign="top">(3<i>S</i>,6<i>R</i>)-<b>28a</b></th><th class="colsep0 rowsep0" align="center" valign="top">(3<i>R</i>,6<i>S</i>)-<b>37c</b></th><th class="colsep0 rowsep0" align="center" valign="top"><b>43a</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDB code</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCQ">3QCQ</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCS">3QCS</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCX">3QCX</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCY">3QCY</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD0">3QD0</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD3">3QD3</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD4">3QD4</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">Data Collection</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>3<sub>2</sub>21</td><td class="colsep0 rowsep0" align="left"><i>P</i>3<sub>2</sub>21</td><td class="colsep0 rowsep0" align="left"><i>P</i>3<sub>2</sub>21</td><td class="colsep0 rowsep0" align="left"><i>P</i>3<sub>2</sub>21</td><td class="colsep0 rowsep0" align="left"><i>P</i>3<sub>2</sub>21</td><td class="colsep0 rowsep0" align="left"><i>P</i>3<sub>2</sub>21</td><td class="colsep0 rowsep0" align="left"><i>P</i>3<sub>2</sub>21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell dimensions</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a</i>, <i>b</i>, <i>c</i> (Å)</td><td class="colsep0 rowsep0" align="left">123.7, 123.7, 47.1</td><td class="colsep0 rowsep0" align="left">123.9, 123.9, 47.0</td><td class="colsep0 rowsep0" align="left">123.4, 123.4, 47.0</td><td class="colsep0 rowsep0" align="left">123.7, 123.7, 47.1</td><td class="colsep0 rowsep0" align="left">123.9, 123.9, 47.0</td><td class="colsep0 rowsep0" align="left">123.5, 123.5, 46.9</td><td class="colsep0 rowsep0" align="left">124.3, 124.3, 47.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α, β, γ (deg)</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">99−2.5 (2.6−2.5)</td><td class="colsep0 rowsep0" align="left">50−2.5 (2.6−2.5)</td><td class="colsep0 rowsep0" align="left">30−2.3 (2.38−2.3)</td><td class="colsep0 rowsep0" align="left">30−2.2 (2.28−2.2)</td><td class="colsep0 rowsep0" align="left">30−2.0 (2.03−2.0)</td><td class="colsep0 rowsep0" align="left">30−2.0 (2.07−2.0)</td><td class="colsep0 rowsep0" align="left">30−2.3 (2.38−2.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>sym</sub> or <i>R</i><sub>merge</sub></td><td class="colsep0 rowsep0" align="left">0.114 (0.524)</td><td class="colsep0 rowsep0" align="left">0.091 (0.484)</td><td class="colsep0 rowsep0" align="left">0.077 (0.537)</td><td class="colsep0 rowsep0" align="left">0.086 (0.483)</td><td class="colsep0 rowsep0" align="left">0.082 (0.668)</td><td class="colsep0 rowsep0" align="left">0.10 (0.573)</td><td class="colsep0 rowsep0" align="left">0.078 (0.582)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>I</i>/σ<i>I</i></td><td class="colsep0 rowsep0" align="left">26.8 (3)</td><td class="colsep0 rowsep0" align="left">22.1 (3.3)</td><td class="colsep0 rowsep0" align="left">18.8 (2.7)</td><td class="colsep0 rowsep0" align="left">21.5 (4.2)</td><td class="colsep0 rowsep0" align="left">25.7(4.1)</td><td class="colsep0 rowsep0" align="left">20.0 (3.7)</td><td class="colsep0 rowsep0" align="left">23.9 (3.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">99.6 (99.0)</td><td class="colsep0 rowsep0" align="left">99.8 (98.8)</td><td class="colsep0 rowsep0" align="left">99.9(99.7)</td><td class="colsep0 rowsep0" align="left">99.9 (100)</td><td class="colsep0 rowsep0" align="left">100 (100)</td><td class="colsep0 rowsep0" align="left">100 (100)</td><td class="colsep0 rowsep0" align="left">99.9 (100)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">redundancy</td><td class="colsep0 rowsep0" align="left">10 (5.3)</td><td class="colsep0 rowsep0" align="left">10.2 (6.9)</td><td class="colsep0 rowsep0" align="left">4.9 (4.3)</td><td class="colsep0 rowsep0" align="left">6.2 (6.1)</td><td class="colsep0 rowsep0" align="left">8.7 (8.6)</td><td class="colsep0 rowsep0" align="left">7.4 (7.1)</td><td class="colsep0 rowsep0" align="left">7.1 (6.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">Refinement</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)</td><td class="colsep0 rowsep0" align="left">43 − 2.5</td><td class="colsep0 rowsep0" align="left">41 − 2.5</td><td class="colsep0 rowsep0" align="left">28 − 2.3</td><td class="colsep0 rowsep0" align="left">30 − 2.2</td><td class="colsep0 rowsep0" align="left">28 − 2.0</td><td class="colsep0 rowsep0" align="left">29 − 2.0</td><td class="colsep0 rowsep0" align="left">30 − 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. reflections</td><td class="colsep0 rowsep0" align="left">14029</td><td class="colsep0 rowsep0" align="left">14265</td><td class="colsep0 rowsep0" align="left">17623</td><td class="colsep0 rowsep0" align="left">20458</td><td class="colsep0 rowsep0" align="left">28628</td><td class="colsep0 rowsep0" align="left">26925</td><td class="colsep0 rowsep0" align="left">17921</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub>/<i>R</i><sub>free</sub></td><td class="colsep0 rowsep0" align="left">0.182/0.251</td><td class="colsep0 rowsep0" align="left">0.182/0.251</td><td class="colsep0 rowsep0" align="left">0.180/0.225</td><td class="colsep0 rowsep0" align="left">0.178/0.212</td><td class="colsep0 rowsep0" align="left">0.189/0.231</td><td class="colsep0 rowsep0" align="left">0.183/0.211</td><td class="colsep0 rowsep0" align="left">0.194/0.244</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">no. atoms</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein</td><td class="colsep0 rowsep0" align="left">2328</td><td class="colsep0 rowsep0" align="left">2261</td><td class="colsep0 rowsep0" align="left">2244</td><td class="colsep0 rowsep0" align="left">2233</td><td class="colsep0 rowsep0" align="left">2226</td><td class="colsep0 rowsep0" align="left">2280</td><td class="colsep0 rowsep0" align="left">2245</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligand</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water/ion</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">109</td><td class="colsep0 rowsep0" align="left">132</td><td class="colsep0 rowsep0" align="left">133</td><td class="colsep0 rowsep0" align="left">121</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left"><i>B</i> factors</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein</td><td class="colsep0 rowsep0" align="left">41.1</td><td class="colsep0 rowsep0" align="left">43.4</td><td class="colsep0 rowsep0" align="left">41.6</td><td class="colsep0 rowsep0" align="left">29.6</td><td class="colsep0 rowsep0" align="left">31.0</td><td class="colsep0 rowsep0" align="left">25.4</td><td class="colsep0 rowsep0" align="left">39.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligand</td><td class="colsep0 rowsep0" align="left">29.8</td><td class="colsep0 rowsep0" align="left">29.1</td><td class="colsep0 rowsep0" align="left">30.0</td><td class="colsep0 rowsep0" align="left">21.7</td><td class="colsep0 rowsep0" align="left">22.1</td><td class="colsep0 rowsep0" align="left">18.2</td><td class="colsep0 rowsep0" align="left">28.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water/ion</td><td class="colsep0 rowsep0" align="left">63.5</td><td class="colsep0 rowsep0" align="left">69.9</td><td class="colsep0 rowsep0" align="left">51.5</td><td class="colsep0 rowsep0" align="left">43.0</td><td class="colsep0 rowsep0" align="left">38.3</td><td class="colsep0 rowsep0" align="left">31.2</td><td class="colsep0 rowsep0" align="left">42.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">rms deviations</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bond lengths (Å)</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.010</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bond angles (deg)</td><td class="colsep0 rowsep0" align="left">1.13</td><td class="colsep0 rowsep0" align="left">0.96</td><td class="colsep0 rowsep0" align="left">1.35</td><td class="colsep0 rowsep0" align="left">0.97</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.17</td><td class="colsep0 rowsep0" align="left">1.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last">Values in parentheses are for highest-resolution shell.</p></div></div></div></div><div id="sec5_1_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Phospho-AKT (S473, T308, Total AKT) and Phospho-RSK ELISA</h3><div class="NLM_p">PC3 cells (ATCC, Manassas, VA) were plated in 96-well flat bottom plates (Corning, Lowell, MA) at a density of 15000 cells/well in RPMI 1640 medium supplemented with 10% FBS. Cells were incubated at 37 °C, 5% CO<sub>2</sub>, for 18−20 h. Compounds (dissolved in 100% DMSO) were diluted in an 11-point 3-fold dilution in DMSO. Compound dilution stocks were further diluted in RPMI 1640 with 10% FBS and added to each cell well. DMSO without compound was used in control wells. Final concentration of DMSO in each well was 0.15%. After 6 h at 37 °C, cells were washed with cold PBS (without calcium or magnesium) and lysed in lysis buffer (Meso Scale Discovery, Gaithersburg, MD) supplemented with 1 protease inhibitor tablet/10 mL (Roche, Indianapolis, IN), 10 mM NaF, and 200 μL/10 mL Sigma phosphatase inhibitors 1 and 2 (Sigma Aldrich, St Louis, MO) for 30 min at 4 °C. All washes were performed on a Bio Tek ELx405 plate washer (Bio Tek Instruments, Winooski, VT).</div><div class="NLM_p last">ELISA plates (Meso Scale Discovery; AKT Duplex, cat. N41100B-1; phospho AKT, cat. N411CAB-1; RSK, cat. N41ZB-1) were prepared by the addition of blocking buffer (3% Blocker A diluted in wash buffer (Meso Scale Discovery) for AKT duplex assay and phospho AKT assays; 5% Blocker A/1% Blocker B in Tris-buffered saline for RSK) for 1 h and washed with wash buffer. Lysates were transferred to assay wells and incubated overnight at 4 °C. Following washing with wash buffer, detection buffer (1% Blocker A in wash buffer for AKT duplex and phospho AKT or 1% Blocker A in TBS for RSK) with appropriate antibodies was added. Detection of AKT duplex and phospho AKT was carried out using a sulfo-tagged detection antibodies (Meso Scale Discovery). Detection of phospho-RSK was carried out sequentially with anti phospho-RSK1 (S221)/RSK2 (S227) (R&D Systems, Minneapolis, MN, cat. AF892) and goat antirabbit sulfo-tag antibody (cat R32AB-1; Meso Scale Discovery). Plates were incubated for 1 h at room temperature and washed with wash buffer. Plates were read on a SECTOR Imager 6000 (Meso Scale Discovery) using Workbench software (Meso Scale Discovery) following addition of read buffer (Meso Scale Discovery) to each well. For analysis, phospho-AKT (S473) signals were normalized to total AKT, while phospho-AKT (T308) and phospho-RSK signals were analyzed without normalization. All values were expressed as percent of the DMSO-treated controls. IC<sub>50</sub>s were determined from inhibition curves using XLfit4 software (IDBS, Guildford, UK).</div></div><div id="sec5_1_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Pharmacodynamic Studies</h3><div class="NLM_p last">Female SCID mice bearing subcutaneous OCI-AML2 tumor xenografts of ∼500−600 mm<sup>3</sup> in size were treated with vehicle (1% DMSO, 20% PEG400, pH 4.2) or PDK1 inhibitor (100 mg/kg) by intraperitoneal administration. Three and six hours later, 10 μg of hIGF-I (via the tail vein) were administered, and animals were euthanized after 10 min for collection of tumor tissue and blood. Frozen tumors samples were homogenized in lysis buffer and analyzed for phosphor- and total AKT and RSK by ELISA, as described above. Concentration of compound in the blood and tumor samples was also analyzed by LC/MS/MS.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesús R. Medina</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2248475157510c500c4f47464b4c43624551490c414d4f"><span class="__cf_email__" data-cfemail="7b111e080e08550955161e1f12151a3b1c081055181416">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Becker</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles W. Blackledge</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celine Duquenne</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanhong Feng</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seth W. Grant</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Heerding</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William H. Li</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William H. Miller</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart P. Romeril</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daryl Scherzer</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur Shu</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. Bobko</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antony R. Chadderton</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Dumble</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine M. Gardiner</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seth Gilbert</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Liu</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sridhar K. Rabindran</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valery Sudakin</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Xiang</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pat G. Brady</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nino Campobasso</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paris Ward</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey M. Axten</span> - <span class="hlFld-Affiliation affiliation">‡Oncology Research and §Molecular Discovery Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm101527u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i101" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i101"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i102" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i102"> Abbreviations Used</h2><tr><td class="NLM_term">PDK1</td><td class="NLM_def"><p class="first last">phosphoinositide-dependent protein kinase-1</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">PIP2</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3,4,-diphosphate</p></td></tr><tr><td class="NLM_term">PIP3</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3,4,5-triphosphate</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">SGK</td><td class="NLM_def"><p class="first last">serum- and glucocorticoid-induced protein kinase</p></td></tr><tr><td class="NLM_term">S6K1</td><td class="NLM_def"><p class="first last">p70 ribosomal S6 kinase</p></td></tr><tr><td class="NLM_term">RSK</td><td class="NLM_def"><p class="first last">p90 ribosomal S6 kinase</p></td></tr><tr><td class="NLM_term">ALK5</td><td class="NLM_def"><p class="first last">TGF-β type I receptor</p></td></tr><tr><td class="NLM_term">ROCK1</td><td class="NLM_def"><p class="first last">Rho-associated protein kinase-1</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">G-loop</td><td class="NLM_def"><p class="first last">glycine rich loop</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Pearce, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">The nuts and bolts of AGC protein kinases</span> <span class="citation_source-journal">Nature Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1038%2Fnrm2822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=20027184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFymt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=9-22&author=L.+R.+Pearceauthor=D.+Komanderauthor=D.+R.+Alessi&title=The+nuts+and+bolts+of+AGC+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The nuts and bolts of AGC protein kinases</span></div><div class="casAuthors">Pearce, Laura R.; Komander, David; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-22</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The AGC kinase subfamily of protein kinases contains 60 members, including protein kinase A (PKA), protein kinase G (PKG), and protein kinase C (PKC).  The family comprises some intensely examd. protein kinases (such as Akt, S6K, RSK, MSK, PDK1 and GRK) as well as many less well-studied enzymes (such as SGK, NDR, LATS, CRIK, SGK494, PRKX, PRKY, and MAST).  Research has shed new light onto the architecture and regulatory mechanisms of these kinases.  In addn., AGC kinases mediate diverse and important cellular functions, and their mutation and/or dysregulation contributes to the pathogenesis of many human diseases, including cancer and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDlqo5AR3FN7Vg90H21EOLACvtfcHk0lgC196mLT3T9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFymt7bI&md5=9752bf2068b10ab67b97e257f1f127d5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm2822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2822%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DL.%2BR.%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DThe%2520nuts%2520and%2520bolts%2520of%2520AGC%2520protein%2520kinases%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mora, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aalten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">PDK1, the master regulator of AGC kinase signal transduction</span> <span class="citation_source-journal">Semin. Cell. Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2Fj.semcdb.2003.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=15209375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=161-170&author=A.+Moraauthor=D.+Komanderauthor=D.+M.+Van+Aaltenauthor=D.+R.+Alessi&title=PDK1%2C+the+master+regulator+of+AGC+kinase+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PDK1, the master regulator of AGC kinase signal transduction</span></div><div class="casAuthors">Mora, Alfonso; Komander, David; van Aalten, Daan M. F.; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The interaction of insulin and growth factors with their receptors on the outside surface of a cell, leads to the activation of phosphatidylinositol 3-kinase (PI 3-kinase) and generation of the phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) second messenger at the inner surface of the cell membrane.  One of the most studied signaling events controlled by PtdIns(3,4,5)P3, comprises the activation of a group of AGC family protein kinases, including isoforms of protein kinase B (PKB)/Akt, p70 ribosomal S6 kinase (S6K), serum- and glucocorticoid-induced protein kinase (SGK) and protein kinase C (PKC), which play crucial roles in regulating physiol. processes relevant to metab., growth, proliferation and survival.  Here, we review recent biochem., genetic and structural studies on the 3-phosphoinositide-dependent protein kinase-1 (PDK1), which phosphorylates and activates the AGC kinase members regulated by PI 3-kinase.  We also discuss whether inhibitors of PDK1 might have chemotherapeutic potential in the treatment of cancers in which the PDK1-regulated AGC kinases are constitutively activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqieBvmRgWKULVg90H21EOLACvtfcHk0lgC196mLT3T9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFWlu7Y%253D&md5=928f74f6fcaf5ea8228ede20142eaa4a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2003.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2003.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DMora%26aufirst%3DA.%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DVan%2BAalten%26aufirst%3DD.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DPDK1%252C%2520the%2520master%2520regulator%2520of%2520AGC%2520kinase%2520signal%2520transduction%26jtitle%3DSemin.%2520Cell.%2520Dev.%2520Biol.%26date%3D2004%26volume%3D15%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, P. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2FS0960-9822%2806%2900122-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=9094314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFOjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=261-269&author=D.+R.+Alessiauthor=S.+R.+Jamesauthor=C.+P.+Downesauthor=A.+B.+Holmesauthor=P.+R.+J.+Gaffneyauthor=C.+B.+Reeseauthor=P.+Cohen&title=Characterization+of+a+3-phosphoinositide-dependent+protein+kinase+which+phosphorylates+and+activates+protein+kinase+B%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα</span></div><div class="casAuthors">Alessi, Dario R.; James, Stephen R.; Downes, C. Peter; Holmes, Andrew B.; Gaffney, Piers R. J.; Reese, Colin B.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Protein kinase B (PKB), also known as c-Akt, is activated rapidly when mammalian cells are stimulated with insulin and growth factors, and much of the current interest in this enzyme stems from the observation that it lies 'downstream' of phosphoinositide 3-kinase on intracellular signaling pathways.  We recently showed that insulin or insulin-like growth factor 1 induce the phosphorylation of PKB at two residues, Thr308 and Ser473.  The phosphorylation of both residues is required for maximal activation of PKB. The kinases that phosphorylate PKB are, however, unknown.  We have purified 500,000-fold from rabbit skeletal muscle exts. a protein kinase which phosphorylates PKBα at Thr308 and increases its activity over 30-fold.  We tested the kinase in the presence of several inositol phospholipids and found that only low micromolar concns. of the D enantiomers of either phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) or PtdIns(3,4)P2 were effective in potently activating the kinase, which has been named PtdIns(3,4,5)P3-dependent protein kinase-1 (PDK1).  None of the inositol phospholipids tested activated or inhibited PKBα or induced its phosphorylation under the conditions used.  PDK1 activity was not affected by wortmannin, indicating that it is not likely to be a member of the phosphoinositide 3-kinase family.  PDK1 is likely to be one of the protein kinases that mediate the activation of PKB by insulin and growth factors.  PDK1 may, therefore, play a key role in mediating many of the actions of the second messenger(s) PtdIns(3,4,5)P3 and/or PtdIns(3,4)P2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2sSM5v7MnWrVg90H21EOLACvtfcHk0liKOgjz6nv1xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFOjtb8%253D&md5=7f3794216810a4273d091b8d4590aaa9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2806%2900122-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252806%252900122-9%26sid%3Dliteratum%253Aachs%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DJames%26aufirst%3DS.%2BR.%26aulast%3DDownes%26aufirst%3DC.%2BP.%26aulast%3DHolmes%26aufirst%3DA.%2BB.%26aulast%3DGaffney%26aufirst%3DP.%2BR.%2BJ.%26aulast%3DReese%26aufirst%3DC.%2BB.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520a%25203-phosphoinositide-dependent%2520protein%2520kinase%2520which%2520phosphorylates%2520and%2520activates%2520protein%2520kinase%2520B%25CE%25B1%26jtitle%3DCurr.%2520Biol.%26date%3D1997%26volume%3D7%26spage%3D261%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Biondi, R. M.</span><span> </span><span class="NLM_article-title">Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=136-142&author=R.+M.+Biondi&title=Phosphoinositide-dependent+protein+kinase+1%2C+a+sensor+of+protein+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26atitle%3DPhosphoinositide-dependent%2520protein%2520kinase%25201%252C%2520a%2520sensor%2520of%2520protein%2520conformation%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2004%26volume%3D29%26spage%3D136%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAKT+Pathway+for+Cancer+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAKT%2520Pathway%2520for%2520Cancer%2520Drug%2520Discovery%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating Downstream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=AKT%2FPKB+Signaling%3A+Navigating+Downstream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520Downstream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiades, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutsilieris, M.</span><span> </span><span class="NLM_article-title">The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.2174%2F1568009043333032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=15134532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Gnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=235-256&author=C.+S.+Mitsiadesauthor=N.+Misiadesauthor=M.+Koutsilieris&title=The+Akt+Pathway%3A+Molecular+Targets+for+Anti-Cancer+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt pathway: Molecular targets for anti-cancer drug development</span></div><div class="casAuthors">Mitsiades, Constantine S.; Mitsiades, Nicholas; Koutsilieris, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-256</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serine/threonine kinase Akt functions intracellularly as a cardinal nodal point for a constellation of converging upstream signaling pathways, which involve stimulation of receptor tyrosine kinases such as IGR-1R, HER2/Neu, VEGF-R, PDGF-R, and an assembly of membrane-localized complexes of receptor-PI-3K and activation of Akt through the second messenger PIP3.  The integration of these intracellular signals at the level of Akt and its kinase activity, regulates the phosphorylation of its several downstream effectors, such as NF-κB, mTOR, Forkhead, Bad, GSK-3 and MDM-2.  These phosphorylation events in turn mediate the effects of Akt on cell growth, proliferation, protection from pro-apoptotic stimuli, and stimulation of neoangiogenesis.  Because Akt and its upstream regulators are deregulated in a wide range of solid tumors and hematol. malignancies, and in view of the aforementioned biol. sequelae of this pathway, the Akt pathway is considered a key determinant of biol. aggressiveness of these tumors, and a major potential target for novel anti-cancer therapies.  This review focuses on ongoing translational efforts to therapeutically target Akt and its biol. sequelae, either at the level of Akt itself or at the levels of its upstream regulators and downstream effectors.  Because Akt is also important for proliferative and anti-apoptotic signaling pathways crit. for normal cells, particular emphasis is placed on the fine-tuning the targeting of individual components of this pathway to maximize the therapeutic index of anti-cancer strategies based on the PI-3K/Akt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGZbuqTPNYgLVg90H21EOLACvtfcHk0liKOgjz6nv1xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Gnu78%253D&md5=299909de4babdbbf0e242bd1a7abdab1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568009043333032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009043333032%26sid%3Dliteratum%253Aachs%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26aulast%3DMisiades%26aufirst%3DN.%26aulast%3DKoutsilieris%26aufirst%3DM.%26atitle%3DThe%2520Akt%2520Pathway%253A%2520Molecular%2520Targets%2520for%2520Anti-Cancer%2520Drug%2520Development%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2004%26volume%3D4%26spage%3D235%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bayascas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Hypomorphic Mutations of PDK1 Suppresses Tumorigenesis in PTEN<sup>±</sup> Mice</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1839</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2Fj.cub.2005.08.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=16243031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1839-1846&author=J.+R.+Bayascasauthor=N.+R.+Leslieauthor=R.+Parsonsauthor=S.+Flemingauthor=D.+R.+Alessi&title=Hypomorphic+Mutations+of+PDK1+Suppresses+Tumorigenesis+in+PTEN%C2%B1+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hypomorphic Mutation of PDK1 Suppresses Tumorigenesis in PTEN+/- Mice</span></div><div class="casAuthors">Bayascas, Jose R.; Leslie, Nick R.; Parsons, Ramon; Fleming, Stewart; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1839-1846</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many cancers possess elevated levels of PtdIns(3,4,5)P3, the second messenger that induces activation of the protein kinases PKB/Akt and S6K and thereby stimulates cell proliferation, growth, and survival.  The importance of this pathway in tumorigenesis has been highlighted by the finding that PTEN, the lipid phosphatase that breaks down PtdIns(3,4,5)P3 to PtdIns(4,5)P2, is frequently mutated in human cancer.  Cells lacking PTEN possess elevated levels of PtdIns(3,4,5)P3, PKB, and S6K activity and heterozygous PTEN+/- mice develop a variety of tumors.  Knockout of PKBα in PTEN-deficient cells reduces aggressive growth and promotes apoptosis , whereas treatment of PTEN+/- mice with rapamycin, an inhibitor of the activation of S6K, reduces neoplasia.  We explored the importance of PDK1, the protein kinase that activates PKB and S6K , in mediating tumorigenesis caused by the deletion of PTEN.  We demonstrate that reducing the expression of PDK1 in PTEN+/- mice, markedly protects these animals from developing a wide range of tumors.  Our findings provide genetic evidence that PDK1 is a key effector in mediating neoplasia resulting from loss of PTEN and also validate PDK1 as a promising anticancer target for the prevention of tumors that possess elevated PKB and S6K activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSldKloWT-v7Vg90H21EOLACvtfcHk0ljPigUJWFM6AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjsL%252FO&md5=faf47bff1fc7b8b2d3d17911e21584e9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.08.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.08.066%26sid%3Dliteratum%253Aachs%26aulast%3DBayascas%26aufirst%3DJ.%2BR.%26aulast%3DLeslie%26aufirst%3DN.%2BR.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DHypomorphic%2520Mutations%2520of%2520PDK1%2520Suppresses%2520Tumorigenesis%2520in%2520PTEN%25C2%25B1%2520Mice%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D1839%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Flynn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span> </span><span class="NLM_article-title">Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1439</span><span class="NLM_x">–</span> <span class="NLM_lpage">1442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2FS0960-9822%2800%2900801-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=11102805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlGisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1439-1442&author=P.+Flynnauthor=M.+Wongauthor=M.+Zavarauthor=N.+M.+Deanauthor=D.+Stokoe&title=Inhibition+of+PDK-1+activity+causes+a+reduction+in+cell+proliferation+and+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 3-phosphoinositide-dependent kinase-1 activity causes a reduction in cell proliferation and survival in human glioblastoma cells</span></div><div class="casAuthors">Flynn, P.; Wong, M.; Zavar, M.; Dean, N. M.; Stokoe, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1439-1442</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">3-Phosphoinositide-dependent kinase-1 (PDK-1) was identified by its ability to phosphorylate and activate protein kinase B (PKB) in vitro and can phosphorylate and activate addnl. protein kinases in the AGC family in vitro.  Its role in vivo has, however, only begun to be addressed.  We used antisense oligonucleotides directed against PDK-1 expression to explore the role of PDK-1 in human glioblastoma cells (U87-MG), which express a mutant PTEN allele.  Redn. in PDK-1 levels resulted in inhibition of PKB activity, and a redn. in phosphorylation on Thr308 and Ser473 of PKB.  P70 S6 kinase (p70SK) activity was also reduced.  Cell proliferation was dramatically inhibited following treatment with PDK-1 antisense oligonucleotides, due to a combination of decreased cell doubling and an increase in apoptosis.  This is in contrast to direct inhibition of phosphoinositide 3-OH kinase (PI 3-kinase), which results in G1 arrest with no effect on apoptosis.  This study confirms both PKB and p70S6K as in vivo substrates for PDK-1.  The effect of acute PDK-1 loss on cell proliferation and survival suggests the involvement of PI 3-kinase dependent and independent signaling events, and implicates PDK-1 as a potential therapeutic target for human neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqezSgKGu1ot7Vg90H21EOLACvtfcHk0ljPigUJWFM6AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlGisLo%253D&md5=864fc5bc85e157be3422306fd6d1afa6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2800%2900801-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252800%252900801-0%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DZavar%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DN.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520PDK-1%2520activity%2520causes%2520a%2520reduction%2520in%2520cell%2520proliferation%2520and%2520survival%26jtitle%3DCurr.%2520Biol.%26date%3D2000%26volume%3D10%26spage%3D1439%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Iorns, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Parallel RNAi and compound screens identify the PDK1 pathway for tamoxifen sensitization</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2009&pages=361-370&author=E.+Iornsauthor=C.+J.+Lordauthor=A.+Ashworth&title=Parallel+RNAi+and+compound+screens+identify+the+PDK1+pathway+for+tamoxifen+sensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIorns%26aufirst%3DE.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DParallel%2520RNAi%2520and%2520compound%2520screens%2520identify%2520the%2520PDK1%2520pathway%2520for%2520tamoxifen%2520sensitization%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D417%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tamgüney, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span> </span><span class="NLM_article-title">Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2Fj.yexcr.2008.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=18514190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A280%3ADC%252BD1czpvFCktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2008&pages=2299-2312&author=T.+Tamg%C3%BCneyauthor=C.+Zhangauthor=D.+Fiederauthor=K.+Shokatauthor=D.+Stokoe&title=Analysis+of+3-phosphoinositide-dependent+kinase-1+signaling+and+function+in+ES+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells</span></div><div class="casAuthors">Tamguney Tanja; Zhang Chao; Fiedler Dorothea; Shokat Kevan; Stokoe David</div><div class="citationInfo"><span class="NLM_cas:title">Experimental cell research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2299-312</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">3-phosphoinositide-dependent kinase-1 (PDK1) phosphorylates and activates several kinases in the cAMP-dependent, cGMP-dependent and protein kinase C (AGC) family.  Many putative PDK1 substrates have been identified, but have not been analyzed following transient and specific inhibition of PDK1 activity.  Here, we demonstrate that a previously characterized PDK1 inhibitor, BX-795, shows biological effects that are not consistent with PDK1 inhibition.  Therefore, we describe the creation and characterization of a PDK1 mutant, L159G, which can bind inhibitor analogues containing bulky groups that hinder access to the ATP binding pocket of wild type (WT) kinases.  When expressed in PDK1(-/-) ES cells, PDK1 L159G restored phosphorylation of PDK1 targets known to be hypophosphorylated in these cells.  Screening of multiple inhibitor analogues showed that 1-NM-PP1 and 3,4-DMB-PP1 optimally inhibited the phosphorylation of PDK1 targets in PDK1(-/-) ES cells expressing PDK1 L159G but not WT PDK1.  These compounds confirmed previously assumed PDK1 substrates, but revealed distinct dephosphorylation kinetics.  While PDK1 inhibition had little effect on cell growth, it sensitized cells to apoptotic stimuli.  Furthermore, PDK1 loss abolished growth of allograft tumors.  Taken together we describe a model system that allows for acute and reversible inhibition of PDK1 in cells, to probe biochemical and biological consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQh3Amc1EGikudfST00W0BcfW6udTcc2ea18qvykOiWd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czpvFCktg%253D%253D&md5=c599aebb40c985a56df5133423dd89de</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2008.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2008.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DTamg%25C3%25BCney%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DFieder%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%26aulast%3DStokoe%26aufirst%3DD.%26atitle%3DAnalysis%2520of%25203-phosphoinositide-dependent%2520kinase-1%2520signaling%2520and%2520function%2520in%2520ES%2520cells%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2008%26volume%3D314%26spage%3D2299%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banfi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casuscelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccotto, F.</span><span> </span><span class="NLM_article-title">Structure-based optimization of potent PDK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4095-4099&author=M.+Angioliniauthor=P.+Banfiauthor=E.+Casaleauthor=F.+Casuscelliauthor=C.+Fiorelliauthor=M.+B.+Saccardoauthor=M.+Silvagniauthor=F.+Zuccotto&title=Structure-based+optimization+of+potent+PDK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DBanfi%26aufirst%3DP.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCasuscelli%26aufirst%3DF.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DSilvagni%26aufirst%3DM.%26aulast%3DZuccotto%26aufirst%3DF.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%2520PDK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4095%26epage%3D4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nittoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingalls, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[<i>c</i>]naphthyridin-4-ylamines as potent inhinitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1379</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1379-1386&author=T.+Nittoliauthor=R.+G.+Dushinauthor=C.+Ingallsauthor=K.+Cheungauthor=M.+B.+Floydauthor=H.+Fraserauthor=A.+Ollandauthor=Y.+Huauthor=G.+Grosuauthor=X.+Hanauthor=K.+Arndtauthor=B.+Guoauthor=A.+Wissner&title=The+identification+of+8%2C9-dimethoxy-5-%282-aminoalkoxy-pyridin-3-yl%29-benzo%5Bc%5Dnaphthyridin-4-ylamines+as+potent+inhinitors+of+3-phosphoinositide-dependent+kinase-1+%28PDK-1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNittoli%26aufirst%3DT.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DIngalls%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DFraser%26aufirst%3DH.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGrosu%26aufirst%3DG.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DThe%2520identification%2520of%25208%252C9-dimethoxy-5-%25282-aminoalkoxy-pyridin-3-yl%2529-benzo%255Bc%255Dnaphthyridin-4-ylamines%2520as%2520potent%2520inhinitors%2520of%25203-phosphoinositide-dependent%2520kinase-1%2520%2528PDK-1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1379%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Barile, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riel-Mehan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Structure−Activity Relationships of 3-Ethynyl-1<i>H</i>-indazoles as Inhibitors of the Phosphatidylinositol 3-Kinase Signaling Pathway</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8368</span><span class="NLM_x">–</span> <span class="NLM_lpage">8375</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100825h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8368-8375&author=E.+Barileauthor=S.+K.+Deauthor=C.+B.+Carlsonauthor=V.+Chenauthor=C.+Knutzenauthor=M.+Riel-Mehanauthor=L.+Yangauthor=R.+Dahlauthor=G.+Chiangauthor=M.+Pellecchia&title=Design%2C+Synthesis%2C+and+Structure%E2%88%92Activity+Relationships+of+3-Ethynyl-1H-indazoles+as+Inhibitors+of+the+Phosphatidylinositol+3-Kinase+Signaling+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm100825h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100825h%26sid%3Dliteratum%253Aachs%26aulast%3DBarile%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DS.%2BK.%26aulast%3DCarlson%26aufirst%3DC.%2BB.%26aulast%3DChen%26aufirst%3DV.%26aulast%3DKnutzen%26aufirst%3DC.%26aulast%3DRiel-Mehan%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DChiang%26aufirst%3DG.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%2520of%25203-Ethynyl-1H-indazoles%2520as%2520Inhibitors%2520of%2520the%2520Phosphatidylinositol%25203-Kinase%2520Signaling%2520Pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8368%26epage%3D8375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span> </span><span class="NLM_article-title">Benzo[<i>c</i>][2,7]naphthyridines as inhibitors of PDK-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5225</span><span class="NLM_x">–</span> <span class="NLM_lpage">5228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5225-5228&author=K.+H.+Kimauthor=A.+Wissnerauthor=M.+B.+Floydauthor=H.+L.+Fraserauthor=Y.+D.+Wangauthor=R.+G.+Dushinauthor=Y.+Huauthor=A.+Ollandauthor=B.+Guoauthor=K.+Arndt&title=Benzo%5Bc%5D%5B2%2C7%5Dnaphthyridines+as+inhibitors+of+PDK-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DFraser%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BD.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DArndt%26aufirst%3DK.%26atitle%3DBenzo%255Bc%255D%255B2%252C7%255Dnaphthyridines%2520as%2520inhibitors%2520of%2520PDK-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5225%26epage%3D5228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Echeverría, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garc%C3%ADa-Echeverr%C3%ADa&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of PDK1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1810</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1810-1838&author=C.+Peiferauthor=D.+R.+Alessi&title=Small-Molecule+Inhibitors+of+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520PDK1%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1810%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campobasso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span> </span><span class="NLM_article-title">Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100136n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=439-442&author=J.+R.+Medinaauthor=C.+W.+Blackledgeauthor=D.+A.+Heerdingauthor=N.+Campobassoauthor=P.+Wardauthor=J.+Briandauthor=L.+Wrightauthor=J.+M.+Axten&title=Aminoindazole+PDK1+Inhibitors%3A+A+Case+Study+in+Fragment-Based+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml100136n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100136n%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DBlackledge%26aufirst%3DC.%2BW.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DBriand%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26atitle%3DAminoindazole%2520PDK1%2520Inhibitors%253A%2520A%2520Case%2520Study%2520in%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D439%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Lapuyade, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlewer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermuth, C. G.</span><span> </span><span class="NLM_article-title">Synthesis and conformation analysis of methyl- and phenyl substituted nipecotic acid</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=663-668&author=G.+Lapuyadeauthor=G.+Schlewerauthor=C.+G.+Wermuth&title=Synthesis+and+conformation+analysis+of+methyl-+and+phenyl+substituted+nipecotic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLapuyade%26aufirst%3DG.%26aulast%3DSchlewer%26aufirst%3DG.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26atitle%3DSynthesis%2520and%2520conformation%2520analysis%2520of%2520methyl-%2520and%2520phenyl%2520substituted%2520nipecotic%2520acid%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1986%26spage%3D663%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">The absolute configuration was determined later from the X-ray crystal structure of the final compound (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> bound to PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Breuning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winnacker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, M.</span><span> </span><span class="NLM_article-title">Efficient One-Pot Synthesis of Enantiomerically Pure 2-(hydroxymethyl)-morpholines</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2100-2106&author=M.+Breuningauthor=M.+Winnackerauthor=M.+Steiner&title=Efficient+One-Pot+Synthesis+of+Enantiomerically+Pure+2-%28hydroxymethyl%29-morpholines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreuning%26aufirst%3DM.%26aulast%3DWinnacker%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DM.%26atitle%3DEfficient%2520One-Pot%2520Synthesis%2520of%2520Enantiomerically%2520Pure%25202-%2528hydroxymethyl%2529-morpholines%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26spage%3D2100%26epage%3D2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabowski, E. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J. A</span><span> </span><span class="NLM_article-title">Novel Chromium Trioxide Catalyzed Oxidation of Primary Alcohols to the Carboxylic Acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5323</span><span class="NLM_x">–</span> <span class="NLM_lpage">5326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=5323-5326&author=M.+Zhaoauthor=J.+Liauthor=Z.+Songauthor=R.+Desmondauthor=D.+M.+Tschaenauthor=E.+J.+J.+Grabowskiauthor=P.+J.+A+Reider&title=Novel+Chromium+Trioxide+Catalyzed+Oxidation+of+Primary+Alcohols+to+the+Carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DDesmond%26aufirst%3DR.%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DGrabowski%26aufirst%3DE.%2BJ.%2BJ.%26aulast%3DReider%26aufirst%3DP.%2BJ.%2BA%26atitle%3DNovel%2520Chromium%2520Trioxide%2520Catalyzed%2520Oxidation%2520of%2520Primary%2520Alcohols%2520to%2520the%2520Carboxylic%2520Acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D5323%26epage%3D5326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margarita, R.</span><span> </span><span class="NLM_article-title">1,3-Asymmetric Induction in Dianionic Allylation Reactions of Amino Acid Derivatives—Synthesis of Functionally Useful Enantiopure Glutamates, Pipecolates and Pyroglutamates</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">–</span> <span class="NLM_lpage">5890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=5887-5890&author=S.+Hanessianauthor=R.+Margarita&title=1%2C3-Asymmetric+Induction+in+Dianionic+Allylation+Reactions+of+Amino+Acid+Derivatives%E2%80%94Synthesis+of+Functionally+Useful+Enantiopure+Glutamates%2C+Pipecolates+and+Pyroglutamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DMargarita%26aufirst%3DR.%26atitle%3D1%252C3-Asymmetric%2520Induction%2520in%2520Dianionic%2520Allylation%2520Reactions%2520of%2520Amino%2520Acid%2520Derivatives%25E2%2580%2594Synthesis%2520of%2520Functionally%2520Useful%2520Enantiopure%2520Glutamates%252C%2520Pipecolates%2520and%2520Pyroglutamates%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D5887%26epage%3D5890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ardá, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soengas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrígues, J.</span><span> </span><span class="NLM_article-title">Total Synthesis of (−)-Dysithiazolamide</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2178</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol800551g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=2175-2178&author=A.+Ard%C3%A1author=R.+G.+Soengasauthor=M.+I.+Nietoauthor=C.+Jim%C3%A9nezauthor=J.+Rodr%C3%ADgues&title=Total+Synthesis+of+%28%E2%88%92%29-Dysithiazolamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fol800551g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800551g%26sid%3Dliteratum%253Aachs%26aulast%3DArd%25C3%25A1%26aufirst%3DA.%26aulast%3DSoengas%26aufirst%3DR.%2BG.%26aulast%3DNieto%26aufirst%3DM.%2BI.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADgues%26aufirst%3DJ.%26atitle%3DTotal%2520Synthesis%2520of%2520%2528%25E2%2588%2592%2529-Dysithiazolamide%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D2175%26epage%3D2178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gerwick, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, C. L.</span><span> </span><span class="NLM_article-title">[6-<sup>13</sup>C]-(2<i>S</i>,4<i>S</i>)-5-Chloroleucine: synthesis and incubation studies with cultures of the cyanobacterium, <i>Lyngbya majuscula</i></span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=285-288&author=W.+H.+Gerwickauthor=P.+Leslieauthor=G.+C.+Longauthor=B.+L.+Marquezauthor=C.+L.+Willis&title=%5B6-13C%5D-%282S%2C4S%29-5-Chloroleucine%3A+synthesis+and+incubation+studies+with+cultures+of+the+cyanobacterium%2C+Lyngbya+majuscula"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26aulast%3DLeslie%26aufirst%3DP.%26aulast%3DLong%26aufirst%3DG.%2BC.%26aulast%3DMarquez%26aufirst%3DB.%2BL.%26aulast%3DWillis%26aufirst%3DC.%2BL.%26atitle%3D%255B6-13C%255D-%25282S%252C4S%2529-5-Chloroleucine%253A%2520synthesis%2520and%2520incubation%2520studies%2520with%2520cultures%2520of%2520the%2520cyanobacterium%252C%2520Lyngbya%2520majuscula%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D285%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, J. T.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+T.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2ea4grpPGVuk5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><div class="note"><p class="first last">LE defined as Δ<i>G/N</i><sub>nonhydrogen atoms</sub>, where <i>G</i> ≈ −<i>RT</i> ln IC<sub>50</sub></p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=23484756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for effective drug discovery</span></div><div class="casAuthors">Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-488</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Successful drug discovery requires the optimization of a large no. of variables ranging from strictly physicochem. parameters such as mol. wt. to more complex parameters related to toxicity and bioavailability.  Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclin. characterization.  However, crit. biol. issues along the path to the market have diminished the impact and power of this methodol.  The physicochem. properties of the novel chem. entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate.  The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process.  More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be discussed in the broader context.  Preliminary results and trends obtained using ligand efficiencies as guides are reviewed and their future application to guide drug discovery will be discussed, as well as their integration into the structure-based drug design methods to make them more effective and numerically robust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKduo41JcS7Vg90H21EOLACvtfcHk0lhMknYxVNMaHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D&md5=a1682fbc4545d8eab3a44417c0e88869</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D469%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Johnson, F.</span><span> </span><span class="NLM_article-title">Allylic Strain in Six-Membered Rings</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60254a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1968&pages=375-413&author=F.+Johnson&title=Allylic+Strain+in+Six-Membered+Rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr60254a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60254a001%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DF.%26atitle%3DAllylic%2520Strain%2520in%2520Six-Membered%2520Rings%26jtitle%3DChem.%2520Rev.%26date%3D1968%26volume%3D68%26spage%3D375%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">For a more detailed study on the effect GSK2334470 has on PDK1 signaling at the cellular level, see: </p></div><span class="NLM_contrib-group">Najafov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeYoung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">433</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2010&pages=357-369&author=A.+Najafovauthor=E.+M.+Sommerauthor=J.+M.+Axtenauthor=M.+P.+DeYoungauthor=D.+R.+Alessi&title=Characterization+of+GSK2334470%2C+a+novel+and+highly+specific+inhibitor+of+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNajafov%26aufirst%3DA.%26aulast%3DSommer%26aufirst%3DE.%2BM.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DDeYoung%26aufirst%3DM.%2BP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520GSK2334470%252C%2520a%2520novel%2520and%2520highly%2520specific%2520inhibitor%2520of%2520PDK1%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D433%26spage%3D357%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pearn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darley, R. L.</span><span> </span><span class="NLM_article-title">The role of PKC and PDK1 in monocyte lineage specification by RAS</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">4461</span><span class="NLM_x">–</span> <span class="NLM_lpage">4469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=4461-4469&author=L.+Pearnauthor=J.+Fisherauthor=A.+K.+Burnettauthor=R.+L.+Darley&title=The+role+of+PKC+and+PDK1+in+monocyte+lineage+specification+by+RAS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPearn%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DJ.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DDarley%26aufirst%3DR.%2BL.%26atitle%3DThe%2520role%2520of%2520PKC%2520and%2520PDK1%2520in%2520monocyte%2520lineage%2520specification%2520by%2520RAS%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D4461%26epage%3D4469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">GSK2334470 showed submicromolar antiproliferative activity against 29 cell lines from a panel of ∼300 cancer cell lines, although very few cell lines of epithelial origin were sensitive</p></div><span class="NLM_contrib-group">Axten, J. M.; Medina, J. R.; Shu, A.; Li, W.; Feng, Y.; DeYoung, M. P.; Gardiner, C. M.; Chadderton, A. R.; Dumble, M.; Liu, Q.; Rabindran, S. K.</span><span> </span><span class="NLM_article-title">GSK2334470: A Potent and Highly Selective Inhibitor of PDK1</span>. <span class="NLM_conf-name">AACR 101st Annual Meeting</span>, <span class="NLM_conf-loc">Washington DC</span>, <span class="NLM_conf-date">April 17−21, 2010</span>, <div class="note"><p class="first last">Abstract LB-116</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GSK2334470+showed+submicromolar+antiproliferative+activity+against+29+cell+lines+from+a+panel+of+%E2%88%BC300+cancer+cell+lines%2C+although+very+few+cell+lines+of+epithelial+origin+were+sensitiveAxten%2C+J.+M.%3B+Medina%2C+J.+R.%3B+Shu%2C+A.%3B+Li%2C+W.%3B+Feng%2C+Y.%3B+DeYoung%2C+M.+P.%3B+Gardiner%2C+C.+M.%3B+Chadderton%2C+A.+R.%3B+Dumble%2C+M.%3B+Liu%2C+Q.%3B+Rabindran%2C+S.+K.+GSK2334470%3A+A+Potent+and+Highly+Selective+Inhibitor+of+PDK1.+AACR+101st+Annual+Meeting%2C+Washington+DC%2C+April+17%E2%88%9221%2C+2010%2C+Abstract+LB-116."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26atitle%3DGSK2334470%253A%2520A%2520Potent%2520and%2520Highly%2520Selective%2520Inhibitor%2520of%2520PDK1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Millipore Research and Development.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lgZBisaDL2ZyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liao, J. J.-L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.-L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lgZBisaDL2ZyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.-L.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">For recent biology studies investigating the effect of PDK1 inhibition on PTEN-deficient tumours, see:</p></div><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwanami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">Striking the balance between PTEN and PDK1: it all depends on the cell context</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1699-1704&author=A.+Iwanamiauthor=T.+F.+Cloughesyauthor=P.+S.+Mischel&title=Striking+the+balance+between+PTEN+and+PDK1%3A+it+all+depends+on+the+cell+context"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwanami%26aufirst%3DA.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DStriking%2520the%2520balance%2520between%2520PTEN%2520and%2520PDK1%253A%2520it%2520all%2520depends%2520on%2520the%2520cell%2520context%26jtitle%3DGenes%2520Dev.%26date%3D2009%26volume%3D23%26spage%3D1699%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Finlay, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feijoo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagenbeek, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spits, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, D. A.</span><span> </span><span class="NLM_article-title">Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=2441-2454&author=D.+K.+Finlayauthor=L.+V.+Sinclairauthor=C.+Feijooauthor=C.+M.+Waughauthor=T.+J.+Hagenbeekauthor=H.+Spitsauthor=D.+A.+Cantrell&title=Phosphoinositide-dependent+kinase+1+controls+migration+and+malignant+transformation+but+not+cell+growth+and+proliferation+in+PTEN-null+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DD.%2BK.%26aulast%3DSinclair%26aufirst%3DL.%2BV.%26aulast%3DFeijoo%26aufirst%3DC.%26aulast%3DWaugh%26aufirst%3DC.%2BM.%26aulast%3DHagenbeek%26aufirst%3DT.%2BJ.%26aulast%3DSpits%26aufirst%3DH.%26aulast%3DCantrell%26aufirst%3DD.%2BA.%26atitle%3DPhosphoinositide-dependent%2520kinase%25201%2520controls%2520migration%2520and%2520malignant%2520transformation%2520but%2520not%2520cell%2520growth%2520and%2520proliferation%2520in%2520PTEN-null%2520lymphocytes%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2009%26volume%3D206%26spage%3D2441%26epage%3D2454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':[],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':[],'ref27':['cit27a','cit27b'],'ref28':['cit28a','cit28b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Matthew A. Larsen, Elisabeth T. Hennessy, Madeleine C. Deem, Yu-hong Lam, Josep Saurí, <span class="NLM_string-name hlFld-ContribAuthor">Aaron C. Sather</span>. </span><span class="cited-content_cbyCitation_article-title">A Modular and Diastereoselective 5 + 1 Cyclization Approach to N-(Hetero)Aryl Piperidines. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (2)
                                     , 726-732. <a href="https://doi.org/10.1021/jacs.9b13114" title="DOI URL">https://doi.org/10.1021/jacs.9b13114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b13114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b13114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DA%252BModular%252Band%252BDiastereoselective%252B5%252B%25252B%252B1%252BCyclization%252BApproach%252Bto%252BN-%252528Hetero%252529Aryl%252BPiperidines%26aulast%3DLarsen%26aufirst%3DMatthew%2BA.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D05122019%26date%3D31122019%26date%3D27122019%26volume%3D142%26issue%3D2%26spage%3D726%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleg A.  Volkov</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Brockway</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Wring</span>, <span class="hlFld-ContribAuthor ">Michael  Peel</span>, <span class="hlFld-ContribAuthor ">Zhe  Chen</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Phillips</span>, and <span class="hlFld-ContribAuthor ">Jef K.  De Brabander</span>  . </span><span class="cited-content_cbyCitation_article-title">Species-Selective Pyrimidineamine Inhibitors of Trypanosoma brucei S-Adenosylmethionine Decarboxylase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1182-1203. <a href="https://doi.org/10.1021/acs.jmedchem.7b01654" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01654</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01654%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpecies-Selective%252BPyrimidineamine%252BInhibitors%252Bof%252BTrypanosoma%252Bbrucei%252BS-Adenosylmethionine%252BDecarboxylase%26aulast%3DVolkov%26aufirst%3DOleg%2BA.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D09112017%26date%3D05012018%26date%3D08022018%26date%3D22122017%26volume%3D61%26issue%3D3%26spage%3D1182%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar P. J.  van Linden</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (2)
                                     , 249-277. <a href="https://doi.org/10.1021/jm400378w" title="DOI URL">https://doi.org/10.1021/jm400378w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400378w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400378w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKLIFS%25253A%252BA%252BKnowledge-Based%252BStructural%252BDatabase%252BTo%252BNavigate%252BKinase%2525E2%252580%252593Ligand%252BInteraction%252BSpace%26aulast%3Dvan%2BLinden%26aufirst%3DOscar%2BP.%2BJ.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D14032013%26date%3D20092013%26date%3D23012014%26date%3D13082013%26volume%3D57%26issue%3D2%26spage%3D249%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesús R.  Medina</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective 3-Phosphoinositide-Dependent Kinase 1 (PDK1) Inhibitors: Dissecting the Function and Pharmacology of PDK1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (7)
                                     , 2726-2737. <a href="https://doi.org/10.1021/jm4000227" title="DOI URL">https://doi.org/10.1021/jm4000227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4000227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4000227%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252B3-Phosphoinositide-Dependent%252BKinase%252B1%252B%252528PDK1%252529%252BInhibitors%25253A%252BDissecting%252Bthe%252BFunction%252Band%252BPharmacology%252Bof%252BPDK1%26aulast%3DMedina%26aufirst%3DJes%25C3%25BAs%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D04012013%26date%3D15032013%26date%3D11042013%26date%3D28022013%26volume%3D56%26issue%3D7%26spage%3D2726%26epage%3D2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iman A.  Mansi</span>, <span class="hlFld-ContribAuthor ">Mahmoud A.  Al-Sha'er</span>, <span class="hlFld-ContribAuthor ">Nizar M.  Mhaidat</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>, <span class="hlFld-ContribAuthor ">Rand  Shahin</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of Binding Characteristics of Phosphoinositide-dependent Kinase-1 (PDK1) Co-crystallized Ligands Through Virtual Pharmacophore Modeling Leading to Novel Anti-PDK1 Hits. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2020,</strong> <em>16 </em>
                                    (7)
                                     , 860-880. <a href="https://doi.org/10.2174/1573406415666190724131048" title="DOI URL">https://doi.org/10.2174/1573406415666190724131048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190724131048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190724131048%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252BBinding%252BCharacteristics%252Bof%252BPhosphoinositide-dependent%252BKinase-1%252B%252528PDK1%252529%252BCo-crystallized%252BLigands%252BThrough%252BVirtual%252BPharmacophore%252BModeling%252BLeading%252Bto%252BNovel%252BAnti-PDK1%252BHits%26aulast%3DMansi%26aufirst%3DIman%2BA.%26date%3D2020%26volume%3D16%26issue%3D7%26spage%3D860%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fengxu  Wu</span>, <span class="hlFld-ContribAuthor ">Linsheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Fan  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Gefei  Hao</span>, <span class="hlFld-ContribAuthor ">Guangfu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2020,</strong> <em>23 </em>
                                    (6)
                                     , 101179. <a href="https://doi.org/10.1016/j.isci.2020.101179" title="DOI URL">https://doi.org/10.1016/j.isci.2020.101179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2020.101179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2020.101179%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DAuto%252BIn%252BSilico%252BLigand%252BDirecting%252BEvolution%252Bto%252BFacilitate%252Bthe%252BRapid%252Band%252BEfficient%252BDiscovery%252Bof%252BDrug%252BLead%26aulast%3DWu%26aufirst%3DFengxu%26date%3D2020%26volume%3D23%26issue%3D6%26spage%3D101179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon R.  Rosen</span>, <span class="hlFld-ContribAuthor ">Ehesan  Ul Sharif</span>, <span class="hlFld-ContribAuthor ">Dillon H.  Miles</span>, <span class="hlFld-ContribAuthor ">Nicholas S.  Chan</span>, <span class="hlFld-ContribAuthor ">Manmohan R.  Leleti</span>, <span class="hlFld-ContribAuthor ">Jay P.  Powers</span>. </span><span class="cited-content_cbyCitation_article-title">Improved synthesis of sterically encumbered heteroaromatic biaryls from aromatic β-keto esters. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (20)
                                     , 151855. <a href="https://doi.org/10.1016/j.tetlet.2020.151855" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151855%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DImproved%252Bsynthesis%252Bof%252Bsterically%252Bencumbered%252Bheteroaromatic%252Bbiaryls%252Bfrom%252Baromatic%252B%2525CE%2525B2-keto%252Besters%26aulast%3DRosen%26aufirst%3DBrandon%2BR.%26date%3D2020%26volume%3D61%26issue%3D20%26spage%3D151855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben J.  Davis</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Ligand Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 79-98. <a href="https://doi.org/10.1002/9781118681121.ch4" title="DOI URL">https://doi.org/10.1002/9781118681121.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLigand%252BDiscovery%26aulast%3DDavis%26aufirst%3DBen%2BJ.%26date%3D2020%26date%3D2020%26spage%3D79%26epage%3D98%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramon  Martinez</span>, <span class="hlFld-ContribAuthor ">Amy  Defnet</span>, <span class="hlFld-ContribAuthor ">Paul  Shapiro</span>. </span><span class="cited-content_cbyCitation_article-title">Avoiding or Co-Opting ATP Inhibition: Overview of Type III, IV, V, and VI Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 29-59. <a href="https://doi.org/10.1007/978-3-030-48283-1_3" title="DOI URL">https://doi.org/10.1007/978-3-030-48283-1_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-48283-1_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-48283-1_3%26sid%3Dliteratum%253Aachs%26atitle%3DAvoiding%252Bor%252BCo-Opting%252BATP%252BInhibition%25253A%252BOverview%252Bof%252BType%252BIII%25252C%252BIV%25252C%252BV%25252C%252Band%252BVI%252BKinase%252BInhibitors%26aulast%3DMartinez%26aufirst%3DRamon%26date%3D2020%26date%3D2020%26spage%3D29%26epage%3D59%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNext%252BGeneration%252BKinase%252BInhibitors%26aulast%3DShapiro%26aufirst%3DPaul%26date%3D2020%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mao-Lin  Li</span>, <span class="hlFld-ContribAuthor ">Jin-Han  Yu</span>, <span class="hlFld-ContribAuthor ">Yi-Hao  Li</span>, <span class="hlFld-ContribAuthor ">Shou-Fei  Zhu</span>, <span class="hlFld-ContribAuthor ">Qi-Lin  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Highly enantioselective carbene insertion into N–H bonds of aliphatic amines. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2019,</strong> <em>366 </em>
                                    (6468)
                                     , 990-994. <a href="https://doi.org/10.1126/science.aaw9939" title="DOI URL">https://doi.org/10.1126/science.aaw9939</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aaw9939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aaw9939%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DHighly%252Benantioselective%252Bcarbene%252Binsertion%252Binto%252BN%2525E2%252580%252593H%252Bbonds%252Bof%252Baliphatic%252Bamines%26aulast%3DLi%26aufirst%3DMao-Lin%26date%3D2019%26date%3D2019%26volume%3D366%26issue%3D6468%26spage%3D990%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohong  Liao</span>, <span class="hlFld-ContribAuthor ">Lingrong  Peng</span>, <span class="hlFld-ContribAuthor ">Jin  Zhou</span>, <span class="hlFld-ContribAuthor ">Huiting  Mo</span>, <span class="hlFld-ContribAuthor ">Jialan  Zhao</span>, <span class="hlFld-ContribAuthor ">Zike  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Guo</span>, <span class="hlFld-ContribAuthor ">Peiquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Activity Evaluation of Nasopharyngeal Carcinoma Inhibitors Based on 6‐(Pyrimidin‐4‐yl)‐1
              H
              ‐indazole. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (5)
                                     , e1800598. <a href="https://doi.org/10.1002/cbdv.201800598" title="DOI URL">https://doi.org/10.1002/cbdv.201800598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800598%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BActivity%252BEvaluation%252Bof%252BNasopharyngeal%252BCarcinoma%252BInhibitors%252BBased%252Bon%252B6%2525E2%252580%252590%252528Pyrimidin%2525E2%252580%2525904%2525E2%252580%252590yl%252529%2525E2%252580%2525901%252BH%252B%2525E2%252580%252590indazole%26aulast%3DLiao%26aufirst%3DBohong%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D5%26spage%3De1800598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.N.  Vennila</span>, <span class="hlFld-ContribAuthor ">D.  Sunny</span>, <span class="hlFld-ContribAuthor ">S.  Madhuri</span>, <span class="hlFld-ContribAuthor ">Samuele  Ciattini</span>, <span class="hlFld-ContribAuthor ">Laura  Chelazzi</span>, <span class="hlFld-ContribAuthor ">Kuppanagounder P.  Elango</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, crystal structures and anticancer activity of 4-substituted quinolines to target PDK1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 184-190. <a href="https://doi.org/10.1016/j.bioorg.2018.08.007" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bcrystal%252Bstructures%252Band%252Banticancer%252Bactivity%252Bof%252B4-substituted%252Bquinolines%252Bto%252Btarget%252BPDK1%26aulast%3DVennila%26aufirst%3DK.N.%26date%3D2018%26volume%3D81%26spage%3D184%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Hao</span>, <span class="hlFld-ContribAuthor ">Thierry  Milcent</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ongeri</span>, <span class="hlFld-ContribAuthor ">Benoit  Crousse</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis of Cyclic Fluorinated Amino Acids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (27-28)
                                     , 3688-3692. <a href="https://doi.org/10.1002/ejoc.201800255" title="DOI URL">https://doi.org/10.1002/ejoc.201800255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800255%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BSynthesis%252Bof%252BCyclic%252BFluorinated%252BAmino%252BAcids%26aulast%3DHao%26aufirst%3DJing%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D27-28%26spage%3D3688%26epage%3D3692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcel J.C.  Bijvelds</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Ann  Hellemans</span>, <span class="hlFld-ContribAuthor ">Karine  Smans</span>, <span class="hlFld-ContribAuthor ">Natascha D.A.  Nieuwenhuijze</span>, <span class="hlFld-ContribAuthor ">Kelly F.  Meijsen</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Bongartz</span>, <span class="hlFld-ContribAuthor ">Luc  Ver Donck</span>, <span class="hlFld-ContribAuthor ">Hugo R.  de Jonge</span>, <span class="hlFld-ContribAuthor ">Jan A.J.  Schuurkes</span>, <span class="hlFld-ContribAuthor ">Joris H.  De Maeyer</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of intestinal guanosine 3′,5′-cyclic monophosphate signaling by small-molecule protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (21)
                                     , 8173-8181. <a href="https://doi.org/10.1074/jbc.RA118.002835" title="DOI URL">https://doi.org/10.1074/jbc.RA118.002835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.002835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.002835%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DSelective%252Binhibition%252Bof%252Bintestinal%252Bguanosine%252B3%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-cyclic%252Bmonophosphate%252Bsignaling%252Bby%252Bsmall-molecule%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DBijvelds%26aufirst%3DMarcel%2BJ.C.%26date%3D2018%26volume%3D293%26issue%3D21%26spage%3D8173%26epage%3D8181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Venkataswamy  Sorna</span>, <span class="hlFld-ContribAuthor ">Susie  Choi</span>, <span class="hlFld-ContribAuthor ">Lee  Call</span>, <span class="hlFld-ContribAuthor ">Jared  Bearss</span>, <span class="hlFld-ContribAuthor ">Kent  Carpenter</span>, <span class="hlFld-ContribAuthor ">Steven L.  Warner</span>, <span class="hlFld-ContribAuthor ">Sunil  Sharma</span>, <span class="hlFld-ContribAuthor ">David J.  Bearss</span>, <span class="hlFld-ContribAuthor ">Hariprasad  Vankayalapati</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based design, synthesis, biological evaluation, and SAR of 1 H -benzo[ d ]imidazol-2-yl)-1 H -indazol derivatives as potent PDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (24)
                                     , 5473-5480. <a href="https://doi.org/10.1016/j.bmcl.2017.10.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-based%252Bdesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252BSAR%252Bof%252B1%252BH%252B-benzo%25255B%252Bd%252B%25255Dimidazol-2-yl%252529-1%252BH%252B-indazol%252Bderivatives%252Bas%252Bpotent%252BPDK1%252Binhibitors%26aulast%3DChen%26aufirst%3DTing%26date%3D2017%26volume%3D27%26issue%3D24%26spage%3D5473%26epage%3D5480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Liling  Xu</span>, <span class="hlFld-ContribAuthor ">Samina  Shaheen</span>, <span class="hlFld-ContribAuthor ">Sichen  Liu</span>, <span class="hlFld-ContribAuthor ">Wenjie  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Sun</span>, <span class="hlFld-ContribAuthor ">Zhanguo  Li</span>, <span class="hlFld-ContribAuthor ">Wanli  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Growth of B Cell Receptor Microclusters Is Regulated by PIP 2 and PIP 3 Equilibrium and Dock2 Recruitment and Activation. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2017,</strong> <em>21 </em>
                                    (9)
                                     , 2541-2557. <a href="https://doi.org/10.1016/j.celrep.2017.10.117" title="DOI URL">https://doi.org/10.1016/j.celrep.2017.10.117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2017.10.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2017.10.117%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DGrowth%252Bof%252BB%252BCell%252BReceptor%252BMicroclusters%252BIs%252BRegulated%252Bby%252BPIP%252B2%252Band%252BPIP%252B3%252BEquilibrium%252Band%252BDock2%252BRecruitment%252Band%252BActivation%26aulast%3DWang%26aufirst%3DJing%26date%3D2017%26volume%3D21%26issue%3D9%26spage%3D2541%26epage%3D2557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valerie M.  Jansen</span>, <span class="hlFld-ContribAuthor ">Neil E.  Bhola</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Bauer</span>, <span class="hlFld-ContribAuthor ">Luigi  Formisano</span>, <span class="hlFld-ContribAuthor ">Kyung-Min  Lee</span>, <span class="hlFld-ContribAuthor ">Katherine E.  Hutchinson</span>, <span class="hlFld-ContribAuthor ">Agnieszka K.  Witkiewicz</span>, <span class="hlFld-ContribAuthor ">Preston D.  Moore</span>, <span class="hlFld-ContribAuthor ">Mónica Valéria  Estrada</span>, <span class="hlFld-ContribAuthor ">Violeta  Sánchez</span>, <span class="hlFld-ContribAuthor ">Paula G.  Ericsson</span>, <span class="hlFld-ContribAuthor ">Melinda E.  Sanders</span>, <span class="hlFld-ContribAuthor ">Paula R.  Pohlmann</span>, <span class="hlFld-ContribAuthor ">Michael J.  Pishvaian</span>, <span class="hlFld-ContribAuthor ">David A.  Riddle</span>, <span class="hlFld-ContribAuthor ">Teresa C.  Dugger</span>, <span class="hlFld-ContribAuthor ">Wenyi  Wei</span>, <span class="hlFld-ContribAuthor ">Erik S.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Carlos L.  Arteaga</span>. </span><span class="cited-content_cbyCitation_article-title">Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2017,</strong> <em>77 </em>
                                    (9)
                                     , 2488-2499. <a href="https://doi.org/10.1158/0008-5472.CAN-16-2653" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-16-2653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-16-2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-16-2653%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DKinome-Wide%252BRNA%252BInterference%252BScreen%252BReveals%252Ba%252BRole%252Bfor%252BPDK1%252Bin%252BAcquired%252BResistance%252Bto%252BCDK4%25252F6%252BInhibition%252Bin%252BER-Positive%252BBreast%252BCancer%26aulast%3DJansen%26aufirst%3DValerie%2BM.%26date%3D2017%26date%3D2017%26volume%3D77%26issue%3D9%26spage%3D2488%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evan C  Lien</span>, <span class="hlFld-ContribAuthor ">Christian C  Dibble</span>, <span class="hlFld-ContribAuthor ">Alex  Toker</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K signaling in cancer: beyond AKT. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Cell Biology</span><span> <strong>2017,</strong> <em>45 </em>, 62-71. <a href="https://doi.org/10.1016/j.ceb.2017.02.007" title="DOI URL">https://doi.org/10.1016/j.ceb.2017.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ceb.2017.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ceb.2017.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Cell%2520Biology%26atitle%3DPI3K%252Bsignaling%252Bin%252Bcancer%25253A%252Bbeyond%252BAKT%26aulast%3DLien%26aufirst%3DEvan%2BC%26date%3D2017%26volume%3D45%26spage%3D62%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarita  Wucherer-Plietker</span>, <span class="hlFld-ContribAuthor ">Eugen  Merkul</span>, <span class="hlFld-ContribAuthor ">Thomas J.J.  Müller</span>, <span class="hlFld-ContribAuthor ">Christina  Esdar</span>, <span class="hlFld-ContribAuthor ">Thorsten  Knöchel</span>, <span class="hlFld-ContribAuthor ">Timo  Heinrich</span>, <span class="hlFld-ContribAuthor ">Hans-Peter  Buchstaller</span>, <span class="hlFld-ContribAuthor ">Hartmut  Greiner</span>, <span class="hlFld-ContribAuthor ">Dieter  Dorsch</span>, <span class="hlFld-ContribAuthor ">Dirk  Finsinger</span>, <span class="hlFld-ContribAuthor ">Michel  Calderini</span>, <span class="hlFld-ContribAuthor ">David  Bruge</span>, <span class="hlFld-ContribAuthor ">Ulrich  Grädler</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 7-azaindoles as PDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (13)
                                     , 3073-3080. <a href="https://doi.org/10.1016/j.bmcl.2016.05.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252B7-azaindoles%252Bas%252BPDK1%252Binhibitors%26aulast%3DWucherer-Plietker%26aufirst%3DMargarita%26date%3D2016%26volume%3D26%26issue%3D13%26spage%3D3073%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gordon  Saxty</span>. </span><span class="cited-content_cbyCitation_article-title">FBDD Applications to Kinase Drug Hunting. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 425-446. <a href="https://doi.org/10.1002/9783527683604.ch18" title="DOI URL">https://doi.org/10.1002/9783527683604.ch18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch18%26sid%3Dliteratum%253Aachs%26atitle%3DFBDD%252BApplications%252Bto%252BKinase%252BDrug%252BHunting%26aulast%3DSaxty%26aufirst%3DGordon%26date%3D2016%26date%3D2016%26spage%3D425%26epage%3D446%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel H.  Park</span>, <span class="hlFld-ContribAuthor ">Ekaterina V.  Vinogradova</span>, <span class="hlFld-ContribAuthor ">David S.  Surry</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Design of New Ligands for the Palladium-Catalyzed Arylation of α-Branched Secondary Amines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (28)
                                     , 8377-8380. <a href="https://doi.org/10.1002/ange.201502626" title="DOI URL">https://doi.org/10.1002/ange.201502626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201502626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201502626%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDesign%252Bof%252BNew%252BLigands%252Bfor%252Bthe%252BPalladium-Catalyzed%252BArylation%252Bof%252B%2525CE%2525B1-Branched%252BSecondary%252BAmines%26aulast%3DPark%26aufirst%3DNathaniel%2BH.%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D28%26spage%3D8377%26epage%3D8380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel H.  Park</span>, <span class="hlFld-ContribAuthor ">Ekaterina V.  Vinogradova</span>, <span class="hlFld-ContribAuthor ">David S.  Surry</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Design of New Ligands for the Palladium-Catalyzed Arylation of α-Branched Secondary Amines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (28)
                                     , 8259-8262. <a href="https://doi.org/10.1002/anie.201502626" title="DOI URL">https://doi.org/10.1002/anie.201502626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201502626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201502626%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDesign%252Bof%252BNew%252BLigands%252Bfor%252Bthe%252BPalladium-Catalyzed%252BArylation%252Bof%252B%2525CE%2525B1-Branched%252BSecondary%252BAmines%26aulast%3DPark%26aufirst%3DNathaniel%2BH.%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D28%26spage%3D8259%26epage%3D8262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benedito A  Carneiro</span>, <span class="hlFld-ContribAuthor ">Jason B  Kaplan</span>, <span class="hlFld-ContribAuthor ">Jessica K  Altman</span>, <span class="hlFld-ContribAuthor ">Francis J  Giles</span>, <span class="hlFld-ContribAuthor ">Leonidas C  Platanias</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2015,</strong> <em>16 </em>
                                    (5)
                                     , 648-656. <a href="https://doi.org/10.1080/15384047.2015.1026510" title="DOI URL">https://doi.org/10.1080/15384047.2015.1026510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15384047.2015.1026510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15384047.2015.1026510%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DTargeting%252BmTOR%252Bsignaling%252Bpathways%252Band%252Brelated%252Bnegative%252Bfeedback%252Bloops%252Bfor%252Bthe%252Btreatment%252Bof%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DCarneiro%26aufirst%3DBenedito%2BA%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D5%26spage%3D648%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. Justin  Rettenmaier</span>, <span class="hlFld-ContribAuthor ">Jack D.  Sadowsky</span>, <span class="hlFld-ContribAuthor ">Nathan D.  Thomsen</span>, <span class="hlFld-ContribAuthor ">Steven C.  Chen</span>, <span class="hlFld-ContribAuthor ">Allison K.  Doak</span>, <span class="hlFld-ContribAuthor ">Michelle R.  Arkin</span>, <span class="hlFld-ContribAuthor ">James A.  Wells</span>. </span><span class="cited-content_cbyCitation_article-title">A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2014,</strong> <em>111 </em>
                                    (52)
                                     , 18590-18595. <a href="https://doi.org/10.1073/pnas.1415365112" title="DOI URL">https://doi.org/10.1073/pnas.1415365112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1415365112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1415365112%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DA%252Bsmall-molecule%252Bmimic%252Bof%252Ba%252Bpeptide%252Bdocking%252Bmotif%252Binhibits%252Bthe%252Bprotein%252Bkinase%252BPDK1%26aulast%3DRettenmaier%26aufirst%3DT.%2BJustin%26date%3D2014%26date%3D2014%26volume%3D111%26issue%3D52%26spage%3D18590%26epage%3D18595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M  Scortegagna</span>, <span class="hlFld-ContribAuthor ">C  Ruller</span>, <span class="hlFld-ContribAuthor ">Y  Feng</span>, <span class="hlFld-ContribAuthor ">R  Lazova</span>, <span class="hlFld-ContribAuthor ">H  Kluger</span>, <span class="hlFld-ContribAuthor ">J-L  Li</span>, <span class="hlFld-ContribAuthor ">S K  De</span>, <span class="hlFld-ContribAuthor ">R  Rickert</span>, <span class="hlFld-ContribAuthor ">M  Pellecchia</span>, <span class="hlFld-ContribAuthor ">M  Bosenberg</span>, <span class="hlFld-ContribAuthor ">Z A  Ronai</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of BrafV600E::Pten–/– melanoma. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2014,</strong> <em>33 </em>
                                    (34)
                                     , 4330-4339. <a href="https://doi.org/10.1038/onc.2013.383" title="DOI URL">https://doi.org/10.1038/onc.2013.383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2013.383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2013.383%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DGenetic%252Binactivation%252Bor%252Bpharmacological%252Binhibition%252Bof%252BPdk1%252Bdelays%252Bdevelopment%252Band%252Binhibits%252Bmetastasis%252Bof%252BBrafV600E%25253A%25253APten%2525E2%252580%252593%25252F%2525E2%252580%252593%252Bmelanoma%26aulast%3DScortegagna%26aufirst%3DM%26date%3D2014%26date%3D2013%26volume%3D33%26issue%3D34%26spage%3D4330%26epage%3D4339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuja  Kotasthane</span>, <span class="hlFld-ContribAuthor ">Chandrika  Mulakala</span>, <span class="hlFld-ContribAuthor ">Vellarkad N.  Viswanadhan</span>. </span><span class="cited-content_cbyCitation_article-title">Applying conformational selection theory to improve crossdocking efficiency in 3-phosphoinositide dependent protein kinase-1. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2014,</strong> <em>82 </em>
                                    (3)
                                     , 436-451. <a href="https://doi.org/10.1002/prot.24410" title="DOI URL">https://doi.org/10.1002/prot.24410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.24410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.24410%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DApplying%252Bconformational%252Bselection%252Btheory%252Bto%252Bimprove%252Bcrossdocking%252Befficiency%252Bin%252B3-phosphoinositide%252Bdependent%252Bprotein%252Bkinase-1%26aulast%3DKotasthane%26aufirst%3DAnuja%26date%3D2014%26date%3D2013%26volume%3D82%26issue%3D3%26spage%3D436%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrika  Mulakala</span>, <span class="hlFld-ContribAuthor ">Vellarkad N.  Viswanadhan</span>. </span><span class="cited-content_cbyCitation_article-title">Could MM-GBSA be accurate enough for calculation of absolute protein/ligand binding free energies?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2013,</strong> <em>46 </em>, 41-51. <a href="https://doi.org/10.1016/j.jmgm.2013.09.005" title="DOI URL">https://doi.org/10.1016/j.jmgm.2013.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2013.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2013.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DCould%252BMM-GBSA%252Bbe%252Baccurate%252Benough%252Bfor%252Bcalculation%252Bof%252Babsolute%252Bprotein%25252Fligand%252Bbinding%252Bfree%252Benergies%25253F%26aulast%3DMulakala%26aufirst%3DChandrika%26date%3D2013%26volume%3D46%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor  Solodushko</span>, <span class="hlFld-ContribAuthor ">Heba A.  Khader</span>, <span class="hlFld-ContribAuthor ">Brian W.  Fouty</span>, . </span><span class="cited-content_cbyCitation_article-title">Serum Can Overcome Contact Inhibition in Confluent Human Pulmonary Artery Smooth Muscle Cells. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , e71490. <a href="https://doi.org/10.1371/journal.pone.0071490" title="DOI URL">https://doi.org/10.1371/journal.pone.0071490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0071490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0071490%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DSerum%252BCan%252BOvercome%252BContact%252BInhibition%252Bin%252BConfluent%252BHuman%252BPulmonary%252BArtery%252BSmooth%252BMuscle%252BCells%26aulast%3DSolodushko%26aufirst%3DVictor%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3De71490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Zhou</span>, <span class="hlFld-ContribAuthor ">Zi-Cheng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">3D QSAR pharmacophore-based virtual screening and molecular docking studies for the discovery of potential PDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (7)
                                     , 3416-3427. <a href="https://doi.org/10.1007/s00044-012-0338-x" title="DOI URL">https://doi.org/10.1007/s00044-012-0338-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0338-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0338-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3D3D%252BQSAR%252Bpharmacophore-based%252Bvirtual%252Bscreening%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bpotential%252BPDK1%252Binhibitors%26aulast%3DZhang%26aufirst%3DWei%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D7%26spage%3D3416%26epage%3D3427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Paulo  Arruda</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Stephen  Burley</span>, <span class="hlFld-ContribAuthor ">David H  Drewry</span>, <span class="hlFld-ContribAuthor ">Aled  Edwards</span>, <span class="hlFld-ContribAuthor ">Doriano  Fabbro</span>, <span class="hlFld-ContribAuthor ">Paul  Gillespie</span>, <span class="hlFld-ContribAuthor ">Nathanael S  Gray</span>, <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>, <span class="hlFld-ContribAuthor ">Karen E  Lackey</span>, <span class="hlFld-ContribAuthor ">Paulo  Mazzafera</span>, <span class="hlFld-ContribAuthor ">Nicholas C O  Tomkinson</span>, <span class="hlFld-ContribAuthor ">Timothy M  Willson</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">William J  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">A public-private partnership to unlock the untargeted kinome. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2013,</strong> <em>9 </em>
                                    (1)
                                     , 3-6. <a href="https://doi.org/10.1038/nchembio.1113" title="DOI URL">https://doi.org/10.1038/nchembio.1113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.1113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.1113%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DA%252Bpublic-private%252Bpartnership%252Bto%252Bunlock%252Bthe%252Buntargeted%252Bkinome%26aulast%3DKnapp%26aufirst%3DStefan%26date%3D2013%26date%3D2012%26volume%3D9%26issue%3D1%26spage%3D3%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayaz  Najafov</span>, <span class="hlFld-ContribAuthor ">Natalia  Shpiro</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>. </span><span class="cited-content_cbyCitation_article-title">Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2012,</strong> <em>448 </em>
                                    (2)
                                     , 285-295. <a href="https://doi.org/10.1042/BJ20121287" title="DOI URL">https://doi.org/10.1042/BJ20121287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20121287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20121287%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DAkt%252Bis%252Befficiently%252Bactivated%252Bby%252BPIF-pocket-%252Band%252BPtdIns%2525283%25252C4%25252C5%252529P3-dependent%252Bmechanisms%252Bleading%252Bto%252Bresistance%252Bto%252BPDK1%252Binhibitors%26aulast%3DNajafov%26aufirst%3DAyaz%26date%3D2012%26date%3D2012%26volume%3D448%26issue%3D2%26spage%3D285%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Armando Gagliardi</span>, <span class="hlFld-ContribAuthor ">Laura  di Blasio</span>, <span class="hlFld-ContribAuthor ">Francesca  Orso</span>, <span class="hlFld-ContribAuthor ">Giorgio  Seano</span>, <span class="hlFld-ContribAuthor ">Roberto  Sessa</span>, <span class="hlFld-ContribAuthor ">Daniela  Taverna</span>, <span class="hlFld-ContribAuthor ">Federico  Bussolino</span>, <span class="hlFld-ContribAuthor ">Luca  Primo</span>. </span><span class="cited-content_cbyCitation_article-title">3-Phosphoinositide-Dependent Kinase 1 Controls Breast Tumor Growth in a Kinase-Dependent but Akt-Independent Manner. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2012,</strong> <em>14 </em>
                                    (8)
                                     , 719-IN19. <a href="https://doi.org/10.1593/neo.12856" title="DOI URL">https://doi.org/10.1593/neo.12856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/neo.12856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Fneo.12856%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3D3-Phosphoinositide-Dependent%252BKinase%252B1%252BControls%252BBreast%252BTumor%252BGrowth%252Bin%252Ba%252BKinase-Dependent%252Bbut%252BAkt-Independent%252BManner%26aulast%3DArmando%2BGagliardi%26aufirst%3DPaolo%26date%3D2012%26volume%3D14%26issue%3D8%26spage%3D719%26epage%3DIN19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">Marcel L.  Verdonk</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>. </span><span class="cited-content_cbyCitation_article-title">Experiences in fragment-based drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2012,</strong> <em>33 </em>
                                    (5)
                                     , 224-232. <a href="https://doi.org/10.1016/j.tips.2012.02.006" title="DOI URL">https://doi.org/10.1016/j.tips.2012.02.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2012.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2012.02.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DExperiences%252Bin%252Bfragment-based%252Bdrug%252Bdiscovery%26aulast%3DMurray%26aufirst%3DChristopher%2BW.%26date%3D2012%26volume%3D33%26issue%3D5%26spage%3D224%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Barile</span>, <span class="hlFld-ContribAuthor ">Surya K  De</span>, <span class="hlFld-ContribAuthor ">Maurizio  Pellecchia</span>. </span><span class="cited-content_cbyCitation_article-title">PDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2012,</strong> <em>1 </em>
                                    (2)
                                     , 145-163. <a href="https://doi.org/10.4155/ppa.12.17" title="DOI URL">https://doi.org/10.4155/ppa.12.17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.12.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.12.17%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DPDK1%252Binhibitors%26aulast%3DBarile%26aufirst%3DElisa%26date%3D2012%26volume%3D1%26issue%3D2%26spage%3D145%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Qin  Xu</span>, <span class="hlFld-ContribAuthor ">Liang-yong  Mei</span>, <span class="hlFld-ContribAuthor ">Sheng-ke  Li</span>, <span class="hlFld-ContribAuthor ">Min  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A N-heterocyclic carbene (NHC) platinum complex as pre-catalyst for the intramolecular hydroamination of olefins with secondary alkylamines and oxidative amination of ω-alkenic amines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2012,</strong> <em>68 </em>
                                    (15)
                                     , 3172-3178. <a href="https://doi.org/10.1016/j.tet.2012.02.060" title="DOI URL">https://doi.org/10.1016/j.tet.2012.02.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2012.02.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2012.02.060%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252BN-heterocyclic%252Bcarbene%252B%252528NHC%252529%252Bplatinum%252Bcomplex%252Bas%252Bpre-catalyst%252Bfor%252Bthe%252Bintramolecular%252Bhydroamination%252Bof%252Bolefins%252Bwith%252Bsecondary%252Balkylamines%252Band%252Boxidative%252Bamination%252Bof%252B%2525CF%252589-alkenic%252Bamines%26aulast%3DZhang%26aufirst%3DRui%26date%3D2012%26volume%3D68%26issue%3D15%26spage%3D3172%26epage%3D3178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Catherine  Johnson</span>, <span class="hlFld-ContribAuthor ">Qiyue  Hu</span>, <span class="hlFld-ContribAuthor ">Laura  Lingardo</span>, <span class="hlFld-ContribAuthor ">Rose Ann  Ferre</span>, <span class="hlFld-ContribAuthor ">Samantha  Greasley</span>, <span class="hlFld-ContribAuthor ">Jiangli  Yan</span>, <span class="hlFld-ContribAuthor ">John  Kath</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Jacques  Ermolieff</span>, <span class="hlFld-ContribAuthor ">Gordon  Alton</span>. </span><span class="cited-content_cbyCitation_article-title">Novel isoquinolone PDK1 inhibitors discovered through fragment-based lead discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2011,</strong> <em>25 </em>
                                    (7)
                                     , 689-698. <a href="https://doi.org/10.1007/s10822-011-9456-7" title="DOI URL">https://doi.org/10.1007/s10822-011-9456-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-011-9456-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-011-9456-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DNovel%252Bisoquinolone%252BPDK1%252Binhibitors%252Bdiscovered%252Bthrough%252Bfragment-based%252Blead%252Bdiscovery%26aulast%3DJohnson%26aufirst%3DM.%2BCatherine%26date%3D2011%26date%3D2011%26volume%3D25%26issue%3D7%26spage%3D689%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0004.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds of General Structure <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 95 °C; (b) (i) Ac<sub>2</sub>O, 80 °C, (ii) CH<sub>3</sub>I, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (c) (i) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, 100 °C, (ii) 2,4-dichloropyrimidine, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 100 °C; (d) for <b>8b</b> and <b>8c</b>, (i) amine, THF, 100 °C, (ii) HCl, CH<sub>3</sub>OH, 60 °C; for <b>8d</b>, HCl, CH<sub>3</sub>OH, 50 °C; (e) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, 95 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine, (EtOH, CH<sub>3</sub>OH or THF), 50−100 °C; (b) <b>3</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 90−100 °C; (c) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, 80−100 °C; (d) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, 100 °C; (e) (i) (<b>9k</b>, <b>9l</b>, or <b>9m</b>), PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 100 °C, (ii) HCl, CH<sub>3</sub>OH, 60 °C; (f) (i) <b>3</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 95 °C, (ii) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), 95 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0032.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of α-Alkyl Substituted Cyclic Amines <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) benzaldehyde, toluene, reflux, (ii) NaBH<sub>4</sub>, EtOH, 0 °C; (b) (i) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, 0 °C, (ii) NaOH<sub>(aq)</sub> (pH > 13), rt; (c) Red-Al, toluene, 0−60 °C; (d) H<sub>2</sub>, Pd/C, HCl, CH<sub>3</sub>OH, rt; (e) (i) NaH, toluene, 0 °C, (ii) chloroacetyl chloride, toluene, 90−110 °C; (f) LiAlH<sub>4</sub>, THF, 70 °C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0031.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds of General Structure <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine, EDC, HOBt, <i>N</i>-methylmorpholine, rt; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0030.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Bis-substituted Piperidine Analogues <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) HCl, PtO<sub>2</sub>, CH<sub>3</sub>OH, (ii) CbzCl, DMAP, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 15−25 °C; (b) (i) 10% Pd/C, H<sub>2</sub> (65 psi), EtOAc, EtOH, rt, (ii) crystallization as the tartrate salt (<span class="smallcaps smallerCapital">l</span>-(+)-tartaric acid, IPA, water); (c) (i) LiOH·H<sub>2</sub>O, THF, water, CH<sub>3</sub>OH, rt, (ii) aniline, EDC, HOBt, Hünig’s base, DMF, rt, (iii) 10% Pd/C, H<sub>2</sub>, EtOAc, EtOH, rt; (d) (i) LiOH·H<sub>2</sub>O, water, rt, (ii) <b>27</b>, NaHCO<sub>3</sub>, 1,4-dioxane, 100 °C; (e) (i) amine, HATU, Hünig’s base, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, (ii) route 1 or 2; (f) (i) 1,4-dioxane, conc HCl, 100 °C, (ii) <b>9a</b>, NaHCO<sub>3</sub>, 1,4-dioxane, water, 120 °C, (iii) <b>3</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, 1,4-dioxane, water, 120 °C; (g) (i) cyclohexylamine, HATU, Hünig’s base, DMF, rt, (ii) H<sub>2</sub>NNH<sub>2</sub>, EtOH, 110 °C.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0029.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Bis-substituted Morpholine Analogues <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) (<i>R</i>)-(−)-epichlorohydrin, LiClO<sub>4</sub>, toluene, or 1,2-dichloroethane, rt, (ii) NaOCH<sub>3</sub> in CH<sub>3</sub>OH or NaOEt in EtOH, rt; (b) (i) HCl, EtOH, H<sub>2</sub>, 10% Pd/C (Degussa type), rt, (ii) for <b>30a</b> (<b>9a</b>, Hünig’s base, CH<sub>3</sub>CN, 160 °C (MW)), for <b>30b</b> (<b>27</b>, K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux); (c) (i) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH, rt, (ii) Boc<sub>2</sub>O, Hünig’s base, THF, 40 °C, (iii) TEMPO, iodobenzene diacetate, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C−rt; (d) (i) <b>3</b>, 1,4-dioxane, NaHCO<sub>3</sub>(aq), Pd(PPh<sub>3</sub>)<sub>4</sub>, 100 °C, (ii) for <b>31a</b> (H<sub>5</sub>IO<sub>6</sub>/CrO<sub>3</sub>, wet CH<sub>3</sub>CN, 0−15 °C), for <b>31b</b> (TEMPO, iodobenzene diacetate, CH<sub>2</sub>Cl<sub>2</sub>, water, 0 °C−rt); (e) (i) EDC, HOAt, amine, CH<sub>2</sub>Cl<sub>2</sub>, rt, (ii) HCl, dioxane, rt; (f) (i) aniline, EDC, HOBT, DMF, rt, (ii) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, 100 °C; (g) (i) cyclohexylamine, HATU, Hünig’s base, DMF, rt, (ii) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, 1,4-dioxane, 100 °C.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0028.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) LiOH·H<sub>2</sub>O, THF, water, CH<sub>3</sub>OH, rt, (ii) DPPA, <i>t</i>-butyl alcohol, Et<sub>3</sub>N, 100 °C, (iii) Pd/C, H<sub>2</sub>(50 psi), EtOAc, rt; (b) (i) conc HCl, 0 °C−rt, (ii) benzoyl chloride, NaHCO<sub>3</sub>, THF, water, 0 °C−rt, (iii) HCl, CH<sub>3</sub>OH, 65 °C.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0027.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Analogues <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>3</sub>OH, rt; (b) (i) LiHMDS, THF, −78 °C, (ii) CH<sub>3</sub>I, −78 °C; (c) CaCl<sub>2</sub>, NaBH<sub>4</sub>, EtOH:THF (1:1), 0 °C; (d) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (e) benzylamine, 70 °C; (f) (i) NaH, DMF, rt, (ii) CH<sub>3</sub>I, rt; (g) Pd/C (Degussa type), H<sub>2</sub>, EtOH, rt; (h) (i) <b>9a</b>, Et<sub>3</sub>N, EtOH, 100 °C, (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, (iii) 3,3-dimethylbutanoyl chloride, Hünig’s base, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0026.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of compound <b>1</b> bound to PDK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUN">3NUN</a>). (a) Hydrogen bond distances in Å. (b) Surface of G-loop illustrating small hydrophobic pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0022.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structures and overlay of compounds <b>12k</b> and <b>12f</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0019.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of compound (<i><b>R</b></i>)-<b>18a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0018.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structures of compounds <b>12k</b> and (<i><b>S</b></i>)-<b>21a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray crystal structure of compound (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0010.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystal structure of compound (<b>3<i>R</i></b>,<b>6<i>S</i></b>)-<b>37c</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0007.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray crystal structure of carbamate <b>43a</b> bound to PDK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/medium/jm-2010-01527u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0006.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28d</b> on the pharmacodynamic markers in OCL-AML2 xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101527u/production/images/large/jm-2010-01527u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101527u&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Pearce, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">The nuts and bolts of AGC protein kinases</span> <span class="citation_source-journal">Nature Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1038%2Fnrm2822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=20027184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFymt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=9-22&author=L.+R.+Pearceauthor=D.+Komanderauthor=D.+R.+Alessi&title=The+nuts+and+bolts+of+AGC+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The nuts and bolts of AGC protein kinases</span></div><div class="casAuthors">Pearce, Laura R.; Komander, David; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-22</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The AGC kinase subfamily of protein kinases contains 60 members, including protein kinase A (PKA), protein kinase G (PKG), and protein kinase C (PKC).  The family comprises some intensely examd. protein kinases (such as Akt, S6K, RSK, MSK, PDK1 and GRK) as well as many less well-studied enzymes (such as SGK, NDR, LATS, CRIK, SGK494, PRKX, PRKY, and MAST).  Research has shed new light onto the architecture and regulatory mechanisms of these kinases.  In addn., AGC kinases mediate diverse and important cellular functions, and their mutation and/or dysregulation contributes to the pathogenesis of many human diseases, including cancer and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDlqo5AR3FN7Vg90H21EOLACvtfcHk0lgbx4q_sb5D2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFymt7bI&md5=9752bf2068b10ab67b97e257f1f127d5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm2822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2822%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DL.%2BR.%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DThe%2520nuts%2520and%2520bolts%2520of%2520AGC%2520protein%2520kinases%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mora, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aalten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">PDK1, the master regulator of AGC kinase signal transduction</span> <span class="citation_source-journal">Semin. Cell. Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2Fj.semcdb.2003.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=15209375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=161-170&author=A.+Moraauthor=D.+Komanderauthor=D.+M.+Van+Aaltenauthor=D.+R.+Alessi&title=PDK1%2C+the+master+regulator+of+AGC+kinase+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PDK1, the master regulator of AGC kinase signal transduction</span></div><div class="casAuthors">Mora, Alfonso; Komander, David; van Aalten, Daan M. F.; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The interaction of insulin and growth factors with their receptors on the outside surface of a cell, leads to the activation of phosphatidylinositol 3-kinase (PI 3-kinase) and generation of the phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) second messenger at the inner surface of the cell membrane.  One of the most studied signaling events controlled by PtdIns(3,4,5)P3, comprises the activation of a group of AGC family protein kinases, including isoforms of protein kinase B (PKB)/Akt, p70 ribosomal S6 kinase (S6K), serum- and glucocorticoid-induced protein kinase (SGK) and protein kinase C (PKC), which play crucial roles in regulating physiol. processes relevant to metab., growth, proliferation and survival.  Here, we review recent biochem., genetic and structural studies on the 3-phosphoinositide-dependent protein kinase-1 (PDK1), which phosphorylates and activates the AGC kinase members regulated by PI 3-kinase.  We also discuss whether inhibitors of PDK1 might have chemotherapeutic potential in the treatment of cancers in which the PDK1-regulated AGC kinases are constitutively activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqieBvmRgWKULVg90H21EOLACvtfcHk0lgbx4q_sb5D2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFWlu7Y%253D&md5=928f74f6fcaf5ea8228ede20142eaa4a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2003.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2003.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DMora%26aufirst%3DA.%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DVan%2BAalten%26aufirst%3DD.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DPDK1%252C%2520the%2520master%2520regulator%2520of%2520AGC%2520kinase%2520signal%2520transduction%26jtitle%3DSemin.%2520Cell.%2520Dev.%2520Biol.%26date%3D2004%26volume%3D15%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, P. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2FS0960-9822%2806%2900122-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=9094314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFOjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=261-269&author=D.+R.+Alessiauthor=S.+R.+Jamesauthor=C.+P.+Downesauthor=A.+B.+Holmesauthor=P.+R.+J.+Gaffneyauthor=C.+B.+Reeseauthor=P.+Cohen&title=Characterization+of+a+3-phosphoinositide-dependent+protein+kinase+which+phosphorylates+and+activates+protein+kinase+B%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα</span></div><div class="casAuthors">Alessi, Dario R.; James, Stephen R.; Downes, C. Peter; Holmes, Andrew B.; Gaffney, Piers R. J.; Reese, Colin B.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Protein kinase B (PKB), also known as c-Akt, is activated rapidly when mammalian cells are stimulated with insulin and growth factors, and much of the current interest in this enzyme stems from the observation that it lies 'downstream' of phosphoinositide 3-kinase on intracellular signaling pathways.  We recently showed that insulin or insulin-like growth factor 1 induce the phosphorylation of PKB at two residues, Thr308 and Ser473.  The phosphorylation of both residues is required for maximal activation of PKB. The kinases that phosphorylate PKB are, however, unknown.  We have purified 500,000-fold from rabbit skeletal muscle exts. a protein kinase which phosphorylates PKBα at Thr308 and increases its activity over 30-fold.  We tested the kinase in the presence of several inositol phospholipids and found that only low micromolar concns. of the D enantiomers of either phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) or PtdIns(3,4)P2 were effective in potently activating the kinase, which has been named PtdIns(3,4,5)P3-dependent protein kinase-1 (PDK1).  None of the inositol phospholipids tested activated or inhibited PKBα or induced its phosphorylation under the conditions used.  PDK1 activity was not affected by wortmannin, indicating that it is not likely to be a member of the phosphoinositide 3-kinase family.  PDK1 is likely to be one of the protein kinases that mediate the activation of PKB by insulin and growth factors.  PDK1 may, therefore, play a key role in mediating many of the actions of the second messenger(s) PtdIns(3,4,5)P3 and/or PtdIns(3,4)P2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2sSM5v7MnWrVg90H21EOLACvtfcHk0lgbx4q_sb5D2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFOjtb8%253D&md5=7f3794216810a4273d091b8d4590aaa9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2806%2900122-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252806%252900122-9%26sid%3Dliteratum%253Aachs%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DJames%26aufirst%3DS.%2BR.%26aulast%3DDownes%26aufirst%3DC.%2BP.%26aulast%3DHolmes%26aufirst%3DA.%2BB.%26aulast%3DGaffney%26aufirst%3DP.%2BR.%2BJ.%26aulast%3DReese%26aufirst%3DC.%2BB.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520a%25203-phosphoinositide-dependent%2520protein%2520kinase%2520which%2520phosphorylates%2520and%2520activates%2520protein%2520kinase%2520B%25CE%25B1%26jtitle%3DCurr.%2520Biol.%26date%3D1997%26volume%3D7%26spage%3D261%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Biondi, R. M.</span><span> </span><span class="NLM_article-title">Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=136-142&author=R.+M.+Biondi&title=Phosphoinositide-dependent+protein+kinase+1%2C+a+sensor+of+protein+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26atitle%3DPhosphoinositide-dependent%2520protein%2520kinase%25201%252C%2520a%2520sensor%2520of%2520protein%2520conformation%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2004%26volume%3D29%26spage%3D136%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAKT+Pathway+for+Cancer+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAKT%2520Pathway%2520for%2520Cancer%2520Drug%2520Discovery%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating Downstream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=AKT%2FPKB+Signaling%3A+Navigating+Downstream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520Downstream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiades, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutsilieris, M.</span><span> </span><span class="NLM_article-title">The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.2174%2F1568009043333032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=15134532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Gnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=235-256&author=C.+S.+Mitsiadesauthor=N.+Misiadesauthor=M.+Koutsilieris&title=The+Akt+Pathway%3A+Molecular+Targets+for+Anti-Cancer+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Akt pathway: Molecular targets for anti-cancer drug development</span></div><div class="casAuthors">Mitsiades, Constantine S.; Mitsiades, Nicholas; Koutsilieris, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-256</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serine/threonine kinase Akt functions intracellularly as a cardinal nodal point for a constellation of converging upstream signaling pathways, which involve stimulation of receptor tyrosine kinases such as IGR-1R, HER2/Neu, VEGF-R, PDGF-R, and an assembly of membrane-localized complexes of receptor-PI-3K and activation of Akt through the second messenger PIP3.  The integration of these intracellular signals at the level of Akt and its kinase activity, regulates the phosphorylation of its several downstream effectors, such as NF-κB, mTOR, Forkhead, Bad, GSK-3 and MDM-2.  These phosphorylation events in turn mediate the effects of Akt on cell growth, proliferation, protection from pro-apoptotic stimuli, and stimulation of neoangiogenesis.  Because Akt and its upstream regulators are deregulated in a wide range of solid tumors and hematol. malignancies, and in view of the aforementioned biol. sequelae of this pathway, the Akt pathway is considered a key determinant of biol. aggressiveness of these tumors, and a major potential target for novel anti-cancer therapies.  This review focuses on ongoing translational efforts to therapeutically target Akt and its biol. sequelae, either at the level of Akt itself or at the levels of its upstream regulators and downstream effectors.  Because Akt is also important for proliferative and anti-apoptotic signaling pathways crit. for normal cells, particular emphasis is placed on the fine-tuning the targeting of individual components of this pathway to maximize the therapeutic index of anti-cancer strategies based on the PI-3K/Akt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGZbuqTPNYgLVg90H21EOLACvtfcHk0lg5TpSBTpf6aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Gnu78%253D&md5=299909de4babdbbf0e242bd1a7abdab1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568009043333032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009043333032%26sid%3Dliteratum%253Aachs%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26aulast%3DMisiades%26aufirst%3DN.%26aulast%3DKoutsilieris%26aufirst%3DM.%26atitle%3DThe%2520Akt%2520Pathway%253A%2520Molecular%2520Targets%2520for%2520Anti-Cancer%2520Drug%2520Development%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2004%26volume%3D4%26spage%3D235%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bayascas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Hypomorphic Mutations of PDK1 Suppresses Tumorigenesis in PTEN<sup>±</sup> Mice</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1839</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2Fj.cub.2005.08.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=16243031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1839-1846&author=J.+R.+Bayascasauthor=N.+R.+Leslieauthor=R.+Parsonsauthor=S.+Flemingauthor=D.+R.+Alessi&title=Hypomorphic+Mutations+of+PDK1+Suppresses+Tumorigenesis+in+PTEN%C2%B1+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hypomorphic Mutation of PDK1 Suppresses Tumorigenesis in PTEN+/- Mice</span></div><div class="casAuthors">Bayascas, Jose R.; Leslie, Nick R.; Parsons, Ramon; Fleming, Stewart; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1839-1846</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many cancers possess elevated levels of PtdIns(3,4,5)P3, the second messenger that induces activation of the protein kinases PKB/Akt and S6K and thereby stimulates cell proliferation, growth, and survival.  The importance of this pathway in tumorigenesis has been highlighted by the finding that PTEN, the lipid phosphatase that breaks down PtdIns(3,4,5)P3 to PtdIns(4,5)P2, is frequently mutated in human cancer.  Cells lacking PTEN possess elevated levels of PtdIns(3,4,5)P3, PKB, and S6K activity and heterozygous PTEN+/- mice develop a variety of tumors.  Knockout of PKBα in PTEN-deficient cells reduces aggressive growth and promotes apoptosis , whereas treatment of PTEN+/- mice with rapamycin, an inhibitor of the activation of S6K, reduces neoplasia.  We explored the importance of PDK1, the protein kinase that activates PKB and S6K , in mediating tumorigenesis caused by the deletion of PTEN.  We demonstrate that reducing the expression of PDK1 in PTEN+/- mice, markedly protects these animals from developing a wide range of tumors.  Our findings provide genetic evidence that PDK1 is a key effector in mediating neoplasia resulting from loss of PTEN and also validate PDK1 as a promising anticancer target for the prevention of tumors that possess elevated PKB and S6K activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSldKloWT-v7Vg90H21EOLACvtfcHk0lg5TpSBTpf6aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjsL%252FO&md5=faf47bff1fc7b8b2d3d17911e21584e9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.08.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.08.066%26sid%3Dliteratum%253Aachs%26aulast%3DBayascas%26aufirst%3DJ.%2BR.%26aulast%3DLeslie%26aufirst%3DN.%2BR.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DHypomorphic%2520Mutations%2520of%2520PDK1%2520Suppresses%2520Tumorigenesis%2520in%2520PTEN%25C2%25B1%2520Mice%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D1839%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Flynn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span> </span><span class="NLM_article-title">Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1439</span><span class="NLM_x">–</span> <span class="NLM_lpage">1442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2FS0960-9822%2800%2900801-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=11102805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlGisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1439-1442&author=P.+Flynnauthor=M.+Wongauthor=M.+Zavarauthor=N.+M.+Deanauthor=D.+Stokoe&title=Inhibition+of+PDK-1+activity+causes+a+reduction+in+cell+proliferation+and+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 3-phosphoinositide-dependent kinase-1 activity causes a reduction in cell proliferation and survival in human glioblastoma cells</span></div><div class="casAuthors">Flynn, P.; Wong, M.; Zavar, M.; Dean, N. M.; Stokoe, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1439-1442</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">3-Phosphoinositide-dependent kinase-1 (PDK-1) was identified by its ability to phosphorylate and activate protein kinase B (PKB) in vitro and can phosphorylate and activate addnl. protein kinases in the AGC family in vitro.  Its role in vivo has, however, only begun to be addressed.  We used antisense oligonucleotides directed against PDK-1 expression to explore the role of PDK-1 in human glioblastoma cells (U87-MG), which express a mutant PTEN allele.  Redn. in PDK-1 levels resulted in inhibition of PKB activity, and a redn. in phosphorylation on Thr308 and Ser473 of PKB.  P70 S6 kinase (p70SK) activity was also reduced.  Cell proliferation was dramatically inhibited following treatment with PDK-1 antisense oligonucleotides, due to a combination of decreased cell doubling and an increase in apoptosis.  This is in contrast to direct inhibition of phosphoinositide 3-OH kinase (PI 3-kinase), which results in G1 arrest with no effect on apoptosis.  This study confirms both PKB and p70S6K as in vivo substrates for PDK-1.  The effect of acute PDK-1 loss on cell proliferation and survival suggests the involvement of PI 3-kinase dependent and independent signaling events, and implicates PDK-1 as a potential therapeutic target for human neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqezSgKGu1ot7Vg90H21EOLACvtfcHk0ljdt27X7z08jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlGisLo%253D&md5=864fc5bc85e157be3422306fd6d1afa6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2800%2900801-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252800%252900801-0%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DZavar%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DN.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520PDK-1%2520activity%2520causes%2520a%2520reduction%2520in%2520cell%2520proliferation%2520and%2520survival%26jtitle%3DCurr.%2520Biol.%26date%3D2000%26volume%3D10%26spage%3D1439%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Iorns, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Parallel RNAi and compound screens identify the PDK1 pathway for tamoxifen sensitization</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2009&pages=361-370&author=E.+Iornsauthor=C.+J.+Lordauthor=A.+Ashworth&title=Parallel+RNAi+and+compound+screens+identify+the+PDK1+pathway+for+tamoxifen+sensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIorns%26aufirst%3DE.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DParallel%2520RNAi%2520and%2520compound%2520screens%2520identify%2520the%2520PDK1%2520pathway%2520for%2520tamoxifen%2520sensitization%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D417%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tamgüney, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span> </span><span class="NLM_article-title">Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2Fj.yexcr.2008.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=18514190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A280%3ADC%252BD1czpvFCktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2008&pages=2299-2312&author=T.+Tamg%C3%BCneyauthor=C.+Zhangauthor=D.+Fiederauthor=K.+Shokatauthor=D.+Stokoe&title=Analysis+of+3-phosphoinositide-dependent+kinase-1+signaling+and+function+in+ES+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells</span></div><div class="casAuthors">Tamguney Tanja; Zhang Chao; Fiedler Dorothea; Shokat Kevan; Stokoe David</div><div class="citationInfo"><span class="NLM_cas:title">Experimental cell research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2299-312</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">3-phosphoinositide-dependent kinase-1 (PDK1) phosphorylates and activates several kinases in the cAMP-dependent, cGMP-dependent and protein kinase C (AGC) family.  Many putative PDK1 substrates have been identified, but have not been analyzed following transient and specific inhibition of PDK1 activity.  Here, we demonstrate that a previously characterized PDK1 inhibitor, BX-795, shows biological effects that are not consistent with PDK1 inhibition.  Therefore, we describe the creation and characterization of a PDK1 mutant, L159G, which can bind inhibitor analogues containing bulky groups that hinder access to the ATP binding pocket of wild type (WT) kinases.  When expressed in PDK1(-/-) ES cells, PDK1 L159G restored phosphorylation of PDK1 targets known to be hypophosphorylated in these cells.  Screening of multiple inhibitor analogues showed that 1-NM-PP1 and 3,4-DMB-PP1 optimally inhibited the phosphorylation of PDK1 targets in PDK1(-/-) ES cells expressing PDK1 L159G but not WT PDK1.  These compounds confirmed previously assumed PDK1 substrates, but revealed distinct dephosphorylation kinetics.  While PDK1 inhibition had little effect on cell growth, it sensitized cells to apoptotic stimuli.  Furthermore, PDK1 loss abolished growth of allograft tumors.  Taken together we describe a model system that allows for acute and reversible inhibition of PDK1 in cells, to probe biochemical and biological consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQh3Amc1EGikudfST00W0BcfW6udTcc2ebBDPq7ftzRZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czpvFCktg%253D%253D&md5=c599aebb40c985a56df5133423dd89de</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2008.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2008.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DTamg%25C3%25BCney%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DFieder%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%26aulast%3DStokoe%26aufirst%3DD.%26atitle%3DAnalysis%2520of%25203-phosphoinositide-dependent%2520kinase-1%2520signaling%2520and%2520function%2520in%2520ES%2520cells%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2008%26volume%3D314%26spage%3D2299%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banfi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casuscelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccotto, F.</span><span> </span><span class="NLM_article-title">Structure-based optimization of potent PDK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4095-4099&author=M.+Angioliniauthor=P.+Banfiauthor=E.+Casaleauthor=F.+Casuscelliauthor=C.+Fiorelliauthor=M.+B.+Saccardoauthor=M.+Silvagniauthor=F.+Zuccotto&title=Structure-based+optimization+of+potent+PDK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DBanfi%26aufirst%3DP.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCasuscelli%26aufirst%3DF.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DSilvagni%26aufirst%3DM.%26aulast%3DZuccotto%26aufirst%3DF.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%2520PDK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4095%26epage%3D4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nittoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingalls, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[<i>c</i>]naphthyridin-4-ylamines as potent inhinitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1379</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1379-1386&author=T.+Nittoliauthor=R.+G.+Dushinauthor=C.+Ingallsauthor=K.+Cheungauthor=M.+B.+Floydauthor=H.+Fraserauthor=A.+Ollandauthor=Y.+Huauthor=G.+Grosuauthor=X.+Hanauthor=K.+Arndtauthor=B.+Guoauthor=A.+Wissner&title=The+identification+of+8%2C9-dimethoxy-5-%282-aminoalkoxy-pyridin-3-yl%29-benzo%5Bc%5Dnaphthyridin-4-ylamines+as+potent+inhinitors+of+3-phosphoinositide-dependent+kinase-1+%28PDK-1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNittoli%26aufirst%3DT.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DIngalls%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DFraser%26aufirst%3DH.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGrosu%26aufirst%3DG.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DThe%2520identification%2520of%25208%252C9-dimethoxy-5-%25282-aminoalkoxy-pyridin-3-yl%2529-benzo%255Bc%255Dnaphthyridin-4-ylamines%2520as%2520potent%2520inhinitors%2520of%25203-phosphoinositide-dependent%2520kinase-1%2520%2528PDK-1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1379%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Barile, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riel-Mehan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Structure−Activity Relationships of 3-Ethynyl-1<i>H</i>-indazoles as Inhibitors of the Phosphatidylinositol 3-Kinase Signaling Pathway</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8368</span><span class="NLM_x">–</span> <span class="NLM_lpage">8375</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100825h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8368-8375&author=E.+Barileauthor=S.+K.+Deauthor=C.+B.+Carlsonauthor=V.+Chenauthor=C.+Knutzenauthor=M.+Riel-Mehanauthor=L.+Yangauthor=R.+Dahlauthor=G.+Chiangauthor=M.+Pellecchia&title=Design%2C+Synthesis%2C+and+Structure%E2%88%92Activity+Relationships+of+3-Ethynyl-1H-indazoles+as+Inhibitors+of+the+Phosphatidylinositol+3-Kinase+Signaling+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm100825h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100825h%26sid%3Dliteratum%253Aachs%26aulast%3DBarile%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DS.%2BK.%26aulast%3DCarlson%26aufirst%3DC.%2BB.%26aulast%3DChen%26aufirst%3DV.%26aulast%3DKnutzen%26aufirst%3DC.%26aulast%3DRiel-Mehan%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DChiang%26aufirst%3DG.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%2520of%25203-Ethynyl-1H-indazoles%2520as%2520Inhibitors%2520of%2520the%2520Phosphatidylinositol%25203-Kinase%2520Signaling%2520Pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8368%26epage%3D8375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span> </span><span class="NLM_article-title">Benzo[<i>c</i>][2,7]naphthyridines as inhibitors of PDK-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5225</span><span class="NLM_x">–</span> <span class="NLM_lpage">5228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5225-5228&author=K.+H.+Kimauthor=A.+Wissnerauthor=M.+B.+Floydauthor=H.+L.+Fraserauthor=Y.+D.+Wangauthor=R.+G.+Dushinauthor=Y.+Huauthor=A.+Ollandauthor=B.+Guoauthor=K.+Arndt&title=Benzo%5Bc%5D%5B2%2C7%5Dnaphthyridines+as+inhibitors+of+PDK-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DFraser%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BD.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DArndt%26aufirst%3DK.%26atitle%3DBenzo%255Bc%255D%255B2%252C7%255Dnaphthyridines%2520as%2520inhibitors%2520of%2520PDK-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5225%26epage%3D5228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Echeverría, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garc%C3%ADa-Echeverr%C3%ADa&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of PDK1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1810</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1810-1838&author=C.+Peiferauthor=D.+R.+Alessi&title=Small-Molecule+Inhibitors+of+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520PDK1%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1810%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campobasso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span> </span><span class="NLM_article-title">Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100136n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=439-442&author=J.+R.+Medinaauthor=C.+W.+Blackledgeauthor=D.+A.+Heerdingauthor=N.+Campobassoauthor=P.+Wardauthor=J.+Briandauthor=L.+Wrightauthor=J.+M.+Axten&title=Aminoindazole+PDK1+Inhibitors%3A+A+Case+Study+in+Fragment-Based+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml100136n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100136n%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DBlackledge%26aufirst%3DC.%2BW.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DBriand%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26atitle%3DAminoindazole%2520PDK1%2520Inhibitors%253A%2520A%2520Case%2520Study%2520in%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D439%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Lapuyade, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlewer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermuth, C. G.</span><span> </span><span class="NLM_article-title">Synthesis and conformation analysis of methyl- and phenyl substituted nipecotic acid</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=663-668&author=G.+Lapuyadeauthor=G.+Schlewerauthor=C.+G.+Wermuth&title=Synthesis+and+conformation+analysis+of+methyl-+and+phenyl+substituted+nipecotic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLapuyade%26aufirst%3DG.%26aulast%3DSchlewer%26aufirst%3DG.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26atitle%3DSynthesis%2520and%2520conformation%2520analysis%2520of%2520methyl-%2520and%2520phenyl%2520substituted%2520nipecotic%2520acid%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1986%26spage%3D663%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">The absolute configuration was determined later from the X-ray crystal structure of the final compound (<b>3<i>S</i></b>,<b>6<i>R</i></b>)-<b>28a</b> bound to PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Breuning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winnacker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, M.</span><span> </span><span class="NLM_article-title">Efficient One-Pot Synthesis of Enantiomerically Pure 2-(hydroxymethyl)-morpholines</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2100-2106&author=M.+Breuningauthor=M.+Winnackerauthor=M.+Steiner&title=Efficient+One-Pot+Synthesis+of+Enantiomerically+Pure+2-%28hydroxymethyl%29-morpholines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreuning%26aufirst%3DM.%26aulast%3DWinnacker%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DM.%26atitle%3DEfficient%2520One-Pot%2520Synthesis%2520of%2520Enantiomerically%2520Pure%25202-%2528hydroxymethyl%2529-morpholines%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26spage%3D2100%26epage%3D2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabowski, E. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J. A</span><span> </span><span class="NLM_article-title">Novel Chromium Trioxide Catalyzed Oxidation of Primary Alcohols to the Carboxylic Acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5323</span><span class="NLM_x">–</span> <span class="NLM_lpage">5326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=5323-5326&author=M.+Zhaoauthor=J.+Liauthor=Z.+Songauthor=R.+Desmondauthor=D.+M.+Tschaenauthor=E.+J.+J.+Grabowskiauthor=P.+J.+A+Reider&title=Novel+Chromium+Trioxide+Catalyzed+Oxidation+of+Primary+Alcohols+to+the+Carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DDesmond%26aufirst%3DR.%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DGrabowski%26aufirst%3DE.%2BJ.%2BJ.%26aulast%3DReider%26aufirst%3DP.%2BJ.%2BA%26atitle%3DNovel%2520Chromium%2520Trioxide%2520Catalyzed%2520Oxidation%2520of%2520Primary%2520Alcohols%2520to%2520the%2520Carboxylic%2520Acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D5323%26epage%3D5326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margarita, R.</span><span> </span><span class="NLM_article-title">1,3-Asymmetric Induction in Dianionic Allylation Reactions of Amino Acid Derivatives—Synthesis of Functionally Useful Enantiopure Glutamates, Pipecolates and Pyroglutamates</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">–</span> <span class="NLM_lpage">5890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=5887-5890&author=S.+Hanessianauthor=R.+Margarita&title=1%2C3-Asymmetric+Induction+in+Dianionic+Allylation+Reactions+of+Amino+Acid+Derivatives%E2%80%94Synthesis+of+Functionally+Useful+Enantiopure+Glutamates%2C+Pipecolates+and+Pyroglutamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DMargarita%26aufirst%3DR.%26atitle%3D1%252C3-Asymmetric%2520Induction%2520in%2520Dianionic%2520Allylation%2520Reactions%2520of%2520Amino%2520Acid%2520Derivatives%25E2%2580%2594Synthesis%2520of%2520Functionally%2520Useful%2520Enantiopure%2520Glutamates%252C%2520Pipecolates%2520and%2520Pyroglutamates%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D5887%26epage%3D5890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ardá, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soengas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrígues, J.</span><span> </span><span class="NLM_article-title">Total Synthesis of (−)-Dysithiazolamide</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2178</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol800551g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=2175-2178&author=A.+Ard%C3%A1author=R.+G.+Soengasauthor=M.+I.+Nietoauthor=C.+Jim%C3%A9nezauthor=J.+Rodr%C3%ADgues&title=Total+Synthesis+of+%28%E2%88%92%29-Dysithiazolamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fol800551g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800551g%26sid%3Dliteratum%253Aachs%26aulast%3DArd%25C3%25A1%26aufirst%3DA.%26aulast%3DSoengas%26aufirst%3DR.%2BG.%26aulast%3DNieto%26aufirst%3DM.%2BI.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADgues%26aufirst%3DJ.%26atitle%3DTotal%2520Synthesis%2520of%2520%2528%25E2%2588%2592%2529-Dysithiazolamide%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D2175%26epage%3D2178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gerwick, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, C. L.</span><span> </span><span class="NLM_article-title">[6-<sup>13</sup>C]-(2<i>S</i>,4<i>S</i>)-5-Chloroleucine: synthesis and incubation studies with cultures of the cyanobacterium, <i>Lyngbya majuscula</i></span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=285-288&author=W.+H.+Gerwickauthor=P.+Leslieauthor=G.+C.+Longauthor=B.+L.+Marquezauthor=C.+L.+Willis&title=%5B6-13C%5D-%282S%2C4S%29-5-Chloroleucine%3A+synthesis+and+incubation+studies+with+cultures+of+the+cyanobacterium%2C+Lyngbya+majuscula"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26aulast%3DLeslie%26aufirst%3DP.%26aulast%3DLong%26aufirst%3DG.%2BC.%26aulast%3DMarquez%26aufirst%3DB.%2BL.%26aulast%3DWillis%26aufirst%3DC.%2BL.%26atitle%3D%255B6-13C%255D-%25282S%252C4S%2529-5-Chloroleucine%253A%2520synthesis%2520and%2520incubation%2520studies%2520with%2520cultures%2520of%2520the%2520cyanobacterium%252C%2520Lyngbya%2520majuscula%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D285%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, J. T.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+T.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2eYHeS0XYESwTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><div class="note"><p class="first last">LE defined as Δ<i>G/N</i><sub>nonhydrogen atoms</sub>, where <i>G</i> ≈ −<i>RT</i> ln IC<sub>50</sub></p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=23484756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for effective drug discovery</span></div><div class="casAuthors">Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-488</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Successful drug discovery requires the optimization of a large no. of variables ranging from strictly physicochem. parameters such as mol. wt. to more complex parameters related to toxicity and bioavailability.  Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclin. characterization.  However, crit. biol. issues along the path to the market have diminished the impact and power of this methodol.  The physicochem. properties of the novel chem. entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate.  The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process.  More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be discussed in the broader context.  Preliminary results and trends obtained using ligand efficiencies as guides are reviewed and their future application to guide drug discovery will be discussed, as well as their integration into the structure-based drug design methods to make them more effective and numerically robust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKduo41JcS7Vg90H21EOLACvtfcHk0lgUOKu1N20pDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D&md5=a1682fbc4545d8eab3a44417c0e88869</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D469%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Johnson, F.</span><span> </span><span class="NLM_article-title">Allylic Strain in Six-Membered Rings</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60254a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1968&pages=375-413&author=F.+Johnson&title=Allylic+Strain+in+Six-Membered+Rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr60254a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60254a001%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DF.%26atitle%3DAllylic%2520Strain%2520in%2520Six-Membered%2520Rings%26jtitle%3DChem.%2520Rev.%26date%3D1968%26volume%3D68%26spage%3D375%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">For a more detailed study on the effect GSK2334470 has on PDK1 signaling at the cellular level, see: </p></div><span class="NLM_contrib-group">Najafov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeYoung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">433</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2010&pages=357-369&author=A.+Najafovauthor=E.+M.+Sommerauthor=J.+M.+Axtenauthor=M.+P.+DeYoungauthor=D.+R.+Alessi&title=Characterization+of+GSK2334470%2C+a+novel+and+highly+specific+inhibitor+of+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNajafov%26aufirst%3DA.%26aulast%3DSommer%26aufirst%3DE.%2BM.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DDeYoung%26aufirst%3DM.%2BP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520GSK2334470%252C%2520a%2520novel%2520and%2520highly%2520specific%2520inhibitor%2520of%2520PDK1%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D433%26spage%3D357%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pearn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darley, R. L.</span><span> </span><span class="NLM_article-title">The role of PKC and PDK1 in monocyte lineage specification by RAS</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">4461</span><span class="NLM_x">–</span> <span class="NLM_lpage">4469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=4461-4469&author=L.+Pearnauthor=J.+Fisherauthor=A.+K.+Burnettauthor=R.+L.+Darley&title=The+role+of+PKC+and+PDK1+in+monocyte+lineage+specification+by+RAS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPearn%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DJ.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DDarley%26aufirst%3DR.%2BL.%26atitle%3DThe%2520role%2520of%2520PKC%2520and%2520PDK1%2520in%2520monocyte%2520lineage%2520specification%2520by%2520RAS%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D4461%26epage%3D4469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">GSK2334470 showed submicromolar antiproliferative activity against 29 cell lines from a panel of ∼300 cancer cell lines, although very few cell lines of epithelial origin were sensitive</p></div><span class="NLM_contrib-group">Axten, J. M.; Medina, J. R.; Shu, A.; Li, W.; Feng, Y.; DeYoung, M. P.; Gardiner, C. M.; Chadderton, A. R.; Dumble, M.; Liu, Q.; Rabindran, S. K.</span><span> </span><span class="NLM_article-title">GSK2334470: A Potent and Highly Selective Inhibitor of PDK1</span>. <span class="NLM_conf-name">AACR 101st Annual Meeting</span>, <span class="NLM_conf-loc">Washington DC</span>, <span class="NLM_conf-date">April 17−21, 2010</span>, <div class="note"><p class="first last">Abstract LB-116</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GSK2334470+showed+submicromolar+antiproliferative+activity+against+29+cell+lines+from+a+panel+of+%E2%88%BC300+cancer+cell+lines%2C+although+very+few+cell+lines+of+epithelial+origin+were+sensitiveAxten%2C+J.+M.%3B+Medina%2C+J.+R.%3B+Shu%2C+A.%3B+Li%2C+W.%3B+Feng%2C+Y.%3B+DeYoung%2C+M.+P.%3B+Gardiner%2C+C.+M.%3B+Chadderton%2C+A.+R.%3B+Dumble%2C+M.%3B+Liu%2C+Q.%3B+Rabindran%2C+S.+K.+GSK2334470%3A+A+Potent+and+Highly+Selective+Inhibitor+of+PDK1.+AACR+101st+Annual+Meeting%2C+Washington+DC%2C+April+17%E2%88%9221%2C+2010%2C+Abstract+LB-116."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26atitle%3DGSK2334470%253A%2520A%2520Potent%2520and%2520Highly%2520Selective%2520Inhibitor%2520of%2520PDK1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Millipore Research and Development.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Fjm101527u&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Fjm101527u&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lhP0wjiywXYKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liao, J. J.-L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm101527u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.-L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lhP0wjiywXYKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.-L.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">For recent biology studies investigating the effect of PDK1 inhibition on PTEN-deficient tumours, see:</p></div><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwanami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">Striking the balance between PTEN and PDK1: it all depends on the cell context</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1699-1704&author=A.+Iwanamiauthor=T.+F.+Cloughesyauthor=P.+S.+Mischel&title=Striking+the+balance+between+PTEN+and+PDK1%3A+it+all+depends+on+the+cell+context"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwanami%26aufirst%3DA.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DStriking%2520the%2520balance%2520between%2520PTEN%2520and%2520PDK1%253A%2520it%2520all%2520depends%2520on%2520the%2520cell%2520context%26jtitle%3DGenes%2520Dev.%26date%3D2009%26volume%3D23%26spage%3D1699%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Finlay, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feijoo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagenbeek, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spits, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, D. A.</span><span> </span><span class="NLM_article-title">Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=2441-2454&author=D.+K.+Finlayauthor=L.+V.+Sinclairauthor=C.+Feijooauthor=C.+M.+Waughauthor=T.+J.+Hagenbeekauthor=H.+Spitsauthor=D.+A.+Cantrell&title=Phosphoinositide-dependent+kinase+1+controls+migration+and+malignant+transformation+but+not+cell+growth+and+proliferation+in+PTEN-null+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DD.%2BK.%26aulast%3DSinclair%26aufirst%3DL.%2BV.%26aulast%3DFeijoo%26aufirst%3DC.%26aulast%3DWaugh%26aufirst%3DC.%2BM.%26aulast%3DHagenbeek%26aufirst%3DT.%2BJ.%26aulast%3DSpits%26aufirst%3DH.%26aulast%3DCantrell%26aufirst%3DD.%2BA.%26atitle%3DPhosphoinositide-dependent%2520kinase%25201%2520controls%2520migration%2520and%2520malignant%2520transformation%2520but%2520not%2520cell%2520growth%2520and%2520proliferation%2520in%2520PTEN-null%2520lymphocytes%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2009%26volume%3D206%26spage%3D2441%26epage%3D2454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCQ','PDB','3QCQ'); return false;">PDB: 3QCQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCS','PDB','3QCS'); return false;">PDB: 3QCS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCX','PDB','3QCX'); return false;">PDB: 3QCX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QCY','PDB','3QCY'); return false;">PDB: 3QCY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD0','PDB','3QD0'); return false;">PDB: 3QD0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD3','PDB','3QD3'); return false;">PDB: 3QD3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QD4','PDB','3QD4'); return false;">PDB: 3QD4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NUN','PDB','3NUN'); return false;">PDB: 3NUN</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101527u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-6%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm101527u%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101527u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b78012a013dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
